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Abstract
Modelling the Evolution of HIV-1 Protein-Coding Sequences with Particular
Focus on the Early Stages of Infection
Natasha Thandi Wood, February 2010
The evolution of the viral genome sequence over the course of HIV-1 infection is of
interest for vaccine and drug design, and for the development of effective treatment strategies.
Characteristics of the transmitted viral genome that could render the virus more sensitive
to host immune responses, are of particular interest for vaccine studies. However, sequence
samples from the earliest phase of HIV infection are scarce, and inferences about the nature
of the infecting virus and its evolution during the course of early infection are often made
from samples isolated from later stages, or from chronic infections.
To establish in detail the adaptive changes that occur in early infection, an investigation
was carried out on a large dataset consisting of sequences isolated from individuals in early
infection. The majority of these infections were inferred to have resulted from transmission
of a single virion or virally infected cell, which permitted a detailed investigation of HIV-1
diversification in early infection for the first time. Comparing viral diversification across
multiple patients, it was possible to identify specific evolutionary patterns in the HIV-1
genome that occur frequently during the earliest stages of infection. The analyses revealed
that APOBEC-mediated hypermutation has an important role in early viral diversification
and may enable rapid escape from the first wave of host immune responses. Several mutations
in early infection that were likely to result in immune escape were identified, some of which
have subsequently been confirmed experimentally. In general, experimental verification of
model-based inferences is necessary, but can be expensive and time-consuming. To reduce
the costs involved, it is essential that the evolutionary methods produce accurate results.
Simulation results presented in this thesis show that inferences made about viral evolution
can be subject to bias when key aspects of viral biology are not accounted for by the
models used. In particular, some previous comparisons between sequence groups that share
genealogical histories, positive selection studies that fail to account for recombination, and
research on HIV covariation, may need to be revisited, using more accurate evolutionary
models.
The results presented in this thesis demonstrate the importance of accurate evolutionary
models to understand the selection pressures acting on the virus during various stages of
infection. Furthermore, using a phylogenetic model it was possible to identify sites in the
HIV genome that were evolving adaptively and are implicated in CTL immune escape during
early infection. Characterising escape mutations in the transmitted virus may lead to novel
approaches to develop vaccines and antiviral drugs.
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Introduction
The human immunodeficiency virus (HIV) genome is extremely variable, and high levels of
recombination further contribute to the number of different forms of the virus currently circu-
lating in the human population. The degree of sequence heterogeneity is of interest for drug
and vaccine design since anti-HIV drugs or vaccine-induced immune responses commonly
recognise particular amino acid patterns., and broad effectivity depends on the sequence
similarity across multiple viral subtypes. The characteristics of the virus around the time of
transmission are of particular interest for vaccine and drug development. However, investi-
gations of the sequences of transmitted viruses have been hampered by the lack of available
sequence data. HIV samples from the later stages of infection are, therefore, investigated
more frequently, and various computational methods have been developed to identify spe-
cific characteristics that play a role in viral fitness. These evolutionary approaches are often
aimed at modelling the changes that occur along the phylogenetic tree relating the sequences
of viral variants. Models of sequence evolution rely on a number of assumptions, for exam-
ple the absence of recombination, and violation of these assumptions can lead to unreliable
results. This thesis explores the diversification of HIV, with particular focus on the early
stages of infection and the context under which various evolutionary models are applied.
Chapter 1 describes the general background of both HIV and models of adaptive sequence
evolution, and is aimed at presenting an overview of viral features and modelling approaches
that are further investigated in the subsequent chapters. The first section provides a back-
ground to evolutionary analysis and to models of protein-coding sequence evolution. Com-
mon approaches for detecting positive Darwinian selection, and caveats that may bias the
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inference of selection, are also discussed. The second half of the chapter describes the HIV
genome, the viral life cycle and the different phases of infection. It also covers HIV genome
features that are targeted by anti-HIV drugs and the human immune response to HIV in-
fection, illustrating the challenges for effective drug and vaccine design.
Chapter 2 presents an approach to identify the founder virus responsible for productive HIV
infection in a new host. The work carried out in Chapter 2 and 3 forms part of a collaboration
through CHAVI (Center for HIV/AIDS Vaccine Immunology) . These international collab-
orative studies were aimed at describing the transmitted virus and identifying the selection
pressures present during the earliest stages of infection. In Chapter 2 coalescent-based meth-
ods and the use of Bayesian coalescent simulations together with a relaxed molecular clock to
estimate various population parameters, are first described. The software package BEAST
(Bayesian Evolutionary Analysis Sampling Trees) is then applied to a large collection of
HIV datasets derived from sequencing samples isolated from patients in the earliest stages
of infection. The aim was to estimate the time to most recent common ancestor (tMRCA)
for each individual patient, and, thereby, to classify HIV-1 infections as consistent with ho-
mogeneous (if the tMRCA was shorter than the infection time estimated from clinical data)
or heterogeneous infection (if the tMRCA was longer than the clinically estimated duration
of infection).
In Chapter 3, sequences from the HIV-1 subtype B infections that were inferred to represent
homogeneous infections were further investigated. The availability of multiple homogeneous
early infection datasets created the opportunity to evaluate the selection pressures present
at the point of transmission and during early infection. A method that incorporates the
data from all homogeneous infections is described, and was used to establish whether the
virus evolves adaptively in early infection. In this way, specific amino acid sites that are
evolving under positive selection can be identified, and through experimental evaluation it
was possible to establish whether these sites are implicated in viral escape from the immune
system. Furthermore, the impact of APOBEC-mediated hypermutation is explored, and the
extent to which the data relates to the notion that reduced Env variable loop lengths are a
feature of transmission, is discussed.
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Chapter 4 expands upon the hypothesis that the length of the envelope variable loops is
implicated in a transmission bottleneck. The degree to which sequences with shared genetic
history may bias the experiments aimed at describing the association between Env loop
lengths and transmission, is investigated by carrying out a simulation study. A novel method
that accounts for the shared sequence history is then described. This approach is used
to re-evaluate the results from a previous study that applied a method dependent on the
phylogenetic tree relating the sequences.
Chapter 5 and chapter 6 investigate the application of codon models to HIV-1 evolution more
generally, and not necessarily in the context of early infection. The focus of these chapters
is on biases that can affect phylogenetic models of HIV-1 evolution and on the reanalysis
of previously published studies, using methods to correct these biases. The extent to which
recombination has affected the inference of positive selection in HIV sequence datasets is re-
evaluated. Chapter 5 describes features of HIV-1 evolution , for example recombination and
overlapping coding regions, that can cause a high rate of false positive inference of positive
Darwinian selection. The results of a number of previous studies of adaptive evolution in
HIV-1 protein-coding genes are re-evaluated using methods that account for these biases.
Chapter 6 describes the covarion model of sequence evolution where switching between rate
classes is allowed. Simulation studies are carried out to determine whether sequence datasets
that fit the covarion model of sequence evolution better than the M2a null model, are an
artifact of under-fitting of the distribution of rate classes in the null model. The last section
of the chapter focuses on the zoonotic event where SIV crossed the species barrier to humans.
Ancestral sequences of a collection of SIV and HIV-1 group M sequences are reconstructed,
and the sites where switching between rate classes are implicated, are identified. The premise
for carrying out this analyses is that sites where selective pressures change along the branch
leading to HIV-1 descendent sequences, may be associated with specific adaptation within
the new host.
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Chapter 1
Background
1.1 Methods of Evolutionary Analysis
1.1.1 Introduction to Molecular Evolution and Phylogenetics
The theory of evolution has enjoyed renewed attention with the 200th celebration of Charles
Darwin’s birthday and the 150th anniversary of Darwin’s book On the Origin of Species
(Darwin, 1859). Since the initial understanding of evolution, which included ideas regarding
the role of pure chance and natural selection (Koonin, 2009), evolutionary analysis has
progressed substantially. The progress in computer design and subsequent availability of
processing power, the abundance of diverse genomic data, and the development of powerful
tools has allowed scientists to re-create lost genetic information and explain the forces that
dictate the complex life-forms that exist today.
Researchers in the field of molecular evolution endeavour to understand the changes that
render descendants functionally and morphologically different from their predecessors. They
are interested in the underlying mechanisms that gave rise to the physical features which
define the variation between and within species (Pevsner, 2003). These efforts were benefited
significantly by the development of PCR (Mullis et al., 1986), which assured an abundance of
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easily-obtainable samples of nucleotide sequence data, and DNA sequencing, which provided
means to compare the organisation of genomes within and between species.
Phylogenetic trees are commonly used to represent the shared history of a set of DNA
sequences. Genes, made from the four-character DNA alphabet (nitrogen bases: adenine
“A”, cytosine “C”, guanine “G”, and thymine “T”), are transmitted from one generation
to the next, during which they can undergo numerous changes in their DNA architecture.
These changes are reflected in the resulting genealogy, where coalescent events occur at
the nodes and sequence changes occur along the branches of the tree. The relationship
and difference (distance) between two sequences is apparent from the tree structure. Long
branches represent large differences in base composition, whereas short branches indicate
limited variation between the parental gene copy and that of its offspring (Galtier et al.,
2005).
Different tree-building methods have been developed to illustrate the relationship between
different sequences. Two of the main approaches were distance- and character-based meth-
ods. Distance-based methods are fast and straightforward, and include UPGMA (unweighted
pair group method with arithmic mean) and the Neighbour-joining (NJ) methods. Character
based methods include maximum parsimony (MP) and maximum likelihood (ML) methods.
Parsimony analysis provides the most parsimonious tree, which describes the sequence rela-
tionships with the minimum number of character changes that would result in the observed
differences. Maximum likelihood methods on the other hand, produce the tree with the high-
est probability of resulting in the observed differences (Pevsner, 2003). Maximum likelihood
methods were considered as early as the 1960s, although at the time the calculation was too
computationally complex, and simpler, approximate methods were used (Huelsenbeck and
Crandall, 1997).
Developments in computing power have allowed researchers to use maximum likelihood ap-
proaches to implement models of sequence evolution. In the genealogical sense, the likelihood
of a phylogeny can be defined as the probability of observing the data, given the specified
model parameters. In the maximum likelihood framework, the values that maximise the
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probability of the data are chosen (Huelsenbeck and Crandall, 1997). Although maximum
likelihood methods are computationally intensive, their flexibility and usefulness for hy-
pothesis testing, together with computational developments allowing faster run times, have
ensured that they are commonly used in evolutionary analysis.
Ancient molecular data is extremely sparse and researchers generally only have information
from existing organisms; therefore statistical inference is a central component of evolutionary
analysis (Nielsen, 2005). Various models of molecular sequence change exist, each with their
own underlying assumptions and applicable to specific genomes or genomic regions (Galtier
et al., 2005). These models attempt to describe the substitution process that occurred
along the branches of a phylogenetic tree. Evolutionary changes are commonly modelled
as Markov chains that are stochastic and memoryless, that is past states are irrelevant and
future processes are dependent only on the present state. Together with this mathematical
quality, a range of different biological constraints are also taken into consideration, resulting
in several distinct Markov models of sequence evolution (Yang, 2006; Galtier et al., 2005).
1.1.2 Probabilistic Models of DNA Substitution
The first DNA model was proposed by Jukes and Cantor in 1969 (Jukes and Cantor, 1969).
This one parameter model specifies equal base frequencies, i.e. piA= piC = piG = piT = 0.25, and
assumes that each base has an equal probability of changing to any of the other three bases.
However, this assumption is unrealistic since substitutions between bases do not occur at
the same rate. Two base classes are distinguished: the double ring purines A and G, and
the single ring pyrimidines C and T. Changes within purines or within pyrimidines, called
transitions, are more likely to occur than transversions, which refer to changes between
purines and pyrimidines (Klug and Cummings, 1999). Kimura’s subsequent two-parameter
model took the transition/transversion rate bias into account (Kimura, 1980). Following
these basic models, parameters that account for unequal base frequencies, models F81 and
HKY for example, were also included. (Felsenstein, 1981a; Hasegawa et al., 1985). The most
general reversible model that has 9 free parameters, is the GTR (General Time Reversible)
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or REV model (Tavaré, 1986). Two of the commonly used models are the HKY and GTR
models; the decision in favour of implementing either model depends largely on the size of
the dataset and not the specific biological attributes (Delport et al., 2009). As an example,
the GTR model of DNA substitution is shown below. The substitution rate matrix Q, with
stationary base frequencies Π = (pi1,pi2,pi3,pi4), is
Q = {qij} =
∗ x1 x2 x3
pi1x1
pi2
∗ x4 x5
pi1x2
pi3
pi2x4
pi3
∗ x6
pi1x3
pi4
pi2x5
pi4
pi3x6
pi4
∗
where the diagonal “ * ” characters represent the negative sum of the remaining values in
each row. The probability of nucleotide i being exchanged for nucleotide j, is the equal to
the probability of j being exchanged for i, and it follows that qijpii = qjipij. There are 9
free parameters in this model - 6 exchangeability parameters (x1..x6) and 3 free frequency
parameters (pii, where pi1 + pi2 + pi3 + pi4 = 1). The HKY model is a special case of the GTR
model with a single transition exchangeability parameter, and a separate transversion ex-
changeability parameter. The HKY model therefore has five parameters - 2 exchangeability
and 3 frequency parameters (Tavaré, 1986; Galtier et al., 2005). For smaller datasets the
HKY model, with fewer parameters, is more suitable, whereas larger datasets have a better
fit to the GTR model (Delport et al., 2009).
The early models assumed that all sites along a sequence are independent and identical,
which is unrealistic as spatial variation in the evolutionary rate occurs in almost all sequence
data (Yang, 1993, 1994). An alternative is to draw, at random, the value of the rate for
each site from a statistical distribution, a practice first introduced by Yang in 1993 (Yang,
1993). Variable rates are typically drawn from a discrete gamma distribution with a specified
number of categories, in order to allow for feasible computational times (Galtier et al., 2005;
Yang, 1994), and it is also common to allow for a proportion of sites in the sequence to
remain invariable. Generally, when the HKY model of DNA substitution is used together
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with a certain proportion of invariable sites and the remainder of rates drawn from a gamma
distribution, the model is indicated by HKY + I + Γ, where “I” refers to invariable sites
and “Γ” to the gamma distribution.
1.1.3 Models of Coding Sequence Evolution
The advances made in DNA and protein (the latter not discussed) substitution models al-
lowed for the further development of codon models that provide means of describing which
nucleotide mutations cause changes in protein expression. A DNA mutation does not nec-
essarily reflect a change in the structure or function of the associated protein since, due to
the degeneracy of the genetic code, two or more codons can express the same amino acid.
Codons ’CGC’ and ’CGA’ for example both encode Arginine, and a C↔A substitution at
the third codon position has no effect on the encoded protein. These changes are called
synonymous substitutions, as they are silent at the protein level. If, however, there is a
C→A substitution at the first position of codon ’CGC’, the resulting codon (’AGC’) en-
codes a different amino acid (Serine), which could have a marked effect on gene expression.
These changes are referred to as non-synonymous substitutions. Positive Darwinian selec-
tion occurs when alleles that are adaptively advantageous are selectively favoured. Positive
selection is often inferred when the non-synonymous substitution rate is significantly greater
than the synonymous substitution rate. Purifying selection refers to the case where delete-
rious mutations are selectively removed from the population, and can be inferred when the
synonymous substitution rate is significantly higher than the non-synonymous substitution
rate (Yang et al., 2000; Macbeth and Collinson, 2002; Hughes, 1999; Larson, 2006). Coding
DNA sequence data therefore provide additional information about evolution that is not
contained in non-coding DNA or protein sequence data.
The first models of codon evolution were described by Muse and Gaut (1994), and Goldman
and Yang (1994). These models account for the triplet nature of DNA and incorporated
parameters to address non-independence between sites (nucleotides within the same codon).
Codon models have an alphabet size of 61 (4 × (number of nucleotides)3 (word size) = 64,
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less the 3 stop codons) and are described by an instantaneous transition rate matrix, which
contains elements indicating the rate of change from codon i to codon j :
qij =

0 if i and j differ by more than one change,
pij for a synonymous transversion,
κpij for a synonymous transition,
ωpij for a nonsynonymous transversion,
ωκpij for a nonsynonymous transition.
where pij is the equilibrium frequency of either the target nucleotide or target codon, κ is the
transition/transversion rate ratio, and ω is the non-synonymous/synonymous substitution
rate ratio (dN/dS).
1.1.4 Identifying Positive Darwinian Selection
Omega (ω), the ratio of non-synonymous (dN ) to synonymous (dS) substitution rates, pro-
vides an important measure of the selection pressures acting on a protein-coding gene. The
(non)synonymous substitution rate is defined as the number of (non)synonymous substitu-
tions per (non)synonymous site. If a gene is evolving neutrally, then ω = 1, dN and dS
are equal, and all substitutions are fixed at the same rate. If ω < 1, the non-synonymous
substitutions are deleterious and there is a reduced fixation rate due to purifying selection
acting on the gene. A ω > 1 suggests that the non-synonymous substitutions are favoured,
which means that the non-synonymous substitutions are fixed at a higher rate than are the
synonymous substitutions (dN > dS). Positive Darwinian selection can be inferred when
the ratio of non-synonymous to synonymous substitution rates is significantly greater than
one (Martin et al., 1998; Yang, 1998; Anisimova et al., 2001; Suzuki and Nei, 2001; Galtier
et al., 2005; Yang, 2006).
Two types of codon models are commonly used, empirical and mechanistic codon models.
Empirical codon models do not consider differences in amino acid replacement rates that
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influence protein evolution beyond the distinction between synonymous and nonsynonymous
mutations and differences in nucleotide substitution rates. Since these matrices are large
and general evolutionary patterns are thought to be applicable across various datasets,
the parameter estimates are often determined once for a large dataset and subsequently
used again for further analysis of different data (Kosiol et al., 2007; Anisimova and Kosiol,
2009). The parameters of mechanistic codon models are however estimated for each dataset
independently. These models account for a range of evolutionary features, for example, the
frequencies of the observed nucleotides or codons (Schneider et al., 2005; Kosiol et al., 2007;
Anisimova and Kosiol, 2009).
The original codon models were used to estimate an average ω for all the amino acids in the
sequence over the entire evolutionary tree. Positive selection could therefore only be inferred
if on average ω > 1; an unlikely scenario given that large regions of protein sequences tend
to be subject to purifying selection due to functional and structural constraints, and positive
selection is likely to affect only a handful of amino acids at a limited number of time points.
The statistical power of the first codon models was therefore inadequate for detecting positive
selection in a wide-range of datasets (Yang et al., 2000). Yang et al. (2000) extended the
neutral and positive selection models described in 1998 (Nielsen and Yang, 1998) to allow
for heterogeneous ω ratios across sites (Yang et al., 2000). Various models were presented,
each assuming a unique distribution for ω.
The neutral model (M1) described by Yang et al. (2000) includes two rate classes, ω0 = 0
and ω1 = 1, with proportions p0 and p1 = p0 - 1, respectively. The selection model (M2)
allows for an additional class where ω2 > 1, with proportion p2 and requirement for p0 +
p1 + p2 = 1 (Yang et al., 2000; Nielsen and Yang, 1998; Wong et al., 2004). These models
were slightly adapted so as not to constrain ω0 = 0 but rather allow it to vary between 0
and 1, therefore 0 < ω0 < 1. The modified models (M1a and M2a) were shown to perform
better than the original M1 and M2 models (Wong et al., 2004).
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Model Comparison
The neutral and selection models can be used to detect whether protein-coding genes are
evolving under positive selection. Since the neutral model is a special case of the selection
model, a likelihood-ratio test (LRT) statistic can be used to determine which model provides
a better fit for the data. As with the M1a and M2a models, many of the evolutionary models
are nested within or special cases of another, more complex model; they differ only in the
number of estimated parameters. Likelihood-based methods provide means for comparing
the fit of two nested models. The LRT considers the likelihood (L0) of a dataset given the
null model (M0), compared to the likelihood (L1) of the same dataset given the alternative
hypothesis (M1). M0 is nested in M1 and the LRT is defined as
LRT = −2 log
(
max[L0(M0|Data)]
max[L1(M1|Data)]
)
This statistic is asymptotically X2 distributed under the null hypothesis, with the number
of degrees of freedom equal to the difference in number of free parameters between the two
models. Since the null model is a special case of the alternative model L0 must be less than
or equal to L1. The LRT permits evaluation of the log-likelihood increase brought about
by adding additional parameters to a model. A significant increase in log-likelihood would
result in the rejection of the null hypothesis. The general critical rejection level is 5%, or
a p-value of less than 0.05, which signifies that assuming the null hypothesis is true, the
probability of obtaining a result as extreme as the current one is less than 5%. Therefore,
the smaller the p-value, the safer it is to reject the null hypothesis in favour of the alternative
hypothesis (Buschbom and von Haeseler, 2005; Galtier et al., 2005).
Site-Specific Analysis of Selection
The likelihood-ratio test provides a means to evaluate whether there is evidence of sites
evolving under positive selection in a gene or other coding sequences. It does not, however,
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provide information on the selection pressure at specific sites in the alignment. This infor-
mation can be obtained by estimating posterior probabilities for each site belonging to a site
class, for example ω < 1, ω = 1 and ω > 1 in the case of M2a. If the posterior probability
for a site belonging to the ω > 1 class is high, the site is considered to be evolving under
positive selection. One approach to determine the selective pressures at particular sites is
to use the maximum likelihood estimates of the proportion of sites in each site class as prior
probabilities; these estimates are then used to calculate the posterior probabilities of a site
belonging to a specific site class, given the data at that site. This is called the Naive Empiri-
cal Bayes (NEB) approach. Since uncertainties in the estimated maximum likelihood values
are not accounted for, the subsequent posterior probabilities are dependent on the accuracy
of these parameter estimates. The NEB approach therefore relies heavily on the reliabil-
ity of the maximum likelihood estimates (Delport et al., 2009; Bielawski and Yang, 2005;
Kosakovsky-Pond and Muse, 2005). Further fully Bayesian alternatives to this approach
include a full Bayesian method using Markov Chain Monte Carlo (MCMC) to approximate
the posterior distribution (Huelsenbeck and Dyer, 2004; Delport et al., 2009; Scheﬄer and
Seoighe, 2005), and a method which takes uncertainties in the maximum likelihood estimates
into account by integrating over assigned priors for these parameters (hierarchical Bayes or
Bayes Empirical Bayes, BEB) (Yang et al., 2005; Delport et al., 2009).
The methods described above model site-to-site parameter variation using an approach
known as the random-effects likelihood (REL) model. REL assumes that the substitution
rates across sites are random values drawn from a given distribution (Llopart and Com-
eron, 2008; Delport et al., 2009). The alternative approach is to treat the parameters as
fixed, and as belonging to specific classes with distinct parameters. This is referred to as
the fixed-effects likelihood (FEL) model. Several site classes can be defined, even to the
extent of allowing each site in the sequence to be associated with an independent value
of ω. However, the latter scenario with the maximum number of site classes, requires the
estimation of a large number of parameters and therefore renders the model susceptible to
over-parameterisation (Delport et al., 2009). An advantage of the FEL approach is that the
degree to which the branch length parameters, synonymous and non-synonymous substitu-
tion rates, κ values (transition/transversion rate ratios), as well as codon frequencies, are
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shared across classes, can be defined prior to analysis. This saves a great deal of compu-
tational time and prevents potential convergence problems when estimating the maximum
likelihood values (Kosakovsky-Pond and Frost, 2005; Delport et al., 2009).
1.1.5 Violation of the Assumptions of Phylogenetic Models for
Detecting Positive Selection
All models, regardless of the complexity, input data, or computational requirements, make
certain assumptions. If these assumptions are violated the results are often meaningless.
One assumption that most phylogenetic models of sequence evolution make is the absence
of recombination. This means that a single phylogenetic tree is considered to represent the
relationship between all the taxa. However, when the linkage between sites is disrupted
by recombination, the single tree assumption does not hold since this results in several dis-
tinct phylogenetic trees describing the relationships between the taxa in different parts of
the sequence (Shriner et al., 2003). Recombination is known to occur in many organisms,
including viruses, and neglecting to account for recombination can result in a false positive
detection of positive selection (Anisimova et al., 2003; Shriner et al., 2003). Since sites found
to evolve under positive selection are thought to be important for viral escape from the im-
mune system, misidentification of adaptively evolving sites could have a negative impact on
drug design and vaccine development. In 2006, a robust method to detect positive Darwinian
selection called PARRIS (PARtitioning for the Robust Inference of Selection) was developed
that can be applied to recombining sequences (Scheﬄer et al., 2006). Preliminary analyses
indicated that the sites inferred to be evolving under positive selection in certain genes dif-
fered greatly when recombination was taken into account, and the authors recommend that
a method which screens for recombination should be mandatory in analyses of datasets, such
as HIV, where recombination is known to occur (Scheﬄer et al., 2006). Chapter 5 covers
the reanalysis, using PARRIS, of a collection of published HIV datasets for which positive
selection has been described previously.
The site-to-site synonymous substitution rate is often treated as a single parameter; the
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same, constant value is therefore shared over all the sites in the sequence (Delport et al.,
2009). Substantial synonymous substitution rate variation has, however, been shown to oc-
cur in RNA viruses as well as other coding sequences, including sperm lysin, β-globin, and
primate COXI (Hanada et al., 2004; Kosakovsky-Pond and Muse, 2005). Synonymous substi-
tution rate variation has specifically been identified in HIV (Lemey et al., 2005; Kosakovsky-
Pond and Muse, 2005; Ngandu et al., 2008). This feature could reflect a variation in the
mutation rate if the synonymous substitution rate is believed to approximate the neutral
rate of evolution, or could also indicate nucleotide-level selection pressures acting to retain
essential viral functions (Ngandu et al., 2008). Regardless of the underlying reason for the
synonymous substitution rate variation, if it is not accounted for by the model of coding
sequence evolution, then the comparison of dN and dS is invalid and the inference of selec-
tion may be incorrect (Kosakovsky-Pond and Muse, 2005; Ngandu et al., 2008). Allowing
site-to-site synonymous substitution rate variation is therefore an additional consideration
during selection analysis of protein-coding datasets.
A further source of bias is the non-independence between nucleotide sites. The non-independence
relates to both within codon nucleotides, where the triplet nature of the genetic code means
that individual sites do not evolve independently, as well as to nucleotides spread across
a genome. The latter case is harder to account for than within codon non-independence.
For HIV in particular, overlapping coding regions, cis-regulatory regions, potential N-linked
glycosylation sites and specific three-dimensional protein folding, contribute to the non-
independence between nucleotide sites (Stern and Pupko, 2006; Poon et al., 2007; Mayrose
et al., 2007), and these features violate evolutionary model assumptions in many cases. Se-
quence data from various sources are unlikely to fit any one evolutionary model perfectly.
Deciding on the most appropriate model, or adapting an existing model, is important for
obtaining meaningful selection results from evolutionary modelling.
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1.1.6 Covarion Models of Sequence Evolution
In certain contexts, for example when recombination has occurred between sequences, pos-
itive selection can be very hard to detect accurately (Scheﬄer et al., 2006). The general
comparison of the likelihoods between a model allowing sites to evolve under positive se-
lection (as well as neutrally and under purifying selection) and a model that only allows
neutral or purifying selection, is often not sufficient. The covarion approach is one extension
to the general method that allows for the detection of sites that may have been selected for
in only one part of the phylogeny, and where the signal for selection may be too weak and
would be missed if tested with the common approach (Huelsenbeck, 2002; Galtier, 2001).
As described, the traditional models of codon evolution allow different selective processes
at all the sites along a sequence (Nielsen and Yang, 1998; Yang et al., 2000). This allowed
for the development of evolutionary models that provided a more realistic representation
of sequence evolution. With these models, a site is found to be evolving under positive
selection if the average ω is greater than one over all lineages. Positive selection would
therefore not be detected if adaptive evolution took place in a short branch of the tree
and only affected a couple of protein sites. Nevertheless, averaging the variation in rate
over lineages was thought to be less of a concern than averaging the rates across sites. It
is, however, unrealistic to assume that the selection regime at a given position along the
sequence remains constant through time (Yang and Nielsen, 2002).
Covarion models of sequence evolution were developed to allow site-specific rate variation
among lineages. The first formal covarion model was described by Tuﬄey and Steel, where
a site could either vary (“on” state) or not (“off” state) (Tuﬄey and Steel, 1998). The
model was later extended by Huelsenbeck to allow among-site rate variation; each site was
therefore either invariable, or evolving at a rate drawn from a discrete gamma distribution
with a given number of rate classes (Figure 1.1, Huelsenbeck, 2002).
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Figure 1.1: Rate switching in the Huelsenbeck model. A site is either invariable (OFF) or is
allowed to vary according to a number of rate classes, ω1 – ω3. The probabilities of switching
from the ON to OFF state is pnf , and from the OFF to ON state pfn.
Another adaptation to the original model was implemented by Galtier in 2001. Here, a
proportion of sites evolve under the covarion model whereas the remainder do not (Figure
1.2). The site-specific rates of the latter sites (those not evolving under covarion evolution)
are drawn from a discrete gamma distribution and do not change over time. The rates for
the covarying sites are also drawn from this gamma distribution and fall into a given number
of rate classes, and covary, that is switch between rate classes, at a constant rate (Wang et
al., 2007).
Figure 1.2: Rate switching in the Galtier model. A proportion of sites are invariable (OFF)
and the remaining proportion is allowed to vary (ON). Site that fall within the ON class,
are allowed switch between a number of rate classes, ω1 – ω3, with equal probabilities.
These two models supplied means of obtaining an estimate of which, and how many, sites
are undergoing episodic adaptive evolution. Huelsenbeck and Galtier’s analyses provided
evidence that covariation was taking place and argued that the conventional models were
underestimating the degree and importance of positive selection (Huelsenbeck, 2002; Galtier,
2001). Despite the apparent value of covarion models of sequence evolution, they have been
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applied to only a limited extent in studies of molecular sequence evolution.
1.2 HIV/AIDS
1.2.1 A Brief History and Background of HIV/AIDS
Almost twenty-eight years after Michael Gottlieb described the symptoms of this immuno-
compromising disease amongst homosexual men (Gottlieb et al., 1981), the human immun-
odeficiency virus (HIV) continues to challenge scientists worldwide. An estimated 33 million
people were living with HIV in 2007; of this total, 50% were infected before they turned
25, and a significant majority of these individuals will die, or have died, before the age of
35 (UNAIDS, 2008). A global view of the HIV adult prevalence rates reveals how the low-
and middle-income countries are the hardest struck by this pandemic (Figure 1.3, UNAIDS,
2008).
Figure 1.3: A global view of HIV infection in 2007.
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1.2.2 The HIV Genome
HIV is part of the genus Lentivirus (of the Retroviridae family), and the RNA genome of
HIV-1 consists of 9 genes: gag, pol, env, tat, rev, vif, vpr, vpu, and nef (Levy, 2007). HIV-2
does not have vpu, but a further gene, vpx, is present. The main functions of each of the 9
HIV-1 proteins are shown in Table 1.1 (Levy, 2007; Kuiken et al., 2008). HIV-1 is thought
to have been transmitted from chimpanzees to humans, whereas HIV-2 is believed to have
crossed the species barrier from sooty mangabeys, found in Western Africa (Gao et al., 1999;
Newman et al., 2006). HIV-2 is less pathogenic and less prevalent than HIV-1 (Reeves and
Doms, 2002). Both HIV-1 and HIV-2 share tropism for T lymphocytes (key cells of the
human immune system), predominantly infecting CD4 T lymphocytes (helper cells) and
CD8 T lymphocytes (killer cells) respectively (Brites et al., 2009).
Table 1.1: The nine HIV-1 proteins and the main function(s) of each.
The genome size of HIV-1 is approximately 10kb, and a single virion is about 100nm in
diameter (Burmester et al., 2003). HIV-1 is divided into four groups, M, N, O, and P
(Plantier et al., 2009); group M consists of several different viral subtypes, including A1, A2,
B, C, D, F1, F2, G, H, J, and K. There are also continually increasing numbers of circulating
recombinant forms (CRFs), which are intersubtype recombinant viruses that have formed a
significant epidemic distribution (Robertson et al., 2000). The combined variability of CRFs
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add to the complexity of developing a broadly effective vaccine.. Furthermore, the genetic
differences between group M, N and O viruses can extend up to 30% in gag, and 50% in env
(Gao et al., 2005).
1.2.3 The HIV Life Cycle and Disease Progression
There are a number of steps that need to take place for HIV to infect a cell and reproduce.
The life cycle includes attachment of the virus to a CD4 receptor of an immune cell, fusion
in a pH independent manner, entry of the viral RNA and reverse transcription to produce a
DNA copy (cDNA) of the viral genome, integration of the cDNA into the host chromosomal
DNA, production of viral mRNA transcripts, translation to produce HIV proteins, assembly
of the viral proteins near the cell membrane, and finally budding of the new mature HIV
virus, which then ultimately attaches to another cell surface receptor, and so the cycle is
repeated. Through this process, millions of virions can be produced per day, destroying the
human immune system (Levy, 2007; Klimas et al., 2008).
HIV-1 infection, progression to disease, and finally AIDS follows a well established pattern
(Figure 1.41). Upon initial infection there is a significant drop in CD4 T cells, which are
the primary target of HIV-1 infection, until immune responses are able to control viral
replication and stabilisation occurs during which the number of viral RNA copies and CD4
cell count remains relatively stable. The asymptomatic period (Clinical Latency phase in
Figure 1.4) during which the viral load maintains a relatively steady state, is often referred
to as the viral set-point (Mei et al., 2008; Levy, 2007).
1Figure from http://en.wikipedia.org/wiki/HIV_infection
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Figure 1.4: HIV disease progression indicating the decline in CD4 T cell counts and steady
increase in HIV RNA copies.
The period between infection and AIDS differs vastly amongst infected individuals. Certain
individuals remain symptomless for over 20 years, whereas others can die within 2 years of
the original infection. Regardless of the duration of clinical latency during which an infected
person can appear completely healthy, once the immune response is no longer able to keep
viral replication in check, the progression to AIDS is inevitable without drug treatment.
Antiretroviral therapy is typically introduced when the CD4 count is less than 200 cells/mm3
(Klimas et al., 2008; Levy, 2007).
A classification method, which characterises the stage of HIV infection, is important for
inter-study comparative analysis and for identifying recently infected individuals for re-
search purposes. Such a classification method that uses different viral markers to define
disease stage, was described by Fiebig et al. in 2003. The stages are distinguished based
on laboratory evidence of the progressive appearance of viral markers, including viral RNA,
the presence of p24 antigen, and detecting anti-HIV antibodies (seroconversion), using en-
zyme immunoassays and Western blot. Data was obtained from serial plasma donors with a
median interval between donations of 4 days; the reactivity to the assays were highly consis-
tent among donors, which resulted in the classification of six primary HIV-1 infection stages
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(Table 1.22). As seen in Table 1.2, the antibody enzyme immunoassays (EIAs) were carried
out with both the second-generation indirect sandwich EIA, which is not IgM-sensitive, as
well as the IgM-sensitive third-generation HIV-1/HIV-2 antigen sandwich EIA (Fiebig et
al., 2003). A parametric Markov model was applied to the data in order to obtain estimates
of the duration of each stage, including the 95% confidence intervals (CIs) for the estimates
(Table 1.2).
Table 1.2: Classification of primary HIV infection based on laboratory assays, first described
by Fiebig et al. (2003). Positive (+) and negative (-) tests to the various assays are shown
in red.
The first four primary stages are very short and, on average, stage V is reached within a
month of the date of infection. No cut-off was defined for stage VI, which stretches from
recent to early chronic infection. These staging criteria are useful for characterising HIV
primary infections and thereby allowing comparisons between different studies where the
infections share viral assay profiles (Fiebig et al., 2003). Several studies have used Fiebig
classification for, for example, staging primary HIV infections, and/or estimating the time
of HIV transmission (Novitsky et al., 2009; Abrahams et al., 2009; Haaland et al., 2009;
Keele et al., 2008).
Disease progression has been shown to be impacted by HIV dual infection, where two di-
vergent strains establish HIV infection in an individual (Chohan et al., 2005b; Gottlieb et
al., 2004; Grobler et al., 2004). Furthermore, extensive inter- and intra-subtype recombi-
nation has been observed in HIV-1 infected patients (Robertson et al., 2000; Rousseau et
2Table adapted from Fiebig et al. (2003).
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al., 2007; Abecasis et al., 2007). The implications of dual infections and the added recom-
bination events are widespread (Gottlieb et al., 2004; Grobler et al., 2004); for example,
dual infection is associated with a rapid progression to disease, and also has a large im-
pact on epidemiological assessment (Steain et al., 2004). Moreover, phylogenetic analysis
of recombinant sequences can lead to incorrect estimates of the rate of HIV evolution, an
overestimation of positively selected sites during selection analysis, as well as impact the
inference of the most recent common ancestor (MRCA) (Rousseau et al., 2007; Anisimova
et al., 2003). Drug resistance and greater viral fitness as result of recombination of two
or more pre-existing viral strains is an additional important consideration for broad-based
vaccine development (Gottlieb et al., 2004). Mutations that result in escape from the human
immune system further impact HIV-1 disease progression (Chopera et al., 2008). Escape
mutants may have lower fitness compared to the wild-type, and this has been linked to a
slower rate of disease progression (Chopera et al., 2008; Goulder et al., 1996)
1.2.4 Drug and Vaccine Targets
The HIV life cycle presents a number of potential vaccine and drug targets; 25 anti-HIV
compounds have been developed and approved since the 1987 when zidovudine was first
licensed (de Clercq, 2009; Stürmer et al., 2009). Anti-HIV agents fall into different groups
depending on their mechanism of action: nucleoside reverse transcriptase inhibitors (NRTIs),
nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase in-
hibitors (NNRTIs), protease inhibitors (PIs), fusion and co-receptor inhibitors, and integrase
inhibitors (INIs) (Levinson, 2006; de Clercq, 2009; Stürmer et al., 2009). In 2006 it was esti-
mated that anti-HIV compounds had collectively saved 3 million years of life in the United
States (Walensky et al., 2006)
Antiviral drugs thus far target the viral reverse transcriptase, protease and integrase, which
are encoded by the pol gene, as well as Env, which is targeted by the fusion inhibitor and
co-receptor inhibitors (de Clercq, 2009; Stürmer et al., 2009). Anti-HIV drug and vaccine
research covers a broad field of study, but particular focus is given to env, as it is responsible
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for the initial interaction with the host cells and is thus essential for transmission (Doms
and Moore, 2000).
Env is a trimeric glycoprotein composed of three gp120 and gp41 heterodimers that are
exposed on the viral surface and are anchored to the viral particle by the transmembrane
domain of the gp41 subunit. Viral cell entry is initiated by the binding of gp120 to the
CD4 receptor, followed by conformational changes that allow CCR5 or CXCR4 coreceptor
binding (Wyatt and Sodroski, 1998), which then induces further conformational changes in
gp120 that trigger the activation of gp41 (Blish et al., 2007; Hollier and Dimmock, 2005;
Sattentau, 1998). Activated gp41 leads to fusion of the viral and cell membranes, followed
by release of viral RNA into the target cell (Hollier and Dimmock, 2005; Root and Hamer,
2003).3
The development of vaccines capable of eliciting antibodies against Env that can block viral
entry is complicated by the vast sequence variability between viruses, which in env can differ
up to 50% between viral groups (Hollier and Dimmock, 2005; Johnston and Fauci, 2007; Gao
et al., 2005). Furthermore, adding to the complexity are escape variants arising through the
high mutation and recombination rates coupled with immune selection, as well as by the
large number of N-linked glycans in gp120 that provide the virus with a protective coat
(Derdeyn et al., 2004). In addition, gp120 consists of five highly variable regions (V1-V5)
interspersed among more conserved regions (C1-C5) (Burton et al., 2005); of these, V1, V2,
V4 and V5 are notable for rapid shifts in length, number and localisation of glycosylation
sites (Blay et al., 2006; Zhang et al., 2004). The variable loops shield more conserved
receptor binding regions (Wyatt et al., 1998), and only when the CD4-gp120 binding takes
place, do structural changes expose previously masked epitopes and surfaces (Zhang et al.,
1999; Rits-Volloch et al., 2006). 4
The HIV genome diversity within and between subtypes, together with the presence of
circulating recombinant forms (CRFs) arising due to multiple infection and recombination,
lends further support to the argument that an anti-HIV vaccine needs to be effective against
3Text adapted from Wood et al., 2009.
4Text adapted from Wood et al., 2009.
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a very wide range of HIV variants (Chohan et al., 2005b; McBurney and Ross, 2008).
1.2.5 The Immune Response to HIV Infection
1.2.5.1 Innate Immune Characteristics During HIV Infection
The specificity of the immune response, as well as the strength of the attack, against HIV
varies depending on the stage of infection. Innate immunity, which provides the initial,
rapid, defense against any foreign invading organism, is also the first point of prevention,
besides surface barriers, against HIV infection. These defenses include cytokines (signalling
proteins), dendritic cells (DCs), macrophages, natural killer (NK) cells, and soluble com-
ponents, for example mannose-binding lectins and complement (Levy, 2007; Vander et al.,
2001a; Goepfert, 2003).
The NK cells and DCs constitute two of the fundamental cellular factors of the innate
immune system (Fortis and Poli, 2005); NK cells have inhibitory as well as activating cell-
surface receptors that through interactions regulate, for example, NK cell-mediated cytotoxi-
city of virus-infected cells. DCs initiate various innate as well as adaptive immune responses
and, together with macrophages, have important roles as antigen-presenting cells (Levy,
2007). DCs and other mucosal surface cells, including Langerhans cells and macrophages,
recognise HIV as a foreign organism and secrete cytokines, and these interactions may in-
fluence the replicative capacity of the virus in the genital tract and other mucosa (Lehner,
2003; Levy, 2007). Interestingly, because DCs are present in the mucosal epithelia in the
genital tract, and are able to bind Env, it has been suggested that these cells may be the first
cells to take up HIV (Levy, 2007; Piguet and Steinman, 2007; Lama and Planelles, 2007).
Since the innate immune cells recognise pathogen-associated molecular patterns (PAMPs)
and not specific epitopes, the innate response to invading pathogens is rapid (Levy, 2007).
Specific pattern recognition receptors (PRRs), including the Toll-like receptors (TLR), recog-
nise PAMP and act as sensors. PRRs are found on many cells of the immune system, for
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example macrophages, DCs, and NK cells. These pathogen sensors activate a response
pathway that leads to cytokine and chemokine production, which in turn elicits a wide-
range of immune-modulating processes (Levy, 2007; Katsikis et al., 2007). For example,
the production of cytokines results in the further activation of natural killer (NK) cells and
macrophages, and in turn this generates inflammatory responses and cytotoxic processes
(Ekene, 2008; Levy, 2007). NK cells also produce cytokines that effect the adaptive immune
response, and therefore play a role in both the primary as well as the secondary response
to HIV infection. Similarly, DCs play a large role in regulating the initial adaptive immune
response through signals resulting in B and T cell activation, resulting in further immune
pathways which are discussed in section 1.2.5.3 (Levy, 2007).
The initial immune response against the invading virus can have a large effect on the ability
of HIV to successfully infect an individual. The innate immune system can induce cell-
lysis and destroy virus-infected cells, and can also activate important adaptive immune
responses. Moreover, a strong innate immune response has been associated with a slower
rate of progression to AIDS (Levy, 2007; Borrow and Bhardwaj, 2008).
1.2.5.2 Host-specific Factors Influencing the Course of HIV Infection
Although there are many host-specific factors that can alter the expected prognosis for
an HIV infected individual (Lama and Planelles, 2007; Kumar et al., 2006), only a short
overview is presented here, with particular focus given to the anti-HIV protein, APOBEC.
Human genes that disrupt the infectivity of the virus are valuable to our knowledge of
how HIV has evolved to evade destruction by the immune system. Several human factors
have been identified that have an impact on HIV’s replication capacity to different degrees
(Lama and Planelles, 2007). A well-known polymorphism that leads to resistance to HIV-1
infection is the homozygous allelic variation CCR5∆32. In individuals who have this form of
the allele, the CCR5 coreceptor is mutated to such a degree that the virus can not enter the
host cells via this route. HIV-1 strains that use the CXCR4 coreceptor can still infect these
individuals and the resistance to infection is therefore not guaranteed (Lama and Planelles,
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2007; Levy, 2007).
Certain allelic forms of, for example, TRIM5α, RANTES, and various other chemokines,
have been associated with varying rates of disease progression (Lama and Planelles, 2007;
Newman and Johnson, 2007). Furthermore, DC-SIGN, which is present on immature DCs
and activated B cells, binds to HIV via particular carbohydrate moieties present on Env
gp120, and although the exact mechanisms of action are not yet known, certain polymor-
phisms within the promoter region of DC-SIGN have been associated with increased sus-
ceptibility to HIV infection (Lama and Planelles, 2007; Hong et al., 2002). In contrast,
Langerin, which is expressed on Langerhans cells and found throughout the mucosal sur-
faces where HIV-infection occurs, has been linked to prevention of HIV-transmission (Lama
and Planelles, 2007). Human defensins, which are grouped into α- β- and Θ-defensins ac-
cording to the distribution and size of their disulphide bridges, are also anti-HIV factors
that combat HIV in various ways in order to prevent infection, although there have been
reports that certain defensins can enhance infection (Ding et al., 2009). Certain α-defensins
can act to down-modulate CD4 expression, or disrupt the viral membrane and thereby in-
activate the virus (Lama and Planelles, 2007; Ding et al., 2009). A particular homozygous
polymorphism in the DEFB1 gene that encodes the β-defensin, HBD-1, has been linked
to exposed seronegative individuals, suggesting a degree of resistance in individuals har-
bouring this polymorphism (Zapata et al., 2008; Ding et al., 2009). It is evident that the
genetic variation found from one infected individual to another has a considerable effect
on HIV-transmission and manifestation of disease; research on how an individual’s genetic
background can influence the infectivity of HIV therefore plays a big role in understanding
natural complete, or partial, immunity. A recently identified human factor that can also in-
fluence the course of infection is the anti-HIV cellular protein APOBEC3G (Apolipoprotein
B mRNA editing enzyme, catalytic polypeptide-like 3G) (Chiu and Greene, 2008; Williams
and Burdo, 2009). This protein is from the Apobec superfamily that all have cytidine deam-
ination capacity (Kobayashi et al., 2004). APOBEC3G induces cytosine to uracil (C-to-U)
changes in the reverse transcript resulting in guanine to adenine (G-to-A) hypermutation in
the sense-strand (Jern et al., 2009; Yu et al., 2003). These hypermutations change the genetic
composition of HIV and in many cases render the virus non-viable (Zhang and Webb, 2004).
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Shortly after APOBEC3G was discovered, another protein, APOBEC3F, was also shown to
have similar activity (Zheng et al., 2004; Pillai et al., 2008). It is possible to approximate
the effect of APOBEC by the extent of hypermutation observed, and thus allows a valuable
measure of the role APOBEC3G/F has in conferring protection against HIV infection.
Notwithstanding this innate defense mechanism against infection, HIV evolved a mechanism
to evade APOBEC-induced hypermutation. The viral accessory protein Vif (virion infectiv-
ity factor) causes degradation of the APOBEC3G/F proteins in the host cells, enabling viral
replication (Goila-Gaur and Strebel, 2008; Jern et al., 2009). The interplay between viral
vif and human APOBEC provides an additional target for potential antiviral compounds,
since a strong inhibition of Vif would allow cytidine deaminase activity to control viral repli-
cation (Russell et al., 2009; Goila-Gaur and Strebel, 2008). A recent study suggests that
such antiviral avenues require careful consideration. G-to-A hypermutations are frequently
observed in drug resistant HIV strains, and it is therefore feasible that the virus uses such
increases in genome variation to evolve resistance to both innate antiviral factors as well as
drug treatments (Berkhout and de Ronde, 2004; Chiu and Greene, 2008). Drugs or vaccines
mimicking APOBEC3G/F activity would have to be thorough and absolute since incomplete
functionality could ultimately drive HIV evolution (Chiu and Greene, 2008).
1.2.5.3 The Adaptive Immune Response to HIV Infection
The adaptive immune response specifically recognises foreign invading organisms and acts
through lymphocytes to eliminate the antigens (and therefore the pathogens) selectively.
Two types of lymphocytes are distinguished: B cells (humoral response) and T cells (cell-
mediated response) (Levy, 2007). Humoral immunity involves antigen-recognition and the
subsequent maturation of B cells into antibody producing cells, as well as the establishment
of a reservoir of memory cells. (Porth, 2007). Therefore, when B cells attach to a foreign
antigen they develop into mature memory B cells or plasma cells. Memory B cells ensure that
the future recognition and eliminating response against a specific pathogen is rapid, since
their primary maturation was initiated by the same pathogen antigen. Plasma cells are
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responsible for producing antibodies that specifically recognise the originally encountered
antigen. Antibody production is mediated by T helper cells (described below), and the
production of sufficient amounts of antibody against a specific invading organism can take
several days after it is first recognised by B cells (Vander et al., 2001a; Levy, 2007). In HIV-
infection, the envelope protein is the main target for inactivation through neutralisation by
antibodies (Levy, 2007; Sattentau et al., 1999).
Neutralising Antibodies Targeting HIV
Research suggests that an effective HIV-vaccine would have to induce a broadly neutralising
antibody (NAb) response as well as stimulate vigorous HIV-specific T-cell activity (Johnston
and Fauci, 2008; Haynes and Montefiori, 2006; Hessell et al., 2009). Neutralising antibodies
compete with CD4 cells to bind to Env gp120, and the ease at which the NAbs outcompete
the CD4 cells determines the antibodies’ neutralising efficiency (Prabakaran et al., 2006;
Nabel, 2002; Korber et al., 2001). Given the high genetic diversity of HIV, the ability to
elicit an antibody response that recognises a wide array of viruses is not an easy task, and
only a few broadly effective neutralising antibodies have been identified (Scheid et al., 2009;
Dhillon et al., 2007).
A recent screening of the neutralisation breadth of sera samples obtained from approximately
1800 HIV-1 infected individuals, lead to the identification of a donor that displayed potent
antibody mediated neutralisation (Walker et al., 2009). Two antibodies, P9 and P16, that
elicited a broadly reactive neutralising response were identified during the analysis of the
sample from this HIV-1 subtype A infected donor. These antibodies primarily recognised
conserved regions of the V2 and V3 loops, and displayed preferential binding to a subunit
of the stable trimeric form of Env (Walker et al., 2009).
Previous studies have also focused on identifying monoclonal antibodies (mAbs) that bind to
complete viral particles and complex epitopes, as opposed to soluble viral proteins (Moulard
et al., 2002; Gorny et al., 2005). The first mAb identified in this way, was mAb 2909, which
had potent neutralisation potential and recognised a composite epitope consisting of parts
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of V2, V3 and the CD4 binding region (Gorny et al., 2005). However, the activity of mAb
2909 was specific to only certain virus strains (Gorny et al., 2005). These studies suggest
that the V2 and V3 loops contain conserved regions that can serve as targets for neutralising
antibodies, and in addition, antibodies that target these regions elicited a broadly reactive
neutralisation response (Walker et al., 2009). These results are therefore very promising for
future vaccine research, since vaccine-induced antibodies with similar breadth and potency
may have the potential to inactivate HIV upon entry into the host (Walker et al., 2009).
Therefore focussing on the envelope gene, and establishing its transmission characteristics,
adaptation to immune pressures, and evolutionary constraints, forms a critical part of the
endeavor to develop a successful HIV vaccine (Derdeyn et al., 2004; Mahalanabis et al., 2009;
Zhou et al., 2007).
The T Cell Response to HIV Infection
The second class of cells associated with the adaptive immune response, are T cells. These
cells are also able to distinguish self from non-self cells, and are divided into three types:
cytotoxic T cells, helper T cells, and regulatory T cells (not discussed here). Cytotoxic
T lymphocytes (CTLs) express the CD8 surface protein and function by attacking and
destroying cells displaying non-self antigens. CTL activity has also been observed for cells
expressing the CD4 protein on their surface membranes, however, CD4+ cells predominantly
have helper T cell activity (Levy, 2007; Vander et al., 2001a; Ye et al., 2008). T helper (TH)
cells, similar to B cells and CTLs, bind to specific antigens, and subsequently undergo
activation. Once activated, TH cells secrete cytokines which stimulate antigen-bound B cell
and CTL functioning, as well as cytokines that mediate the inflammatory response (Vander
et al., 2001a). T helper cell activity is essential for B cell and CTL functioning (Levy, 2007;
Vander et al., 2001a; Ye et al., 2008).
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1.2.5.4 Human Leukocyte Antigen Diversity and the Course of HIV Infection
Whereas neutralising antibodies prevent infection, CTLs are responsible for recognising and
destroying cells that have been infected by a pathogen. When a cell is infected by HIV,
peptide fragments (epitopes) of the invading pathogen are presented as antigens on the
surface of the host cell, bound to the major histocompatibility complex class one (MHC-I)
molecules. The genes encoding MHC molecules in humans, human leukocyte antigen (HLA)
genes, are located on chromosome 6 and the HLA complex extends to almost four million
DNA base pairs. The HLA class I antigens are encoded by different allelic forms of the
three major HLA genes, HLA-A, -B, and -C, and the three minor genes HLA-E, -F, and -G.
(Vander et al., 2001b; Marsh et al., 2000). In 2008, more than 230 HLA-A alleles and more
than 300 HLA-B alleles were described (Holdsworth et al., 2009), and collectively, over 1500
class I molecules exist, demonstrating the highly polymorphic nature of HLA molecules
present in the human population (Nielsen et al., 2008). The diversity of HLA allotypes,
and hence peptide-binding specificity, dictates the range of epitopes that can be bound and
presented to resist infection by pathogens (Trachtenberg et al., 2003).
Various host genetic factors, in addition to those mentioned in the innate immune section
(section 1.2.5.2), have been associated with HIV pathogenesis and progression to AIDS (Kaur
and Mehra, 2009; Roger, 1998; Singh and Spector, 2009). Specific HLAs are known to either
increase (Roger, 1998; Qing et al., 2006), or decrease (Cornelissen et al., 2009; Crawford et
al., 2009) disease progression. Individuals with a large degree of heterozygosity at HLA-I loci
tend to produce broader and stronger CTL responses against invading pathogens (Carrington
et al., 1999; Kimman, 2001). A relationship between the HLA-B*57 allele and long-term
nonprogression has been described (Langford et al., 2007; Miura et al., 2009), and varying
degrees of protection against disease progression have been associated with, for example, the
HLA-B*5801 and HLA-B*51 alleles (Langford et al., 2007; Brumme et al., 2008; Delport
et al., 2008; Chopera et al., 2008). CTL escape mutations that lead to viruses with lower
reproductive fitness have also been described for individuals carrying either the HLA-B*57
or HLA-B*5801 alleles (Chopera et al., 2008; Martinez-Picado et al., 2006; Crawford et al.,
2007). Due to the fitness cost incurred as result of these CTL escape mutations, the HLA
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background can have a considerable impact on HIV disease progression (Chopera et al.,
2008).
The host genetic background is currently the only factor that can consistently predict the
long-term prognosis of infected individuals (Levy, 2007), and further exploitation of the
known effective anti-HIV immune responses may be useful for developing approaches for
controlling HIV infection and progression. Moreover, although host factors can not be al-
tered, research on individual genetic differences and the corresponding variation in control
of HIV-infection could provide a valuable resource for establishing patient-specific thera-
peutic guidelines (Langford et al., 2007). Individuals with natural complete immunity, or
partial immunity, are a further important resource for studying the interactions between
the infected host and virus, and investigating these interactions could lead to novel vaccine
strategies (Kaur and Mehra, 2009; Langford et al., 2007).
Progress in developing an anti-HIV agent is reliant on an understanding of host genetic
factors related to HIV-infection, HIV specific viral characteristics, and the dynamics of the
host-virus interaction. An effective anti-HIV vaccine needs to recognise and remove the
virus that is transmitted (Keele et al., 2008), before infection is established and viral evolu-
tion enables evasion of the vaccine response. It is therefore also important to identify viral
features that are essential for successful transmission from one individual to another. HIV
samples obtained from newly-infected individuals are ideal for studying transmission charac-
teristics, since these sequences represent the HIV population capable of infecting new hosts
and surviving the earliest immune responses elicited against them. Therefore, investigating
the events that occur during transmission and the earliest stages of HIV-infection, together
with the known host specific factors and viral dynamics, could provide significant insights
into how the virus evolves to escape the immune response to establish productive infection.
Ultimately, such research avenues may lead to novel strategies for vaccine and drug design.
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Chapter 2
Use of Coalescent Simulations to
Identify Homogeneous Acute and
Early HIV-1 Infections
2.1 Introduction
Ample data from chronic infections have lead to the understanding that HIV is able to
maintain extremely high levels of sequence diversity due to the error prone nature of the
reverse transcriptase (Roberts et al., 1988; Taylor et al., 2008), and high replication (Julg
and Goebel, 2005; Lynch et al., 2009) and recombination (Ramirez et al., 2008; Jetzt et al.,
2000) rates. These characteristics have allowed drug resistance mutations to accumulate over
the course of antiretroviral treatment, and have made the search for an effective treatment
strategy very challenging (Clavel and Hance, 2004; Bennett et al., 2009; Okazaki et al.,
2006).
Due to the logistical difficulties associated with identifying individuals immediately after
HIV infection, the early stage of infection has been studied in detail in a relatively small
number of patients (Lewis et al., 2008). Our understanding of viral transmission and the
32
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
establishment of new infections, as well as the mechanisms by which HIV evades the immune
response during the earliest stages of infection, is also hampered by the difficulty of obtaining
samples from acute and early HIV infection (Keele et al., 2008). Since the transmitted virus
is the variant that an effective vaccine needs to target, obtaining samples from acute and
early HIV-infected individuals is essential.
Remarkably, HIV infection can be caused by a small subset of the viruses present in the
donor quasiespecies (Wolfs et al., 1992; McNearney et al., 1992; Zhang et al., 1993; Delwart
et al., 2002). In 2004, a study by Derdeyn et al. (2004) on the neutralisation sensitivity
of envelope genes after transmission between heterosexual transmission pairs, suggested
that HIV transmission is associated with an extreme bottleneck. They further argued that
HIV infection is likely to take place through the transmission of an individual sequence
from the donor viral population, or from the expansion of a single virally infected cell. If
productive infection is established through the transmission or outgrowth of a single virus,
then characterising these sequences may lead to new ideas for preventing HIV transmission
and infection.
A method to directly sequence uncloned DNA amplicons generated from single genome
amplification (SGA) of plasma viral RNA has been described (Simmonds et al., 1990; Shriner
et al., 2004; Palmer et al., 2005; Salazar-Gonzalez et al., 2008). Acute and early infection
sequences obtained from such a method, provide an ideal source of data for identifying the
transmitted, or founder, virus (Keele et al., 2008; Wood et al., 2009). Differentiating between
infections caused by multiple viral strains and those caused by a single virus is interesting
for various reasons. Apart from elucidating the extent of sequence diversity in transmitted
HIV strains as well as describing the associated transmission bottleneck, analyses of single
HIV transmission datasets allows us to describe the diversity of the virus caused solely by
changes that occurred post-infection (Abrahams et al., 2009; Wood et al., 2009; Keele et al.,
2008).
In addition to gaining a greater understanding of the diversification of HIV after infection
has been established, it is also of interest to investigate the HIV population history of an
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infected individual and to estimate the time frame in which the infection is likely to have
taken place (Hué et al., 2005; Keele et al., 2008). Evolutionary analysis of a sample of HIV
sequences obtained from an infected individual can provide information about the likely time
of infection, and could therefore contribute valuable information on the evolutionary history
of the virus from the point of transmission and subsequent manifestation of infection (Hué
et al., 2005; Keele et al., 2008; Wood et al., 2009; Abrahams et al., 2009).
Establishing whether a sample from an infected individual consists of homogeneous sequences
(derived from a single infecting viral strain) or heterogeneous sequences (derived from the
transmission of two or more of the viral strains in the donor individual) is therefore a pri-
mary step for characterising the transmitted virus. Examining the sequence alignment, and
determining the heterogeneity of the viral infection within a single patient, provides an ini-
tial insight into the number of viral strains that caused productive infection. If the diversity
of the sample taken from an individual is higher than a given diversity threshold, it is likely
that more than one virus was transmitted and multiple strains caused the infection (Keele et
al., 2008). A model-based approach to further corroborate the primary findings of multiple
virus infection, involves estimating the minimum time it would take for a viral population
to obtain the observed level of diversity under the assumption of an initial homogeneous in-
fection (Keele et al., 2008). The results of this model-based approach can then be compared
to the clinical stage of infection, determined in the laboratory, for example using the clinical
stages proposed by Fiebig et al. (2003).
2.1.1 The Coalescent
In population history, a coalescence describes the point where lineages join to form a common
ancestor at some time in the past (Rosenberg and Nordborg, 2002; Fu and Li, 1999; Kuhner
et al., 1995). As described in depth by Kingman in 1982, the coalescent therefore describes
the ancestral relationship between a sample of sequences (Kingman, 1982a,b, 2000; Wakeley,
2008). An example of a coalescent genealogy is show in Figure 2.1. In this example, there
are n = 6 individuals, and n− 1 coalescent events, indicated with blue circles (Figure 2.1).
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Going backward in time from the present (T0), each coalescent event reduces the number of
lineages by one, until the most recent common ancestor (at the point TMRCA) of the sample
is reached. The coalescent is therefore a stochastic process by which genealogies are mod-
elled (Nordborg, 2001; Rosenberg and Nordborg, 2002), which includes a rooted bifurcating
tree, and n − 1 coalescent events that occur at particular time intervals (Wakeley, 2008).
Where classical population genetics describes divergence events where branching to newer
forms take place, the coalescent process is concerned with merging events going back in time
(Fu and Li, 1999; Stone et al., 2007).
Figure 2.1: A coalescent genealogy of a sample with n = 6 individuals. The blue circles
indicate the points where two lineages coalesce, and Ti illustrates the time interval from the
point where only two lineages remain, to the final coalescent event when the most recent
common ancestor is reached.
Coalescent theory provides a way to use the observed pattern of polymorphisms in samples
of DNA sequences to make inferences about the genealogical history (Wakeley, 2008). Since
the coalescent process is stochastic in nature, there exists a sample space that describes all
the possible outcomes of a model (Wakeley, 2008). A population genetics model includes
features such as mutation, recombination, and population size. These are examples of pro-
cesses that need to be modelled based on the observations made from the polymorphisms
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present in the sampled sequences (Hudson, 1991; Wakeley, 2008). Two of the popular and
well-researched population genetics models, are the Wright-Fisher model (Kingman, 1982b;
Fu and Li, 1999), and the Moran model (Moran, 1958; Itoh and Mahmoud, 2005; Wakeley
and Sargsyan, 2009), which make different assumptions regarding the population param-
eters. Various extensions of these population models have been described, allowing for,
for example, recombination (Hudson and Kaplan, 1988; Griffiths and Marjoram, 1996) and
selection (Krone and Neuhauser, 1997; Neuhauser and Krone, 1997; Kaplan et al., 1988).
Coalescent-based methods can therefore be very useful for determining, for example, the
time a pathogen first entered the human population, or for estimating the rate of evolution
of a pathogen in a new host (Rosenberg and Nordborg, 2002). In this study, a coalescent-
based method was used to determine the most recent common ancestor for each of the viral
samples isolated from multiple early infection patients.
2.1.2 Bayesian Evolutionary Analysis Sampling Trees (BEAST)
BEAST, Bayesian Evolutionary Analysis Sampling Trees, is a software package that was
developed to offer a flexible platform for coalescent-based Bayesian statistical analysis of
molecular sequence data using phylogenies (Drummond and Rambaut, 2007). Since a large
number of parameters are modelled during the analysis, high dimensional probability dis-
tributions are generated. Markov chain Monte Carlo (MCMC) methods can be applied
to integrate over the large dimensional space and to solve complex optimisation problems
(Andrieu et al., 2003). MCMC is used for generating samples from a multidimensional
distribution, as well as exploring and evaluating expectations based on the posterior prob-
ability distributions (Andrieu et al., 2003; Gilks et al., 1998; Kedem and Fokianos, 2002).
The distribution resulting from the MCMC eventually converges to the posterior probability
distribution of the parameters, and can therefore be treated as a representative sample from
the distribution from which predictions and inferences can then be made (Qian et al., 2003;
Mossel and Vigoda, 2005).
BEAST uses a Metropolis-Hastings MCMC algorithm to generate estimates of a large num-
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ber of parameters. The algorithm works by sampling from a posterior distribution that was
generated from a particular parameterisation of an evolutionary model relating an align-
ment of molecular sequences (Drummond and Rambaut, 2007). In this way, for each new
sample, the Metropolis-Hastings algorithm generates a proposal distribution from the cur-
rent states, which is accepted or rejected depending on values contained in the posterior
probability density functions of the current as well as proposed states (Christensen et al.,
2004; Larget and Simon, 1999; Chib and Greenberg, 1995). In practice, the MCMC is run
for several thousand steps until convergence is reached, and sampling occurs at specified
intervals. The ideal result is a set of of posterior probability distributions for the parameters
of interest (Miller et al., 2004; Drummond and Rambaut, 2007). An evolutionary model
in BEAST is comprised of five features, including the substitution model, among-site rate
heterogeneity model, the rate model among branches, the tree, and tree prior. The user can
specifically parameterise these five components of the evolutionary model for a given dataset
of aligned DNA or protein sequences (Drummond and Rambaut, 2007).
An important consideration for Bayesian statistical analysis is how to set the prior prob-
ability distributions for each parameter. Specifying priors is an inherent part of Bayesian
statistical analysis, and although including definitive information could lead to more accu-
rate estimates of the posterior probability, deciding on relevant prior values can be very
difficult. The posterior probability distribution for each parameter is dependent on the
original incorporated prior distribution, and inaccurate priors could lead to distorted evo-
lutionary parameter estimates (Drummond and Rambaut, 2007; Yang and Rannala, 2005).
Tree priors are used to model population size changes over time, where calibration priors
can also be added if dates or other units of time are known for specific nodes. Specifying a
realistic model of demographic history, for example an exponential or logistic growth model,
is particularly important for studies interested in estimating rates of evolution, since the tree
prior can significantly bias the rate parameter of interest (Drummond et al., 2002, 2005).
Despite the potential bias that may arise due to unsubstantiated priors, BEAST, as a flex-
ible programme incorporating various model possibilities and extensibility, is an extremely
useful tool for Bayesian evolutionary analysis.
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2.1.3 Relaxed Molecular Clocks
The molecular clock hypothesis asserts that the rate of molecular evolution, for all genes
(or proteins), is approximately constant over time (Zuckerkandl and Pauling, 1965; Nei and
Kumar, 2000; Pevsner, 2003). The significance of the hypothesis is evident; if a gene evolves
at a constant rate then the rate of nucleotide substitution and divergence times can be
estimated (Pevsner, 2003). However, not all proteins evolve according to the molecular clock
hypothesis, and various factors contribute to evolutionary rate heterogeneity, for example
generation time and metabolic rate can vary across lineages. A strict uniform molecular
clock is therefore not an accurate assumption in many cases (Pybus, 2006; Martin and
Palumbi, 1993). The relaxed molecular clock model provides an alternative as it allows the
evolutionary rate to vary among lineages (Pybus, 2006; Kumar, 2005; Sanderson, 1997).
Various approaches to relax and overcome the limitations resulting from the molecular clock
hypothesis have been proposed (Aris-Brosou and Yang, 2002). One method suggests es-
sentially ignoring the clock, and therefore allowing complete rate heterogeneity across all
branches of the phylogeny. However, in most cases it is not possible to estimate dates of
divergence or absolute evolutionary rates with such an approach, since time and divergence
dates are linked (Ho et al., 2005). An alternative is to assign a unique local rate to different
parts of the phylogenetic tree, the so called local molecular clock model (Aris-Brosou and
Yang, 2002). This approach is however not always tractable when large phylogenies are
analysed, since there can be multiple possibilities for assigning rates in different regions of
the tree (Ho et al., 2005).
The relaxed molecular clock that allows rates to vary across branches but accounts for
close and distant evolutionary relationships, provides an alternative to the above-mentioned
methods. By allowing sequences that are closely related to share similar evolutionary rates,
the rates are effectively inherited along the tree (Ho et al., 2005; Aris-Brosou and Yang,
2002). The Bayesian approach of this methodology allows priors to be selected for how
the descendant rate is related to the ancestral rate (Thorne et al., 1998; Ho et al., 2005).
The rates amongst all branches are therefore autocorrelated, and the rate for each branch
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depends on the selected prior distribution, where the mean rate on the descendant branch is a
function of the estimated rate on the ancestral branch (Thorne et al., 1998; Aris-Brosou and
Yang, 2002; Ho et al., 2005; Drummond et al., 2006). A drawback of these relaxed molecular
clock models is that the tree topology has to be specified; this is problematic when there
are ambiguities in particular regions of the tree that, therefore, result in numerous possible
tree topologies (Drummond et al., 2006).
Drummond et al. (2006) proposed a new method for incorporating the relaxed molecular
clock, where both the divergence times and phylogeny are estimated. This approach therefore
overcomes the drawback of the previous methods where a specific tree topology has to be
provided. In addition, the authors describe a relaxed clock model which, as opposed to the
autocorrelated model, does not, a priori, specify rate correlation among related branches
on a tree. This uncorrelated relaxed clock model, avoids the requirement of having to
specify a prior on the degree of autocorrelation (Drummond et al., 2006). The fundamental
contribution of relaxed molecular clock models is that they allow for the estimation of
divergence times and the rates of substitution from sequence data where different lineages
do not share the same evolutionary rate (Sanderson, 2003). The relaxed molecular clock is
therefore particularly useful for analysing HIV sequences, where the rate of evolution can
vary substantially over the course of HIV infection.
The Bayesian MCMC method is implemented in BEAST, and presents an application to
perform relaxed phylogenetics (Drummond et al., 2006). Here, BEAST was used to esti-
mate the time to the most recent common ancestor of a set of HIV-1 sequences in early
infection, and therefore, in the case of homogeneous infections, a lower bound on the time
to infection. This approach was applied to a large sample of HIV-1 subtype B and C se-
quences isolated from early infections (Keele et al., 2008; Abrahams et al., 2009). The
results obtained from this coalescent-based estimation were subsequently compared to both
the clinically determined stage assigned to each sample, as well as to the estimates obtained
from a mathematical model of sequence diversification. The analyses formed part of two
international collaborative studies focusing on identifying the transmitted virus in HIV-1
subtype B (Keele et al., 2008) and subtype C (Abrahams et al., 2009) sequence datasets.
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2.2 Methods
Coalescent analysis was carried out on 102 HIV-1 subtype B sequence alignments, and 69
HIV-1 subtype C alignments obtained from acute and early infected patients. These analyses
formed part of two international collaborative projects (Keele et al., 2008; Abrahams et al.,
2009); sequencing, as well as Fiebig clinical staging for each infected individual, was carried
out by collaborators (Keele et al., 2008; Abrahams et al., 2009).
2.2.1 Clinical Staging
The stage of disease for each of the infections was clinically categorised based on an adap-
tation of the original Fiebig stages (Fiebig et al., 2003; Lee et al., 2009). One of the major
changes compared to the original staging was the inclusion of an eclipse period. Keele et al.
(2008) allowed a period of time, 10 days, during which plasma viral RNA is undetectable.
This eclipse phase was estimated to last between 7 and 21 days (Table 2.1). A further 2
days were also added to Fiebig stage I to account for the greater sensitivity of the current
assays as compared to those available in 2003, when Fiebig et al. published the original
classification (Lee et al., 2009). Finally, the confidence intervals were recalculated using the
quadrature approach, in which the errors for each stage duration are assumed to be uncor-
related (Lee et al., 2009; Drosg, 2007). Combining individual errors in quadrature means
that the cumulative error n at Fiebig stage i is calculated as:
ni =
√
m2i + n2i−1
where mi is the difference between the mean and the minimum (or -maximum) 95% CI
estimate for Fiebig stage i, and ni−1 is the result of the previous calculation. If i = 1, then
ni−1 = 3, which is the difference between the mean and minimum (or -maximum) 95% CI
for the eclipse phase. The cumulative errors for both the minimum and maximum ranges
were calculated with this method (Table 2.1). Combining individual errors in quadrature
40
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
results in cumulative error estimates that are smaller than the sum of the individual errors,
but larger than the errors in either measurement (Drosg, 2007). The cumulative measures
indicate the expected time interval spanned by each stage. For example, Fiebig stage I
ranges from day 10, the end of the Eclipse phase, to day 17, and Fiebig stage II occurs
between 17 and 22 days after infection. Throughout the chapter, where reference is made
to Fiebig stage classification, the cumulative durations are the modified estimates, as shown
in Table 2.1.
Table 2.1: Adapted Fiebig stage ranges for classification of HIV-1 primary infection. The
individual durations of each phase as well as the cumulative durations are shown.
2.2.2 Poisson Model of Replication and Diversification
A mathematical model, described in detail by Lee et al. (2009), was used to estimate the
extent of diversification of each dataset (Keele et al., 2008; Abrahams et al., 2009). The
model design and development, as well as the analysis performed using the model, was
carried out by collaborators and is described here in brief for comparative purposes.
The model uses previously published estimates of parameters related to the HIV-1 life cycle;
a generation time of two days (Markowitz et al., 2003), reproductive ratio, R0, of 6 (Stafford
et al., 2000), and a nucleotide substitution rate equal to 2.16 x 10−5 substitutions per site per
generation (Mansky and Temin, 1995), were applied in an exponentially replicating model
of sequence evolution that assumes no recombination or selection (Keele et al., 2008). This
results in a star-like phylogeny relating the sequences with a frequency distribution of the
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number of differences between any pair of sequences (Hamming Distance), described by a
Poisson distribution. The mean of the distribution is linearly dependent on the number
of generations between the sample and the founder virus (the root of the star phylogeny).
This model therefore provides estimates of the number of generations (or time) required to
produce the observed sequence diversity. See Lee et al. (2009) for a detailed justification of
this model.
The coalescent analysis carried out using BEAST (described in the subsequent sections
2.2.3.1 and 2.2.3.2) provides an alternative estimate of the number of generations since the
last common ancestor of the population, but this estimate is in the reverse direction - that
is, the results reflect the number of generations required to reach a hypothetical most recent
common ancestor from the present viral population, as opposed to the number of generations
required to generate the present observed diversity starting from a single viral particle. The
mathematical model described first by Keele et al. (2008) and later extensively discussed
by Lee et al. (2009), therefore represents a forward evolution simulation, whereas BEAST
simulates in the reverse direction (Drummond and Rambaut, 2007).
2.2.3 Applying a Coalescent Model of Evolution to HIV-1 Sub-
type B and C Sequences
2.2.3.1 Estimating the MRCA for 102 HIV-1 Subtype B Datasets
A Bayesian MCMC approach, implemented in BEAST v1.4.1 (Drummond et al., 2006;
Drummond and Rambaut, 2007), was used to estimate the time, in days, to the MRCA for
each of the 102 HIV-1 subtype B datasets. The analyses were carried out by using the gen-
eral time reversible (GTR) substitution model with invariant sites and gamma-distributed
rate heterogeneity (four gamma categories). Furthermore, the mean substitution rate was
fixed (2.16 x 10−5 substitutions per site per generation), and the substitution and rate het-
erogeneity models were unlinked across codon positions. Exponential population growth
and a relaxed (uncorrelated exponential) molecular clock was assumed. These model pa-
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rameters were used for all the analyses, and the MCMC algorithm was run for at least 107
generations (logging every 1000 generations; burn-in was set to 10% of the original chain
length). Additional runs were carried out if the effective sample size for the estimate was
less than 100, as recommended by the documentation on BEAST and commonly used in
the literature (for example Hughes et al., 2004, Edwards et al., 2006, and Bello et al., 2009).
The results were visualised in TRACER (Rambaut and Drummond, 2007).
The analyses were repeated with fixed values for the GTR model instead of 5 free parameters.
The fixed values were estimated with the HyPhy package (Kosakovsky-Pond and Muse, 2005)
by using the combined data from all homogeneous early infection patients. Furthermore, two
additional demographic and evolutionary models (relaxed uncorrelated molecular clock with
logistic population growth, and strict molecular clock with exponential population growth)
were used. Similar results (estimates and confidence intervals) for the MRCA times were
obtained for the alternative relaxed clock models. However, the estimates were 25% lower
when the strict molecular clock was used (data not shown).
2.2.3.2 Estimating the MRCA for 69 HIV-1 Subtype C Datasets
BEAST v1.4.7. (Drummond and Rambaut, 2007) was used to estimate the time to most
recent common ancestor (tMRCA) of the 69 HIV-1 subtype C sequence datasets (Abrahams
et al., 2009). Similar to the subtype B analysis, a GTR substitution model with gamma
distributed rates (four categories) and a proportion of invariant sites was used to model
rate heterogeneity among sites. The relative substitution rate priors of the GTR model
were set to the empirical estimates obtained from analysis carried out on the entire acute
homogeneous dataset using the HYPHY package (Kosakovsky-Pond and Muse, 2005). The
models were unlinked across codon positions and the mean substitution rate was fixed to
2.16 x 10−5 substitutions per site per generation, following the analyses carried out on the
HIV-1 subtype B sequences (Mansky and Temin, 1995; Keele et al., 2008). A relaxed (un-
correlated exponential) molecular clock, and both a constant piecewise model of population
growth, where the demographic parameter estimates are obtained from a Bayesian skyline
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plot (BSP), and an exponential population growth model were used to describe the popu-
lation size changes over time (Drummond et al., 2005). The Bayes factor (Suchard et al.,
2001) estimates did not provide evidence in favour of either of the demographic models,
which suggests that the parametric (exponential) and non-parametric (constant piecewise
derived from a BSP) models provide an equally good fit to the data; the tMRCA estimates
and confidence intervals were also similar for each model (data not shown). Results from
the constant piecewise BSP model are given because the the MCMC chain appeared to con-
verge faster for all the datasets under this model of population growth. The MCMC was
initially run for 107 steps (logging every 1000 steps, with the first 10% of the run discarded
as burn-in) and subsequently repeated if the effective sample size for the estimate was below
100. As with the subtype B data, the results were visualised in TRACER (Rambaut and
Drummond, 2007).
In both the HIV-1 subtype B and subtype C analyses the tMRCA estimate generated by
BEAST represents the time in generations, since the substitution rate provided as input,
2.16 x 10−5, is in units of substitutions per site per generation. The same generation time
estimate as was used in the Poisson model was also applied here. The generation time was
therefore multiplied by 2 (Markowitz et al., 2003) in order to obtain the final time, in days,
to the MRCA.
2.3 Results and Discussion
2.3.1 BEAST Estimates of the tMRCA
2.3.1.1 First Round of Classification of Homogeneous Infection
The time to most recent common ancestor (tMRCA) for 102 HIV-1 subtype B and 69 HIV-1
subtype C datasets was determined using BEAST. The MCMC chain was run until the
effective sample size (ESS) for the tMRCA estimate was above 100. The BEAST estimates
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and highest posterior densities present coalescent-based estimates of the evolutionary time
needed to reach the MRCA of each individual patient sample. In this study, a patient is
believed to harbour a homogeneous infection if the BEAST estimate of the tMRCA, as well
as the results from the Poisson evolution model, are consistent with the estimates to the time
of infection based on the clinical stage. If the BEAST tMRCA estimate for a patient does
not correspond to the clinical diagnosis, further investigation is warranted. The concept is
illustrated in Figure 2.2.
Figure 2.2: Phylogenetic tree illustrating a situation where the sequence diversity present in
the sample, suggests that the MRCA existed at a time before the infection took place. The
time of infection, estimated from the Fiebig clinical stage, is shown in blue.
In this example, at the time when infection is believed to have taken place based on the
Fiebig clinical stage (shown in blue), the diversity of the sample is greater than would be
expected if the infection resulted from transmission of a single virus. The sequence diversity
therefore suggests that the MRCA existed further back in time than the transmission event,
implying that some of the diversity in donor individual was transmitted to the recipient
(Figure 2.2).
The coalescent analysis was carried out on all the HIV-1 subtype B (n = 102) and C (n =
69) acute and early sequences, and the BEAST values, in units of days, were compared to
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the clinically determined Fiebig stage estimates assigned to each patient (Keele et al., 2008;
Abrahams et al., 2009). The comparisons resulted in three different groups, and patients
were categorised depending on the degree of overlap between the BEAST and Fiebig stage
estimates. The three scenarios are illustrated by specific examples below. Examples are
from HIV-1 subtype B infections, however, the same analysis steps were performed on both
subtype B and C patient datasets. One situation resulting from the comparison between
the clinical and coalescent-based estimates, is when the BEAST and Fiebig stage estimates
overlap. This situation is depicted in Figure 2.3.
Figure 2.3: Timing estimates for Patient 9032-08. The BEAST tMRCA estimate and Fiebig
stage range overlap, suggestive of a homogeneous infection.
Patient 9032-08 was clinically categorised as Fiebig III, which suggests that infection took
place between 22 and 25 days prior to isolation of the samples (Fiebig et al., 2003). The
BEAST estimate indicated that the time needed for the required number of coalescent
events to take place in order to reach the MRCA, was between 6 and 24 days. The results
are consistent with infection by a single HIV-1 strain. The Poisson evolution model provided
similar estimates, between 6 and 13 days, reinforcing the belief that the viral population
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isolated from this patient represents an homogeneous infection.
A further scenario that suggests the presence of a homogeneous infection, is show in Fig-
ure 2.4. The BEAST estimated range for patient SC11, between 2 and 8 days, suggests a
younger MRCA than the clinical Fiebig II range (between 17 and 22 days). It is likely that
patients displaying post-infection diversity, as is represented in Figure 2.4, are also harbour-
ing homogeneous infections. In these cases the overall env diversity is extremely low, and
with a fixed substitution rate of 2.16 x 10−5 together with the other assumptions of the evo-
lutionary model, the upper bound on the time it takes for the diversity to reduce to a single
sequence through coalescent events, is lower than the minimum clinical estimated duration
of infection. The evolutionary constraints acting on these env sequences, may therefore have
limited the diversification of the virus.
Figure 2.4: Timing estimates for Patient SC11. The BEAST estimate of the number of days
to the MRCA is lower than the Fiebig stage range. This suggests that the sequences are less
diverse than would be expected under the provided model of sequence evolution.
The final situation occurs when the BEAST tMRCA estimate suggests that the infection
took place at an earlier time point than the corresponding indication from the clinical esti-
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mate. If the sequences are more diverse than expected under the presented model of sequence
evolution, more coalescent events would need to take place in order to reach the MRCA of
the sample. The BEAST estimated range for patient 1059-09 (Figure 2.5), between 43 and
90 days, places the infection stage as Fiebig IV or V, however the clinical tests resulted in
a Fiebig III classification (between 22 and 25 days).
Figure 2.5: Timing estimates for Patient 1059-09. The BEAST tMRCA range is larger than
that of the Fiebig stage classification, suggesting the presence of more sequence diversity
than expected under the current model of evolution.
Patients in this class, where the comparison between the clinical and the BEAST estimates
are not consistent, fit the heterogeneous infection category. The post-infection diversity in
these cases may have been caused by infection of more than one viral strain (heterogeneous
infection), or an external factor causing an increased rate of mutation. APOBEC-mediated
hypermutation is an example of the last mentioned situation, where an inflated mutation
rate could bias the BEAST results and lead to the classification of a later stage of infection,
despite transmission of a single viral strain. The complete results for the comparisons
between Fiebig stage ranges and BEAST estimated ranges, are shown in Table 2.2.
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Table 2.2: Comparison between the BEAST tMRCA estimate and Fiebig stage range, for
102 HIV-1 subtype B, and 69 HIV-1 subtype C infection datasets.
In total, 72 of 102 (~70%) subtype B, and 49 of 69 (~71%) subtype C, infections were
labelled as homogeneous. This classification was based on the BEAST tMRCA and Fiebig
stage range comparison, where the estimates either overlapped (70/72 subtype B and 49/49
subtype C datasets) or the BEAST estimated range suggested a younger MRCA than the
equivalent Fiebig range (2/72 subtype B and 0/49 subtype C datasets, Table 2.2).
No infections were classified as homogeneous for the subtype C investigations that were not
also within the homogeneous infection group of the published study (Abrahams et al., 2009).
Further investigation, however, revealed that 1 of the subtype B infections that was labelled
homogeneous, was infected with multiple viruses. The polymorphic pattern apparent from
the Highlighter plot, as well as the structure of the phylogenetic tree relating the sequences,
showed a clear distinction between subsets of sequences in the dataset (Figure 2.6).
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Figure 2.6: Neighbour-joining tree and Highlighter plot of env sequences illustrating a mul-
tiple virus infection for patient Z10.
Patient Z10 (Figure 2.6) was classified as Fiebig VI, which occurs from 101 days post-
infection through to chronic infection. Since a Fiebig VI classification provides an open-ended
maximum duration, BEAST tMRCA estimates will always be within, or smaller than, the
corresponding clinical estimate. Comparing Fiebig VI estimates to model-based estimates as
a means to classify homogeneous infections is therefore not suitable. In general it is possible
that viral samples do not represent the entire viral diversity of the population within the
infected individual, and that the coalescent time is therefore shorter than the corresponding
clinical time estimate. Another scenario is where the diversity within env reached some
threshold beyond which the MRCA is difficult to estimate accurately. Selection is also likely
to occur in viral populations from Fiebig stages V and VI (Lee et al., 2009), which BEAST
does not explicitly model, and in such cases the higher diversity due to positive selection
may therefore lead to a tMRCA further back in time than expected under neutral evolution.
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2.3.1.2 Addressing APOBEG3G Hypermutation
APOBEC3G hypermutation is one of the external factors that can affect the BEAST esti-
mate of the tMRCA. Since APOBEC3G causes an excess of A-to-G mutations (see section
1.2.5.2), and is not included in the model, the amount of diversity in sequences affected by
APOBEC hypermutation will be greater than expected for a given time to infection. The vi-
ral population isolated from patient 1059-09 provides an example of a hypermutated dataset
(Figure 2.7). For this patient, the APOBEC3G signature was found to be scattered across
the individual sequences, as indicated by the blue stars (Figure 2.7). The BEAST estimate
originally suggested that the MRCA existed between 43 and 90 days in history, despite the
Fiebig III clinical classification suggesting that infection took place at an earlier time point
(22 - 25 days back in time, Figure 2.8). After removal of the hypermutated sequences, the
BEAST tMRCA estimate was decreased to between 17 and 50 days (Figure 2.8), which
corresponds to the Fiebig III range. Patient 1059-09 was therefore classified as harbour-
ing a homogeneous infection after the APOBEC3G-induced hypermutated sequences were
removed.
Figure 2.7: Sequence alignment for Patient 1059-09. The blue stars indicate sites that are
in the APOBEC3G context, and the tick marks represent other substitutions.
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Figure 2.8: Timing estimates for Patient 1059-09 with APOBEC hypermutated sequences
included as well as removed. The BEAST tMRCA range for the dataset with hypermutated
sequences is larger than that of the Fiebig stage classification, suggesting the presence of
more sequence diversity than expected under the current model of evolution.
The subtype B investigation carried out by collaborators (Keele et al., 2008), revealed that
13 datasets contained significant hypermutation, while 2 others also harboured hypermu-
tated sequences, but the prevalence of hypermutation was not high enough to be labelled
as significant. Among the 13 patients with sequences that were significantly hypermutated,
there were six where the evidence of G-to-A hypermutation was isolated to a single sequence.
In the remaining seven datasets, APOBEC-mediated hypermutation was spread across mul-
tiple sequences (Keele et al., 2008). In the current study, five of the hypermutated datasets
were initially not classified as homogeneous infections due to APOBEC-induced hypermu-
tation resulting in an increase in the diversity of the sequences. The APOBEC-mediated
mutations were excluded for all 15 hypermutated datasets, and reanalysis was carried out.
Where the BEAST estimate originally suggested a MRCA further back in time than the
clinical estimate, removal of mutations likely to be the consequence of APOBEC hyper-
mutation resulted in estimates that overlapped in all cases. In the current study, the five
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infections that were originally determined to be heterogeneous due to the excess mutations,
were therefore classified as homogeneous after the reanalysis.
Similar results were obtained for the HIV-1 subtype C analysis. Eight datasets contained
APOBEC3G hypermutated sequences, and 5 of the 8 infections were originally not classi-
fied as homogeneous. After removal of the hypermutated sequences, the BEAST tMRCA
and Fiebig stage range for all five of these overlapped. The hypermutated sequences were
discarded, and all 8 infections were labelled as homogeneous.
Once the impact of APOBEC3G hypermutation was addressed, the classification of homoge-
neous infections could be updated (Table 2.3). Twenty-five HIV-1 subtype B and 15 subtype
C datasets were not classified as homogeneous infections (Table 2.3). The level of diversity
for these patients was higher than expected under the given model of evolution, which sug-
gested that alternative factors, beyond APOBEC-mediated hypermutation, are responsible.
It is likely that a large number of infections in this group were caused by multiple infections,
and therefore can be classified as heterogeneous infections. However, further investigation is
warranted for these patients because a higher observed diversity does not necessarily imply
that an infection was caused by multiple viruses, as is clear from the APOBEC hypermutated
examples.
Table 2.3: Comparison between the BEAST tMRCA estimate and Fiebig stage range, after
removal of the APOBEC hypermutated sequences. One subtype B overlapping time range
was assumed to be representative of homogeneous infections, but were later shown to be
infected by multiple viruses (indicated in parenthesis).
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2.3.1.3 Categorising the Difficult Cases
In most cases described, the overall diversity observed in a dataset corresponds to the number
of viruses transmitted during infection. Coalescent-based estimates of the tMRCA will
therefore resemble the true time since infection. However, in certain situations transmission
of two closely related viruses that have low overall diversity, or transmission of a single
virus strain where the sequence diversity is higher than expected due to external influences,
for instance APOBEC, the observed diversity will not correspond the number of infecting
viruses. This type of infection is harder to classify and requires further investigation.
An example of a patient sample that was difficult to characterise, is shown in Figure 2.9.
The sequence diversity of the viral envs isolated from patient 6247-08, who was classified as
Fiebig stage II, was consistent for an infection from this clinical stage. The BEAST estimated
range (2 - 25 days) indicated a MRCA that overlapped the Fiebig II range (17 - 22 days).
The sequences diversity was visualised by drawing a Neighbour-joining tree and creating a
Highlighter (http://www.hiv.lanl.gov/) plot (analysis carried out by collaborators, Keele et
al., 2008).
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Figure 2.9: Neighbour-joining phylogeny and Highlighter plot for Patient 6247-08. Evidence
of infection by two closely related viral strains can be observed in both figures. There are
3 polymorphisms that clearly distinguish the two strains, and two distinct populations are
evident from the neighbour-joining tree.
The Highlighter plot revealed 3 apparent differences between two subsets of sequences, as is
clear from Figure 2.9. Furthermore, the phylogenetic tree relating the sequences indicated
that two distinct lineages were discernible (Figure 2.9). One group of sequences resembled
the consensus sequence, where the second contained 3 mutations that differentiated them
from the rest. Patient 6247-08 was therefore classified as infected with two very closely
related viruses (Keele et al., 2008). One patient in the subtype C study displayed similar
characteristics to patient 6247-08, and although both were initially categorised as homoge-
neous infections after comparing the BEAST tMRCA and clinical estimate, a more accurate
explanation resulted from further investigation. These two patients were therefore classified
as infected by two closely related virus strains.
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The BEAST estimates for the infections that were not classified as homogeneous at this
stage, suggested that pre-infection diversity was present in these datasets (Table 2.3). The
25 subtype B infections that were not labelled as homogeneous, were investigated further.
Three of these were identified as homogeneous infections by other methods, for example
low overall nucleotide diversity, and near overlap between the clinical estimated date of
infections and the BEAST tMRCA estimate. For the remainder of the patients (22/25) no
alternative explanation for the high overall levels of diversity contained within these datasets
could be described, and these patients were classified as harbouring heterogeneous infections.
Further investigations were also carried out on the uncharacterised subtype C datasets, and
one patient was classified as homogeneous due to the near overlap between the clinical and
BEAST estimate. The remainder of the infections that displayed pre-infection diversity
(14/15) were classified as heterogeneous due to the high levels of diversity and the presence
of more than one transmitted variants (Abrahams et al., 2009).
The number of individuals identified as harbouring homogeneous infections by compar-
ing the BEAST estimated tMRCA and the Fiebig stage classification (after accounting for
APOBEC3G-induced hypermutation as well as categorising the difficult cases), was 77/102 for
the subtype B analysis, and 54/69 for subtype C (Table 2.4). For 2 subtype B infections, and
1 for subtype C, overlapping time ranges were assumed to be representative of homogeneous
infections, but were later shown to be infected by multiple viruses. Furthermore, the near
overlap between the BEAST and clinical estimates for 3 subtype B infections, and 1 subtype
C infection, suggested that these individuals were infected with a single virus strains (Table
2.4, indicated in parenthesis). The overall results were similar to the numbers determined for
the publications, 78/102 for subtype B (Keele et al., 2008), and 54/69 for subtype C (Abrahams
et al., 2009). Furthermore, the comparative approach described here, resulted in a total of
only 3 misclassifications of homogeneous cases where the individuals were later shown to be
infected by multiple strains (shown in Table 2.4).
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Table 2.4: Final comparison between the BEAST tMRCA estimate and Fiebig stage range.
The misclassifications are indicated in parenthesis.
A recent publication has indicated that the comparative approach for identifying homo-
geneous infections, where model-based estimates and clinical estimates of the time since
infection are compared, is only valid for patients in Fiebig I and II, during which time the
viruses are evolving neutrally (Lee et al., 2009). Since selection is likely to influence model-
based estimates of the tMRCA, the comparative approach on its own is not suitable for
classifying homogeneous infections in patients within the later Fiebig stages (III-VI). Simi-
larly, if the BEAST estimates for datasets from later Fiebig stages (III-VI) suggest a shorter
time from infection than the clinical estimates, which would erroneously place the infection
within the homogeneous group, it is possible that purifying selection has taken place in a
heterogeneous infection (Lee et al., 2009).
Nevertheless, BEAST, as a coalescent-based approach for determining the MRCA of a col-
lection of sequences from a population, provides a very useful tool for evolutionary analysis.
In the present research, if only BEAST estimates and Fiebig stage ranges were available,
only 2/77 infections for the subtype B, and 1/54 infections for the subtype C analyses, would be
classified as homogeneous, although further investigation revealed that the infections were
caused by more than one viral strain (Keele et al., 2008; Abrahams et al., 2009). Further-
more, only 4 infections were misclassified as heterogeneous instead of homogeneous. These
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results suggest that BEAST is a very valuable resource for studies aimed at estimating the
time to most common recent ancestor of a group of sequences, and comparing the estimates
to laboratory staging criteria for classifying homogeneous and heterogeneous infections.
2.3.2 Comparison Between the Poisson Evolution Model
and BEAST
The results from the Poisson evolution model and those obtained from the coalescent analysis
performed with BEAST were compared. A total of 164 estimates were available, and the
BEAST estimate was smaller than the corresponding Poisson model estimate in only 4/164
cases. In the remainder of cases the estimates from the Poisson model were smaller than
the BEAST estimate. The more diverse the underlying sequence alignment, the greater the
difference between the BEAST and Poisson estimates.
The mean tMRCA estimates from the BEAST and Poisson models, for all the homoge-
neous infections, were compared. The scatterplots in Figures 2.10 and 2.11 illustrate the
relationship between the tMRCA estimates from BEAST and the Poisson models for HIV-1
subtype B and subtype C respectively. In both cases the results indicated a strong positive
correlation; for the subtype B analysis, R2 = 0.955 and the gradient for the linear fit is 0.701
(Figure 2.10). The subtype C analysis resulted in a R2 = 0.968 and a slope parameter in
the linear model of 0.504 (Figure 2.11). If the two models produced the same estimates, the
gradient of the linear model is expected to be equal to one. A comparison was carried out
with the aim to establish which model perform better at predicting homogeneous infections.
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Figure 2.10: Scatterplot of the HIV-1 subtype B tMRCA estimates from the Poisson and
BEAST models. The linear model is shown as a blue dashed line.
Figure 2.11: Scatterplot, and linear fit, of the HIV-1 subtype C tMRCA estimates from the
Poisson and BEAST models.
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The performances of the Poisson and BEAST models to classify homogeneous subtype B1
infections, were compared. However, the Poisson model was not applied to all the patient
datasets due to the complexity introduced by hypermutation or multiple recombination
events (Keele et al., 2008), and the comparison was therefore carried out on the the pa-
tients that were classified as homogeneous infections by Keele et al., 2008. The number
of individuals for which the predicted tMRCAs postdated the clinically estimated time of
infection was three for both models. These patients would therefore have been classified
as harbouring heterogeneous infections if further investigation was not carried out. The
similarity between the prediction results is not entirely unexpected considering that the es-
timates from the Poisson model were consistently smaller than the BEAST estimates (as
the gradient of the linear model in Figure 2.10 illustrates) in all but four cases. It is likely
that the Poisson model would therefore do no worse than the BEAST model at classifying
homogeneous infections as homogeneous, as in the present comparison.
2.3.3 Relating the HIV-1 Subtype B and C Analysis
A comparison between the results obtained from the HIV-1 subtype B and C analysis may
reveal interesting subtype-specific transmission characteristics. In the studies carried out by
Keele et al. (2008) and Abrahams et al. (2009), homogeneous infections were identified in
78 of 102 (76.5%) HIV-1 subtype B infected individuals, whereas 54 of 69 (78.3%) subtype
C infections were labelled homogeneous. These results are very similar and lead to the
hypothesis that 3 out of 4 HIV-1 infections are caused by the transmission of a single viral
strain, regardless of the subtype.
Previous reports have suggested the existence of an HIV-1 transmission bottleneck (for
example Derdeyn et al., 2004 and Sagar et al., 2004), however the subtype B and C studies
compared here, have provided a quantification of this bottleneck. Furthermore, multiple
strain infections were considered to be caused by either subsequent individual transmission
events or simultaneous transmission of multiple viruses (Sagar et al., 2004; Gottlieb et al.,
1The analysis was not carried out on the subtype C data since the CIs for the mean estimates from the
Poisson model were not available.
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2004; Ritola et al., 2004). However, the low probability of sexual transmission (Ritola et
al., 2004), together with the support from the results obtained from Keele et al. (2008) and
Abrahams et al. (2009), suggest that multiple infections occur simultaneously and are not
as frequent as homogeneous infections.
2.4 Conclusions
The results described in this chapter illustrate how a coalescent-based approach, for example
BEAST, can be used to estimate the time to the most common recent ancestor of a group
of sequences. If only the BEAST estimates and Fiebig stage durations were available, only
4 patients that were classified as harbouring homogeneous infections in the final published
cases, would not be identified here. Furthermore, only 2/77 subtype B and 1/54 subtype C
infections were classified as homogeneous infections and later shown to be caused by trans-
mission of more than one virus. Therefore, only ~4% (7/171) of cases were misclassified.
Comparing the BEAST tMRCA and modified Fiebig stage estimates to identify homoge-
neous and heterogeneous infections therefore corresponded to the published classification for
~96% of the infections (Abrahams et al., 2009; Keele et al., 2008).
Furthermore, the results from this study suggest that a single strain is transmitted from an
infected individual to a new host in 3 out of 4 transmission events, providing a quantification
to the transmission bottleneck previously described (for example Derdeyn et al., 2004). The
knowledge that a remarkably high proportion of infections are caused by the transmission
of a single viral strain, has a large impact on future early infection studies. If infection
is caused by the transmission or outgrowth of a single virus, then the diversity observed
in the new host represents the changes that occured after infection, and these changes are
likely to play a role in viral adaptation to the new host. Identifying the mutations that occur
after infection may therefore lead to new research avenues for developing effective prevention
strategies. Furthermore, understanding the selective pressures acting on the virus during
the earliest stages of infection may present novel approaches for drug and vaccine design.
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This objective, to identify specific sites in the HIV genome that evolve adaptively during
early infection, was the aim of the next chapter (Chapter 3).
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Chapter 3
Evaluation of Selection Pressures and
the Impact of APOBEC in Early
Infection
3.1 Introduction
The work described in this chapter forms part of an international collaborative project,
which was published in PLoS Pathogens during May 2009 (Wood et al., 2009). Not all of
the content contained in the publication is included here, since parts of the research was
carried out by collaborators. Parts of this chapter that are based on the work of collaborators
and this is indicated clearly in the text. These sections were included to maintain the clarity
and provide the context of this work. Although some changes to the originally published
text have therefore been made, the results and eventual conclusions are the same.
Adaptation of HIV-1 to new hosts, in particular to the initial immune response, is likely
to influence the establishment and progression of HIV infection. Mutations that enable
escape from the host’s immune responses will come under selective pressure, in an order that
reflects the timing of the immune responses, underlying mutational rates, and the relative
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fitness costs of mutations. In addition, escape mutations that occurred in the infecting host,
particularly those resulting in a reduction of viral fitness (Chopera et al., 2008), will come
under selective pressure to revert to wild-type in the newly infected individual (Friedrich et
al., 2004). If transmission itself is a selective process, such that, for example, viral variants
that are adapted to replication in mucosal cell types are selectively transmitted, the virus
may experience selection to acquire forms that are adapted to replication in other host
tissues. Since the viral envelope glycoprotein (Env) plays a vital role in transmission, is an
early target of immune responses, and a key determinant of target cell tropism, the early
evolution of the HIV-1 env gene is of particular interest (See section 1.2.4 for a description
of Env).
The transmission of HIV is associated with a severe population bottleneck, such that, in
most cases, new infections result from transmission or expansion of a single virus (Keele
et al., 2008). As described in Chapter 2, it has recently been shown that the sequence of
the transmitted virus can be identified accurately through direct sequencing of the uncloned
DNA amplicons derived from single genome amplification (SGA) of plasma viral RNA sam-
pled during acute and early infection (Salazar-Gonzalez et al., 2008; Keele et al., 2008).
Keele et al. (2008) classified each of 102 HIV-1 subtype B primary infections into one of six
clinical stages according to patterns of laboratory assay reactivity defined by Fiebig et al.
(2003). Following the analysis described in Chapter 2, of the 102 subtype B patients, there
was evidence of infection by or rapid outgrowth of a single virus (or in three cases possibly
two or more very closely related viruses) for 81 of these individuals (Keele et al., 2008). In
the present study a detailed analysis of the early evolution and divergence of the virus from
the ancestral infecting strain in these 81 homogeneous infections was carried out. The study
was restricted to the homogeneous infections because in these patients the observed sequence
diversity is expected to be due mainly, or entirely (in the case of transmission of a single
viral variant), to mutations that have occurred following transmission. The data analysed in
this study consisted of sets of between 10 and 67 sequences per patient, generated previously
using SGA from single time-points in acute or early infection (Keele et al., 2008).
Phylogenetic trees of the sequences from individual patients had short branch lengths and
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few internal branches, reflecting the short time since transmission and rapid expansion in the
new host. The individual sequence datasets contain very little information, and standard
phylogenetic models are therefore not sufficient to gauge whether it is selection pressures or
stochastic changes that are resulting in the diversification of the virus following transmission.
However, by considering all patients simultaneously, it was possible to determine whether
similar patterns of sequence diversification were repeated either in multiple patients or within
the same patient. Shared patterns of rapid diversification at the same codons in early
infection, can reveal sites that are typically involved in viral adaptation to the new host
at the earliest stage of infection. In cases where these sites are associated with specific
host immune responses, they shed light on the nature, extent, and timing of the immune
responses that most frequently exert selective pressure on the transmitted virus during acute
and early infection. However, there is also the possibility that shared mutations across
multiple patients may be the result of deviation from the expected mutation rates, so that
particular sites with high mutation rates, for example resulting from APOBEC-mediated
substitutions, might be mutated in an unexpectedly high proportion of patients.
In this study, HyPhy (Kosakovsky-Pond and Muse, 2005), an interpreted computer pro-
gramming environment for fitting evolutionary models, was used to develop a method which
can identify sites in env that tend to diversify most rapidly across recently infected patients.
This allowed for a further exploration of the reasons for rapid diversification at these partic-
ular sites. The main findings from the research described here, were that there is evidence
of positive selection in early HIV-1 infection, which appears to be driven in many cases by
escape from early cytotoxic T lymphocyte (CTL) responses; and furthermore, in several
cases CTL escape occurred via mutations in the APOBEC sequence context, suggesting a
role for APOBEC in determining the pathway of immune escape. These results provide the
most detailed view yet of the process of diversification of the homogeneous viral population
following transmission.
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3.2 Methods
3.2.1 Dataset Assessment: Addressing Recombination and Hy-
permutation
Envelope sequences (n = 3476) from 102 individuals infected with HIV-1 subtype B, were
generated using Single Genome Amplification (SGA), as part of a previous study (Keele et
al., 2008). Among these individuals, 81 were found to be likely to have been productively
infected by just a single virion (or infected cell), or two or more closely related viruses, while
21 were multiply infected since the level of diversity seen in these cases was greater than
could have accrued since the time of infection. The 21 heterogeneous cases were not included
in the analysis of selection pressure. Intra-patient alignments were generated through an
iterative process, which included the alignment of all patient consensus sequences, manual
editing, and re-alignment of each patients’ sequence data to the associated consensus, as
described in the Supporting Information of Keele et al. (2008).
Recombination analysis was carried out with GARD (Kosakovsky-Pond et al., 2006b) and
evidence of recombination was found in just two of the homogeneous patients. A further
14 from the heterogeneous group (analysed previously Keele et al., 2008) showed evidence
of recombination that was confirmed by either GARD (Kosakovsky-Pond et al., 2006b) or
Recco (Maydt and Lengauer, 2006). For our previous study, acutely infected patients were
staged using clinical criteria described by Fiebig et al. (2003), into six clinical stages from
the earliest, Fiebig stage I, to the latest stage of early infection, Fiebig stage VI. All regions
of the alignment that are translated in more than one frame, as well as all regions that were
ambiguously aligned, were masked for the analysis of selection pressure.
In addition, for the model-based inference of selection, described in the subsequent sec-
tion (section 3.2.2), individual sequences that showed statistically significant evidence of
APOBEC-mediated hypermutation using Hypermut 2.0 (http://www.hiv.lanl.gov/content/-
/sequence/HYPERMUT/hypermut.html) were discarded. Among the patients, 15 had a
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generalized increase in the rate of G-to-A mutations in the context of the sequence motif
associated with APOBEC hypermutation. In these cases there was an excess of G-to-A
mutations in the APOBEC sequence context across all sequences from the patients and not
concentrated in individual severely hypermutated sequences (Keele et al., 2008). Since in
these cases APOBEC mediated mutations may be occurring at an elevated rate, and this
context-specific rate would deviate from the evolutionary model, a separate analysis of se-
lection excluding these 15 patients was carried out. On the other hand, recurrent G-to-A
mutations in the context of APOBEC substitution motifs are enriched overall in these data,
suggesting APOBEC may have a role in HIV-1 evolution in early infection, therefore, in
parallel the full set of 81 subjects was analysed.
The alignments used for these analyses were from our previous study Keele et al. (2008) and
are available at http://www.hiv.lanl.gov/content/sequence/hiv/user_alignments/keele.
3.2.2 Maximum Likelihood Model for Detecting Selection
HyPhy (Kosakovsky-Pond and Muse, 2005) was used to assess the evidence for a subset
of codon sites in the env gene evolving under the influence of positive Darwinian selection
(Kosakovsky-Pond et al., 2008) in early infection. Essentially, this method works by fitting
standard codon models (Nielsen and Yang, 1998) of sequence evolution to multiple sequence
alignments from all of the patients. The critical parameter of the codon models is ω, the
ratio of nonsynonymous to synonymous substitution rates. If synonymous substitutions are
assumed to be generally neutral, then sites for which ω is significantly greater than one are
inferred to be evolving under positive Darwinian selection (Yang et al., 2003; Delport et al.,
2009). However, deviation from the evolutionary model as a result of enhanced mutation
rates at specific sites, for example, those embedded in APOBEC signature motifs, can also
contribute in some cases to an elevated ω (see section 3.3).
The random effects likelihood approach (Yang and Nielsen, 2000) and a model of site-to-site
variation in ω equivalent to Model M2a from Wong et al. (2004), was used. The selection
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parameter, ω, was modelled using a discrete distribution with three classes: a purifying
selection class for which ω, constrained to be less than one, is estimated from the data; a
neutral class for which ω = 1, and a positive selection class for which ω is estimate from
the data and constrained to be greater than one. The fit of this model is compared, using
the likelihood ratio test, to a model equivalent to M1a from Wong et al. (2004), in which
the proportion of sites in the positive selection category is fixed at zero. Both of these are
mixture models. In the standard implementation of these models the likelihood of the data
is given by:
L(D|θ, T ) = ∏
i
∑
j
L(Di|ωi = j, T, θ)p(ωi = j|θ)

where the product is taken over sites of the alignment, the sum is over the discrete ω classes
(j1..j3), and Di, T and θ are the data at site i in the alignment, the phylogenetic tree and the
parameters of the model, respectively. Here, this is extended to data from multiple patients
by writing the likelihood as:
∏
i
∑
j
∏
k
(
L
(
Dki |ωi = j, Tk, θ
))
p
(
ωi = j|θ
)
where Dik, and Tk are the data and tree from patient k, respectively. In this formulation ω
has the same value at a given site across all within-patient sequence alignments.
Following likelihood parameter estimation, posterior probabilities of belonging to each of the
site classes of ω were estimated for each site using the naïve empirical Bayes method (Yang
et al., 2005). For all of the models, mutation rates were estimated separately for each pair
of nucleotides, thus assuming a general time-reversible model of nucleotide substitution, and
the Goldman and Yang method (Goldman and Yang, 1994) was used to account for biased
codon usage.
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3.2.3 ELIspot and Intracellular Cytokine Assay
The work described in this section (section 3.2.3) was carried out by collaborators (Wood
et al., 2009). The results obtained from these laboratory experiments, are relevant to the
conclusions drawn, and the description of the methods, provided by these collaborators, is
therefore included here.
3.2.3.1 ELISpot assays
Ex-vivo IFN-γ ELISpot assays:
Eighteen- and 9-mer peptides were synthesised (MRC Human Immunology Unit, WIMM,
Oxford UK) to match sequences from patients MEMI, Z13, Z33 and Z36. Cryopreserved
Peripheral Blood Mononuclear Cell (PBMC) samples were defrosted, incubated for 2 hours
and placed in the Enzyme-linked immunosorbent spot (ELISpot) plates at 1 x 105 cells/well.
Peptides in the peptide plates were mixed with 1:1 with PBMC in the ELISpot plate to a
final concentration of 2 µg/ml and incubated for 20 hours at 37◦C, 5% CO2. PBMCs and
peptides were tested in R-10 medium (10% fetal bovine serum, 86% RPMI 1640, 2 mM
L-glutamine, 1 x penicillin-streptomycin solution, 10 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffer and 1 mM sodium pyruvate, all Sigma). Coating,
development and reading of ELISpot plates have been described previously (Goonetilleke
et al., 2006). A definition of positive responses was applied as: ≥ 50 SFU/million, > 4 x
background. For all assays 6 negative control wells (media only) and 2 positive control wells
(10 µg/ml PHA, Sigma) were used.
Cultured IFN-γ ELISpot assays:
This assay has been previously described in Goonetilleke et al. (2006). In brief, short-term
cell lines (STCLs) were set up whereby 2 x 106 cell/ml of PBMCs were stimulated with a
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pool of peptides specific to the patient at 2 µg/ml in the presence of 25 ng/ml IL-7 (R&D
Systems). Cells were cultured at 37◦C, 5% CO2, for 10 days in RAB-10 (10% human AB
serum, 86% RPMI 1640, 2 mM L-glutamine, 1x penicillin-streptomycin solution, 10 mM
HEPES buffer and 1 mM sodium pyruvate, all Sigma) and were stimulated with 1800 U/ml
IL-2 (Novartis) on days 3 and 7. On day 10, the STCLs were washed three times with
PBS (Sigma) and incubated for 30 hours in RAB-10 at 37◦C, 5% CO2. On day 11, 4 x 104
cells/well were placed into an IFN-γ ELISpot as described above and stimulated by each
individual peptide in triplicate at 2 µg/ml in the presence of RAB-10.
HLA typing:
HLA typing was performed by T. Rostron (WIMM, Oxford UK) using the Sequence-Specific
Primer (SSP) method adapted from Bunce (2003), that uses allele-specific primer combina-
tion in PCR amplification to provide absolute HLA resolution to 2-digits and high probability
resolution to 4-digits.
3.2.3.2 Intracellular Cytokine Assay
Cryopreserved PBMCs were defrosted, incubated overnight and stimulated for 6 hours at
37◦C, 5% CO2, with 2 µg/ml of individual HIV-1 peptides representing the wild-type and
escape sequences of the epitopic regions. The stimulation was conducted in the presence of
anti-CD28 mAb (1 mg/ml; L293; BD Biosciences), anti-CD49d mAb (1 mg/ml; L25; BD
Biosciences), anti-CD107a-Alexa 680 (H4A3; BD Biosciences), 5 µg/ml Brefeldin A (Sigma)
and 1 µg/ml Golgi Stop (Pharmingen). After stimulation, the PBMCs were stained with
LIVE/DEAD Fixable Violet Dead Cell Stain (InVitrogen, Eugene, OR), anti-CD14-Cascade
Blue (M5E2), anti-CD19-Cascade Blue (HIB 19) (to exclude non-viable cells), anti-CD4-
Cy5.5-phycoerythrin (PE) (M-T477), anti-CD8-QD705 (RPA-T8), anti-CD27-Cy5-PE (M-
T271), anti-CD57-QD605) (NK-1), anti-CD45RO-PE-Texas Red (all from BD Biosciences,
except CD45RO, which was from BeckmanCoulter) for 20 minutes at room temperature.
PBMCs were then fixed and permeabilised with Cytofix/Cytoperm (Pharmingen). PBMCs
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were stained with anti-CD3-Cy7-APC (SK7), anti-IFN-g-fluorescein isothiocyanate (FITC)
(B27), anti-IL-2-Allophycocyanin (APC) (MQ1-17H12), anti-TNF-a-Cy7-PE (MAb11) and
anti-MIP-1b-PE (D21-1351) (all BD Biosciences) for 45 min at 4◦C. After washing and
fixation, samples were run on a custom built LSRII (BD Bioscences). A minimum of 300,000
total events was acquired using a custom made LSR II flow cytometer (BD Bioscience, San
Jose, CA). Data analysis was performed using FlowJo 8.8.2 software (TreeStar), Pestle for
background subtraction, and Spice for frequency analysis. (Pestle and Spice provided by Dr.
M. Roederer Vaccine Research Center, NIH, Bethesda). ‘Memory’ CD8 T-cells are defined
as live / lymphocytes / CD3 / CD8 / excluding the CD27hiCD45RO-negative population.
Individual and total cytokine responses were considered as positive if the frequency of the
total responding memory CD8+ subset was greater than 0.05% after background subtraction.
3.3 Results and Discussion
The availability of data from a large number of individuals in acute and early infection
that harbour a homogeneous set of viruses, leads to an opportunity to study the pattern
of diversification of HIV-1 upon transmission to a new host. Since 78 of these patients
are believed to have been productively infected by single viruses (three others are likely to
have been infected by two or more closely related viruses), the observed diversity can be
inferred to have arisen in the newly infected patient and not in the individual from whom
the infection was acquired (Keele et al., 2008). The size of the sample and the quality of the
sequence data provide the first opportunity to assess whether there are consistent patterns
of evolution that tend to recur across multiple patients in early infection.
3.3.1 Model-based Inference of Selection in Early Infection
HyPhy (Kosakovsky-Pond and Muse, 2005) was used to assess the selective pressure acting on
viruses in early infection. Models of codon sequence evolution were fitted to 2,207 env coding
sequences from early stages of HIV-1 infection as described in section 3.2.1. In order to
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accumulate evidence of selection from multiple patients, the models were implemented such
that at a given site the value of ω (the ratio of nonsynonymous to synonymous substitution
rates) was constrained to be the same in all patients. This enabled us to use standard model
comparison techniques to investigate whether there was evidence that the mean value of ω
across patients was significantly greater than one at a subset of sites in the alignment (see
section 3.2.2). It was found that, as expected, the majority of codon sites evolve under the
influence of purifying selection (with ω < 1) in early infection, and the mean value of ω
across all sites in all patients, was 0.67.
Three overlapping groups of patients were considered, consisting of individuals in the earliest
clinical stages (Fiebig stages I and II), earliest through intermediate stages (Fiebig stages I
through III) and all patients in early infection (Fiebig stages I through V). For the data from
Fiebig stages I and II the model allowing a subset of sites to evolve under positive selection
did not provide a significantly better fit to the data than the model in which positive selection
was not permitted (p = 0.52; Table 3.1). For the other two datasets, however, the selection
model (M2a) provided a significantly better fit to the data than the model in which selection
was excluded (M1a). M1a was rejected against M2a with p-values 0.006 and 0.0001 in the
case of the datasets from Fiebig stages I-III and stages I-V, respectively (Table 3.1).
Table 3.1: Parameter estimation for the neutral and selection model applied to env sequences
from different Fiebig stage datasets.
Before this analysis was carried out, all individual sequences with evidence of APOBEC-
72
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
mediated hypermutation were removed using Hypermut 2.0 (www.hiv.lanl.gov). For fif-
teen of the patients the env sequences showed an overall elevated rate of G-to-A muta-
tions in a sequence context associated with APOBEC hypermutation (using the method-
ology described in the supporting information of Keele et al., 2008, see Figure 3.1), even
though no individual sequences showed evidence of hypermutation. The Highlighter plots
(http://www.hiv.lanl.gov/content/sequence/HIGHLIGHT/highlighter.html) in Figure 3.1
illustrate the different arrangements of hypermutation. Statistical tests of hypermuta-
tion were performed using Hypermut (http://www.hiv.lanl.gov/content/sequence/HYPER-
MUT/hypermut.html). As described in Chapter 2, most of the patient datasets displayed
no evidence of hypermutation (Figure 3.1 A). A further scenario is where a single sequence
within a patient sample is significantly hypermutated (p < 0.1; Figure 3.1 B). A patient with
an overall elevated rate of hypermutation is shown in Figure 3.1 C. Although no individual
sequence showed significant evidence of hypermutation in this patient, after compressing
the mutations into a single sequence (using a tool available from the Highlighter website,
http://www.hiv.lanl.gov/content/sequence/HIGHLIGHT/highlighter.html), and re-running
Hypermut with the compressed sequence, there was a significant elevation in the rate of G-
to-A mutations in the APOBEC sequence context (p = 9 x 10−6).
Figure 3.1: Highlighter plots illustrating, with green stars, different patterns of hypermu-
tation. A) Sequences from a patient showing no evidence of hypermutation. B) A patient
with a single significantly hypermutated sequence. C) Sequences from a patient showing an
overall elevated rate of hypermutation.
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Hotspots of mutation could create false positive signatures of positive selection. This is
particularly true if the same hotspots are repeated across multiple patients, as would be
expected for mutation hotspots resulting from APOBEC hypermutation. To limit the impact
of hypermutation on our results, these patients were removed from the dataset, leaving 66
subjects. Interestingly, even with these precautions, it was found that sites that were placed
in the set of sites with ω > 1 (positive selection site class) are enriched for the APOBEC-
motif (see Table 3.2). Given the potential biological relevance of these mutations, a second
analysis including all 81 homogeneous patients was performed, bearing in mind the caveat
that the model may be affected by the higher rate of G-to-A mutation in the APOBEC
context. Therefore, some of the sites identified from this dataset may reflect mutational
hotspots rather than selection acting on the amino acid sequence.
A statistical model comparison was used to make the claim that there is evidence of adaptive
evolution in HIV-1. To do this, the fit to the data of a model in which no sites in the
alignment were allowed to evolve with ω >1, was compared to the fit of a model in which a
subset of sites were allowed to have ω >1. The latter model had a significantly better fit to
the data for the sequences from Fiebig stages I-III and Fiebig stages I-V, suggesting that the
virus evolves adaptively in these clinical stages. However, there are two important issues to
consider here. First, the fact that the positive selection model did not have a significantly
better fit to the data in Fiebig stages I-II does not prove that viral diversification is not
shaped by positive selection at this stage of infection. Sequences from stages I-II were highly
homogeneous, thus a very small number of mutations from the infecting virus were observed
in each patient, severely limiting the power to detect evidence of selection. Secondly, a
more general issue is that models of codon evolution used to detect positive selection rely
upon several assumptions about the way the sequences are evolving, including the absence
of recombination and independence between nucleotide sites, and deviations from these
assumptions could lead to false positive results (Suzuki and Nei, 2002).
APOBEC induced mutations give rise to hotspots of amino acid change which have a mu-
tational rather than a selective cause. Although an attempt was made to control for the
effects of hypermutation by removing sequences and patients with evidence of an elevated
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rate of mutation in the APOBEC3 sequence context (Figure 3.1), the enrichment of mu-
tations in this context among sites placed in the positive selection site class, suggests that
hypermutation may have had an effect on the model comparison results.
It is of interest to test for the evidence of directional change in env in early infection, since
this could impact the understanding of the nature of the transmitted virus. As is clear
from several studies (Keele et al., 2008; Derdeyn et al., 2004; Sagar et al., 2006; Edwards
et al., 2006), there is a severe viral population bottleneck during HIV transmission, with
newly transmitted infections resulting frequently from transmission or outgrowth of a single
virion. If this extreme bottleneck is non-random and if viruses that are best adapted for
transmission from one host to the next tend to be less well adapted for replication in the
new host, then there may be selection for reversion of the characteristics associated with
transmission in the newly infected host. If, further, these characteristics are shared across
multiple transmitted viruses, then such reversions in early infection could potentially be
observed through our approach. Here, evidence for purifying selection was found, indicating
that the transmitted virus was a reasonably fit form prior to the initial immune response
imposing new selection constraints. Furthermore, relatively little support for characteristic
patterns of reversion at the population level in this cross-sectional view was identified.
3.3.2 Analysis of Rapidly Evolving Sites
Since the sequence datasets from early infection are very homogeneous and generally well
described by a star-like phylogeny, it was rare to find multiple independent mutations within
the same patient, and consequently, primarily sites that tended to diversify rapidly in many
patients were identified. Twenty-four sites were found in env with posterior probability of
greater than 0.5 of belonging to the positive selection site class based on the 66 subjects
discussed above (Table 3.2).
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Table 3.2: Positive selection results obtained using HyPhy from a dataset excluding indi-
viduals with sequences enriched for APOBEC hypermutation as well as from the complete
dataset including the hypermutated sequences (the latter sites are indicated with +). The
location, timing, and mutational patterns observed are provided. The sites for which CTL
testing was carried out or not are shown in blue font.
Key for Table 3.2:
HXB2: Coordinates listed according to HXB2 numbering (http://www.hiv.lanl.gov/content/sequence/LOCATE/locate.html).
Data: Coordinates listed according to the protein alignment of all 81 early infected subjects.
Location: Region in Envelope.
Posterior Probability: Sites identified in HyPhy with a posterior probability > 0.5 are included in this table.
Number of subjects with variation: Out of the 81 subjects, the number that had any variation in this site.
Contribution of APOBEC: The number of subjects, among those that vary in a given position, that have a G-to-A change
in the context of an APOBEC3 motif.
Number of subjects with a mutational pattern: This summarises all individuals with changes found in this position in
the data. Italics means a change was found more than once in at least one individual with the pattern.
Example 1: HXB2 Site 651: 2 N to S , 1 S to G means: Two people had N as the most common amino acid, but S was present.
PRB931 had 17 N and 2 S, PRB956 had 25 N and 1 S. Because there was more than one S in one of them, it is in italics. One
individual, 700010077, is noted as S to G, and had 51 S and 1 G.
continues...
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Table 3.2 continued:
Example 2: HXB2 Site 518: 2 M to I, 7 M to V means: Nine people had M as the most common amino acid, and each of the
nine had a single variant among their sequences; the variant was I in two, and V in seven subjects. For example, Patient 1012
had 42 sequences, with 41 M and 1 V.
*In Keele et al. (2008), it was noted patients bearing these changes might have been infected with more than one closely related
form. Alternatively, early selection or maintenance of a very early mutational event might be giving rise to the pattern.
**This site was difficult to align in a few patients due to a frameshifting insertion of an A in a string of As in the primary
sequences, thus a number of the 7 noted E to K changes were actually due to a frameshifting indel.
***In an additional subject there was an ambiguous base call in this position.
Thirteen of the selected site occurred in gp120 and eleven in gp41 (Figure 3.2).
Figure 3.2: Posterior probabilities of belonging to the positive selection class (ω > 1) for
all sites in gp160. The dashed line indicates the 0.5 posterior probability, which was used
as a threshold to assign sites to the selection site class. Flat parts of the graph correspond
to sequence regions that were masked either because they were poorly aligned, or coding in
more than one frame.
The three-dimensional structure context of the selected sites in gp120 is shown in Figure 3.3
A. There is a cluster of sites in the C3 region of gp120 (Table 3.2) that are in the positive
selection class. In general, sites evolving under positive selection appear to be at least par-
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tially solvent exposed (Figure 3.3 A). Six additional sites were identified by including all 81
subjects in the analysis (Table 3.2, and Figure 3.3 B); 4 were in gp120.
Figure 3.3: Three-dimensional structure context of the selected sites identified in gp120. A)
13 sites from the dataset excluding sequences with evidence of APOBEC-mediated hyper-
mutation, and B) 4 additional sites identified analyzing the complete dataset. The sites
depicted in blue represent those sites that are embedded in a known or potential CTL epi-
tope and circled site numbers are potentially affected by APOBEC hypermutation. Sites
marked with an asterisk occur in a region for which there is no available structure, therefore
the positions are shown in proximity to their actual locations.
For all of the sites identified, the sequence alignment was considered carefully to assess
the possibility that the evidence of positive selection could be resulting, for example, from
APOBEC-mediated mutations or alignment errors associated with indel hotspots (Table
6.4 in the Appendix provides a detailed list of the observed mutations and their sequence
context). For one site (at position 509 on the HXB2 sequence), alignment error introduced
by an indel hotspot provides a better explanation of the data than selection. This site occurs
at the beginning of a long sequence of Adenines that could serve as an indel hotspot (Pathak
and Temin, 1990) and mutations at this site could, in several cases, be more parsimoniously
explained as indels.
For 7 of the 24 identified sites (indicated in Table 3.2) some or all of the mutations involve
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G-to-A in the APOBEC3G or APOBEC3F hypermutation motif (the motif is GRD, where
R is the IUPAC code for G or A, and D for G, A, or T). A baseline of 12.3% of the bases in
the patients’ transmitted sequences corresponded to a G embedded in an APOBEC3 motif,
while 26.8% (25/93) of the distinct mutations found in the 24 sites identified as evolving
under positive selection involved a G in an APOBEC3 motif. When all 81 patients were
included, 12.3% of the bases in transmitted sequences were G’s in an APOBEC3 motif, while
28.6% (32/112) of the observed changes in selected sites involved a G in an APOBEC3 motif.
In contrast, G’s not embedded in an APOBEC motif were not enriched among sites under
positive selection relative to the transmitted virus. Indeed, the proportion of G’s embedded
in an APOBEC3 motif was significantly higher for the selected sites than for the remainder of
the virus in both the 66 patient subset (Fisher’s exact test p = 0.004), and the full 81 patient
dataset (p = 0.0002) . This suggests that a proportion of the sites are identified as belonging
to the positive selection class due to the elevated APOBEC3 mediated mutation. Since the
waiting time for G-to-A mutations in the APOBEC3 context may be shorter than for other
mutations, it is possible that selection acting on these mutations may be a characteristic of
early immune escape.
3.3.3 Investigating Potential CTL Escape Mutations
There were 9 positively selected sites that were located in 5 potential CTL epitopes. These
selected sites were investigated as potential CTL epitopes because each was embedded in a
localised region with multiple mutations in one of the study subjects (Figure 3.4), and some
of the variants were repeated multiple times within the subject (Figure 3.4), two features
providing corroborative evidence for ongoing positive selection for immune escape.
Specifically, in Figure 3.4, A to E) are based on i) evidence for selection from the model
implemented in HyPhy, ii) evidence of selection from locally concentrated regional evidence
for selection relative to extremely homogeneous early infection alignments, and iii) HLA
appropriate known epitopes or anchor motifs found using the Los Alamos HIV immunology
database epitope location finder, ELF. The set of mutations shown in Figure 3.4 F, includes
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the only other sites in the entire data set of 81 subjects where mutations tended to cluster
over a small region in one person. No site in this region had statistical support for positive
selection, but this cluster of mutations was embedded in a potential epitope.
Figure 3.4: Selected sites that are embedded in potential CTL epitopes. The patient con-
sensus sequence is shown at the top of each alignment, with Fiebig stage, patient ID, and
CON for consensus indicated. The proposed epitope is shown beneath the patient consensus,
followed by the HLA. Previously reported epitopes are provided in full, predicted epitopes
are written with uppercase letters representing the anchor motif embedded in a string of x’s.
Key to patient HLA’s:
MEMI: HLA A01/A02, B08/B58
700010077: HLA A*0205/A*0205, B*5301/B*5701, Cw*0401/Cw*1801
Z33: HLA A02/A68, B45/B53
Z13: HLA A01/A32, B08/B44
Key to selected sites found in the alignment (HXB2/Alignment Coordinate):
0: site 62 / 79 1: site 64 / 81 2: site 66 / 83
3: site 460 / 566 4: site 831 / 979 5: site 833 / 981
6: site 841 / 989 7: site 354 / 431 8: site 360 / 439 9: site 612 / 744
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In each of these five cases, the cross-sectional sample appeared to capture a moment of transi-
tion in the viral population, with the virus exploring different escape options. In each of these
cases, patient HLA data were available, and the clusters of mutations were found to occur
either within a known CTL epitope from the literature, or within anchor motifs appropriate
for the HLA type of the infected individual (all potential epitopes are shown in Figure 3.4
and summarised in Table 3.3, identified using the tool ELF http://www.hiv.lanl.gov/con-
tent/sequence/ELF/epitope_analyzer.html). As this was a cross-sectional study, the se-
quences from which selective pressure is inferred are from the moment of transition, thus
only direct experiments can determine which of the variants represent the susceptible form.
In order to determine whether there indeed was a T-cell response to these putative epitopes,
18 amino acid long peptides representing the most common and second most common form of
the regional variants encompassing the variable sites, as well as the predicted epitopes shown
in Figure 3.4, were synthesised and tested using either ELISpot or ICS (see section 3.2.3).
For example, three sites (79, 81 and 83 in the alignment), showing evidence of adaptive
evolution (Table 3.2) were mutated in patient MEMI. These sites were embedded within a
previously described B*5801 epitope, and MEMI carried HLA B*5801 (Figure 3.4 A). Upon
testing, MEMI in fact did make a T-cell response to the most common form of the B*5801
epitope (KAHDPEVHNVW) and a diminished response to the variant KAHDPEVYNVW
(Table 3.3).
It was possible to detect a T-cell response to 4 of the 5 proposed epitopes tested (Table
3.3). The lack of the response to the other proposed epitope could imply an alternative
cause for the selection at this site (for example, antibody escape or reversion). However, it
is also possible that all of the observed forms of the peptide are escape variants, and that
the susceptible form has decreased in frequency to the extent that it does not appear in
the sample and was therefore not tested. Further possible explanations include a transient
T-cell response driving the escape that was already beginning to subside due to immune
escape and reduced stimulation, or limited sample viability (this was a retrospective study,
and the condition of several of the samples was not ideal).
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Table 3.3: CTL results indicating the five regions tested as well as the specific epitope
sequences. Sites that occur in the APOBEC3 context are shown in italics.
Interestingly, 3 of the 4 validated T-cell escape forms included a G-to-A mutation embedded
in APOBEC3G or 3F motif, a further indication that an APOBEC-mediated enhanced
mutation rate may facilitate early CTL immune escape in some cases (Table 3.3). Clusters
of mutations that co-occur in a patient may represent an alternate way in which immune
escape can be inferred and is consistent with previously observed patterns of escape from
an immune response early in infection (Jones et al., 2004). Again patient MEMI provides
an example with at least three independent nonsynonymous substitutions at site 566, which
was embedded in a proposed, but not validated, epitope for one of the HLA alleles of this
patient (B*0801). Collectively the results suggest that there is strong evidence for selection
preferentially occurring within CTL epitope regions relatively early in infection; all potential
CTL escape variants were found among Fiebig stage V cases in this study (Table 3.3).
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As described, many of the sites identified coincide with experimentally confirmed CTL re-
sponses, indicating the importance of CTL escape early in infection. However, the sites
that were detected are likely to represent only a fraction of the mutations that have been
driven to detectable frequency as a consequence of immune escape. For example, since the
applied method relies on shared patterns of mutation across multiple patients, it is unlikely
that the method has the power to detect escape from immune responses mediated by rare
HLA alleles. Additionally, since parts of env, particularly in the variable loops, were masked
from the analysis due to ambiguous sequence alignment, sites that confer resistance to neu-
tralising antibody escape may have been overlooked. Although the results underscore the
importance of CTL escape in early infection, they do not provide a basis to discount the
potential contribution of escape from antibody responses to the evolution of env early in
HIV-1 infection.
The majority of the rapidly evolving sites that recurred within individuals were clustered
and appeared to be under selection for escape from cellular immune responses, and several
of these mutations are G-to-A substitutions in APOBEC3 motifs. A highly significant
enrichment overall for APOBEC3 motifs among the rapidly diversifying sites identified using
HyPhy was observed, even when stringent precautions were taken to exclude the 15 subjects
that had enrichment of G-to-A mutations within the APOBEC3 motif. This suggests the
possibility that APOBEC3 and imperfect Vif-functioning can play an important biological
role in the patterns of mutation found in early infection, and may contribute to determining
the first immune escape mutations. Thus, base mutation rate may in some cases be making
a contribution to determining which immune escape events happen first, along with fitness
(Asquith and McLean, 2007) and possibly T-cell potency (Leslie et al., 2004). CTL immune
responses have been shown to play a key role in controlling viral replication in early infection
(Goulder et al., 1997; McMichael and Rowland-Jones, 2001; Schmitz et al., 1999; Turnbull et
al., 2006) and, in animal models, positively selected CTL escape variants have been reported
within weeks of infection (Fernandez et al., 2005; Loh et al., 2007, 2008). Escape from CTL
responses has been observed in humans both early and later in infection (Allen et al., 2000;
Goulder et al., 1997) and escape from successive immune responses is an important feature
of HIV disease progression.
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In the analysed dataset several of the rapidly evolving sites are associated with clusters of
mutations that occur in close proximity to one another in the same patient (Figure 3.4).
In some cases there are multiple escape mutations at the same site. Given the short times
since infection in these patients and the otherwise highly homogeneous sequence alignments,
the multiplicity of alternative CTL escape pathways that are already beginning to be ex-
plored by the virus in early infection is remarkable. Several studies have also shown that
upon transmission some HIV-1 escape mutations can revert to the consensus in order to
re-establish effective replication efficiency within the new host (Friedrich et al., 2004; Li et
al., 2007; Allen et al., 2005; Herbeck et al., 2006). These reversion mutations frequently
occur in structurally conserved regions and often reside within defined CD8 epitopes that
are no longer subject to the restrictions of the original host’s HLAs (Friedrich et al., 2004;
Li et al., 2007; Allen et al., 2005; Peyerl et al., 2004). Envelope evolution towards the wild-
type sequence state after transmission is thought to occur in the absence of specific CTL
mediated immune pressure (Leslie et al., 2004; Allen et al., 2004). Even when the newly
infected host has the HLA allele associated with the response, reversion can occur followed
by development of a CTL response targeting the wild-type epitope. Given that essentially
all examples of positive selection, which also exhibited recurrent and localised concentrated
change in these 81 individuals, occurred within one of 4 experimentally validated CTL epi-
topes (or in one of 2 putative epitopes based on the individuals HLA), in this cross-sectional
study the earliest changes seemed to result more commonly from escape rather than from
reversion. However, only in cases where CTL escape was confirmed experimentally can the
conclusion be made with certainty that the mutations are associated with escape.
3.3.4 Further Examination of Positively Selected Sites
The remaining sites that were identified cannot be explained by APOBEC mediation and do
not occur within mutation clusters. These sites were therefore not investigated as possible
CTL epitopes. Two sites (412 and 838 in the alignment) are identified largely because of
mutations in patients Z31 and TT31P, where infection may have resulted from multiple
closely related strains of the virus, rather than a single viral strain (Keele et al., 2008).
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For all but two of the remaining sites, the observed mutation occurred on a single terminal
branch of the within-patient phylogenetic tree and mutations were consequently observed
only once per patient. These sites were identified as under positive selection because the
site was mutated in multiple patients. Thus, unlike the substitution patterns in the putative
CTL epitopes described above, there was no evidence at this stage of infection that these
mutations were spreading in the intra-patient viral populations. As a result, these sites may
be mutational hotspots, albeit hotspots that cannot be explained by known mechanisms of
hypermutation in HIV-1.
Consistent Replacement of a Site by Another Specific Amino Acid
A visual inspection was carried out to determine whether there was evidence of directional
evolution in any of the 30 rapidly evolving sites identified by the HyPhy selection analysis.
Therefore, the goal was to ascertain whether a consistent trend towards replacement of one
amino acid by another amino acid across multiple patients, could be observed. Position 646
(518 in HXB2), which occurs in the fusion peptide of gp41, showed consistent replacement
of Methionine with either Valine or Isoleucine (the observed substitutions relative to the
within patient consensus are summarised for each selected site in the Appendix, Table A1).
This trend is remarkable when the data from all patients are considered. Fewer than half
(38 of 81) of the patients had Methionine at this position in the inferred infecting viruses,
yet all nine of the patients with a nonsynonymous mutation at this site had Methionine in
the patient consensus sequence. The probability of this occurring by chance is 0.001. Such
strong directional selection in early infection suggests the possibility of reversion of amino
acids associated with a selective transmission bottleneck, but could also be explained by
reversion of an escape mutation associated with an immune response in the transmitting
virus. The apparent directionality could also be explained by a sequence-specific mutational
hotspot if the ATG codon, encoding Methionine, results in a sequence motif that promotes
mutation. This is suggested by the fact that the mutation from M to V or I is found in just
a single sequence in each of the patients in which it occurs and thus does not appear to show
evidence of spreading in the intra-patient viral population. However, none of the mutations
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at this site are consistent with APOBEC3G/F mutation, and thus rapid evolution at this
site cannot be explained by known mechanisms of hypermutation.
Therefore, discounting sites that may have been affected by APOBEC3G/F hypermutation,
only a single site with significant evidence for directional change was identified. At site 646
(518 in HXB2), as described, there is only a single mutant sequence observable in each of the
nine patients in which the mutation is found, and this seems inconsistent with a mutation
that is coming under selection for increased frequency in multiple patients. Furthermore,
no increased frequency of Methionine in early infection sequences compared with chronic
sequences at this site was found (data not shown), as would be expected if the consistent
mutations from Methionine to Isoleucine or Valine represented reversion associated with
selective viral transmission. A single site was observed to undergo recurrent change in a
single subject in Fiebig stage II, and as this is prior to the immune response it may be
indicative of rapid reversion. Alternatively, the observation could be explained instead by
transmission of two highly related forms, together with recombination either in the donor
or soon after transmission.
Potential Enrichment of Mutations within Particular Sequence Patterns
Neutralising antibody responses drive the evolution of viral escape and are therefore thought
to play an important role in shaping the evolutionary changes observed in the envelope gene.
Mutations, insertions and deletions, as well as the distribution of glycosylation sites along
the envelope gene mediate the ability of the virus to escape from neutralising antibodies,
although the relative contribution of each of these is unknown (Frost et al., 2005). The role
of N-linked glycosylation sites in the env gene in maintaining the survival of HIV-1 during
the earliest stages of infection, is of particular interest as the carbohydrate surface establishes
the first means of contact between the host and the virus. A previous study (Frost et al.,
2005) compared the rate of phenotypic escape of HIV-1 in recently infected individuals from
neutralising antibodies to various characteristics of the envelope gene, and found that escape
from neutralising antibodies can occur regardless of the variation in glycosylation or rate of
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insertions and deletions in env.
Therefore, since the number of potential N-linked glycosylation sites (PNGSs) in env may
affect the fitness of the virus by rendering it more or less sensitive to neutralising antibodies,
a test for enrichment of mutations within PNGSs was carried out. The observed number
of mutations within PNGSs (NX1[S|T]X2 where X is any amino acid other than Proline)
was not significantly different than the expectation under a model of random mutation.
Therefore, no evidence of a tendency for mutations to disrupt PNGSs, and therefore no
evidence of accelerated diversification, in early infection (p = 0.736; Fisher’s exact test) was
found. This suggests that if escape from neutralising antibodies is among the major driving
forces of HIV-1 evolution at this stage, the mechanism is unlikely to be primarily through
single base substitutions in glycosylation sites, at least in the portion of env that could be
aligned with high confidence.
A similar approach was applied to determine whether there was an overall enrichment in
mutations within epitope-dense regions. In this case, the comparison is between the number
of mutations that occur within epitope rich regions (coordinates based on the best defined
CTL/CD8+ epitope summary Frahm et al., 2008), and the total number of mutations found
outside the epitope regions. There was no evidence of enrichment of mutations occurring
within a CTL epitope-dense region as opposed to less dense regions (p = 0.933, Fisher’s
exact test). However, because all mutations were considered in this case, the lack of such
evidence may result from the high level of noise in the data; that is, the fact that the majority
of the observed mutations are likely to be neutral or under purifying selection, rather than
positively selected. When only the 24 rapidly evolving sites are considered, a weak trend (p
= 0.27) towards enrichment within epitope rich regions (odds ratio: 1.6) is found.
The Impact of Recombination
The phylogenetic codon model that was applied using HyPhy does not account for recombi-
nation, which is known to cause false positive inference of selection (Anisimova et al., 2003;
Shriner et al., 2003). With the highly homogeneous intra-patient datasets analysed here,
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recombination is not likely to have a large effect, because the sequences are, in most cases,
well described by a star phylogeny with little internal structure in the tree. However, in
the case of the later Fiebig stage patients there is some tree structure and recombination in
these patients may have the potential to cause false inference of positive selection.
A test was therefore carried out on all the homogeneous intra-patient sequence data sets
for evidence of recombination using GARD (Kosakovsky-Pond et al., 2006b,a). Evidence
of a single recombination breakpoint in the sequence alignments from each of two patients
(Z31 and MEMI) was found. In both cases the breakpoint is located near the end of the
sequence alignment (just 3% and 10% of the alignment lies to the right of the breakpoint
for MEMI and Z31 respectively), and therefore a single tree topology applies for most of
the alignment. Only in the case of MEMI do nucleotide mutations occur to the right of the
recombination breakpoint and at inferred adaptively evolving sites (979, 981 and 989). Since
these mutations are also clustered and two of the three are confirmed CTL escape mutations
(Table 3.3), it appears unlikely that these sites are false positives.
3.4 Conclusions
This cross-sectional study has provided a glimpse into the nature of the diversification of
HIV-1 following transmission in a population of 81 HIV-1 subtype B infected individuals.
As expected, purifying selection acts on single base mutations at the majority of sites, but
there is also evidence of a subset of sites that diversify more rapidly than expected under a
model of neutral evolution. The results presented here suggest that APOBEC3 may play a
role in shaping the dynamics of early T-cell immune escape. APOBEC3 motifs are highly
enriched among the rapidly diversifying sites. This could be the result of an anomalously high
mutation rate giving the appearance of selection pressure when there is none, or a higher
mutation rate promoting a particular route of immune escape; the two are not mutually
exclusive. Finally early T-cell escape appears to be much more common than reversion.
This study provides new evidence supporting the idea that concentrated regions of change
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within an individual during early infection (Jones et al., 2004) are frequently indicative of
early escape from T-cell responses.
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Chapter 4
A Phylogeny Aware Method to
Compare Sequences from Early and
Chronic HIV-1 Infections
4.1 Introduction
As described in Chapter 3, understanding the selection pressures acting on HIV during
the acute and early stages of infection is crucial towards the development of a successful
vaccine. A potential vaccine must be effective against the virus that is actually transmitted
and knowledge of constraints associated with transmission, if they exist, could help in the
design of more targeted vaccines. Several previous studies have focused on transmission
signatures associated with the envelope gene, due to its importance for infection and for
antibody neutralisation. Neutralising antibodies can appear within two months after the
detection of HIV-specific antibodies in acutely infected individuals and are so restrictive
that the original viruses are entirely superseded by escape mutant populations (Wei et al.,
2003).
In HIV-1 subtypes A and C the variable loops of the env gene have been reported to be
90
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
shorter and to have fewer potential N-linked glycosylation sites (PNGSs) in sequences taken
during acute and early infection compared to sequences isolated later in infection (Chohan
et al., 2005a; Derdeyn et al., 2004; Sagar et al., 2006; Repits et al., 2008). The number of
N-linked glycans presents a crucial balance between efficient protein folding and function
of Env gp120, and the escape from recognition by neutralising antibodies (Li et al., 2009).
The association between resistant viruses and N-linked glycosylation sites has led to the
premise of an evolving glycan shield, where the carbohydrate coat shields the underlying viral
binding regions from antibody detection (Wei et al., 2003; Bunnik et al., 2008). During the
investigation carried out on selected sites in acute and early infection patients, an increased
mutation rate within PNGSs for subtype B viruses was not found (Chapter 3, section 3.3.4).
However, shorter variable loops and fewer PNGSs are thought to be the result of outgrowth
of fitter, but neutralisation sensitive, viruses in newly infected hosts (Chohan et al., 2005a;
Derdeyn et al., 2004; Sagar et al., 2006; Repits et al., 2008) in subtype A and C viruses.
In addition, the viral population in long-term non-progressors, who are said to be able to
maintain an effective neutralising antibody response (Zhang et al., 1997; Wang et al., 2008),
has been shown to have increased V2 lengths compared to rapid progressors (Masciotra et
al., 2002).
In a recent longitudinal study, reversion was shown to occur at amino acid sites driven
to evolve early resistance due to neutralising antibody pressure, reflecting the fitness cost
sacrificed to ensure initial survival (Bunnik et al., 2008). The characteristics associated
with Env loop length and number of PNGSs of the transmitted virus have been inferred
from comparisons of linked donor and recipient sequences in small studies of discordant
couples, where the one partner was HIV-uninfected and the other HIV-positive (Derdeyn et
al., 2004), as well as from comparisons of unlinked sequences from individuals in early and
chronic infection (Chohan et al., 2005a; Repits et al., 2008).
Although epidemiologically linked sequences from studies of discordant couples provide an
ideal source of data to investigate the selective transmission of viruses with specific charac-
teristics, there have been relatively few studies that have acquired a large enough number
of individuals to afford acceptable levels of statistical power to identify signatures of viral
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transmission. Sample sizes in studies of unlinked individuals are much larger, and there-
fore the idea of selective processes influencing the spread of the carbohydrate moieties and
thereby affecting the sensitivity of the virus to neutralisation, can be revisited. However,
published comparisons of the characteristics of viruses from different stages of HIV-1 infec-
tion are potentially subject to biases due to the phylogenetic relatedness of the sequences.
In particular, the presence of sub-clades of sequences (that is, groups of sequences that are
clustered on the phylogenetic tree) from the same stage of infection causes violation of the
key assumption of sample independence, which underlies the standard statistical tests that
have been applied to these data.
In this chapter, to continue the investigation on the transmission characteristics and unique
features of the early infection envelope sequences, the focus was to carry out a comparison
between viruses isolated from early and chronic infections. Therefore, instead of finding
sequence properties that are shared across a large group of very early infection datasets
as described in Chapter 3, a comparative approach was followed using early and chronic
infection datasets.
To this aim, a simulation study was carried out to determine whether false positive results
are likely to occur if the phylogenetic structure of an unlinked sequence dataset is not taken
into account. The focus of these analyses was on a published comparison (Chohan et al.,
2005a) of env variable loop lengths where the authors used the associated phylogenetic
conformation as support for their findings. Furthermore, a novel method that can be used
to compare variable loop lengths or other characteristics of viruses using epidemiologically
unlinked sequences, is proposed. This method was applied to evaluate the evidence of a
reduced length of the env V1-V2 region in sequences from a previous study (Chohan et al.,
2005a).
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4.2 Methods
4.2.1 Simulations
In order to evaluate if the degree of shared phylogenetic history of the early and chronic
sequences from the study by Chohan et al. (2005a) was large enough to create a significant
deviation away from actual difference between the variable loop lengths of the two groups, a
sequence simulation study was carried out. MySSP (Rosenberg, 2005) was used to simulate
1000 sequences evolving with insertions and deletions along the tree inferred from the env
V1-V2 sequences used in the above study, which included 35 sequences sampled from early
infection and 51 sequences isolated from chronic infection Chohan et al. (2005a). The in-
sertion and deletion rate (on average one insertion and one deletion every 70 substitutions)
and size parameters (Poisson distributed indel length with mean = 24bp), that were used
in these simulations, were chosen such that the simulated sequences qualitatively resembled
those from the original study.
This simulation study allows us to calculate the number of times a significant difference
between loop length would be observed by random chance. If the difference is significant
in more than, for instance, 5% of the cases, the test may not be sensitive to bias in the
phylogeny and the results should be interpreted with caution. The statistical programming
environment, R (http://www.r-project.org/), was used to conduct the statistical analysis
(one-sided Wilcoxon rank-sum test) of variable loop lengths carried out on all the simulated
early and chronic sequences.
4.2.2 Phylogeny Aware Method to Compare Variable Loop Lengths
in Early and Chronic Sequences
If the shared history of a significantly sized phylogenetic cluster of early or chronic sequences
is not accounted for during comparative tests, it is reasonable to expect some degree of
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statistical bias towards that characteristic, for example Env variable loop length, which the
cluster favours.
Here a method is proposed that estimates the variable loop lengths at the ancestral nodes
of the phylogenetic tree by averaging over the lengths of the V1-V2 loops of the descendant
sequences, weighted by the reciprocals of the respective branch lengths (Felsenstein, 1981b).
The difference between the loop length of a virus and its immediate ancestor on the phy-
logenetic tree is then used as the variable to be compared between the early and chronic
groups (Figure 4.1).
Figure 4.1: Estimation of the parent V1-V2 length (Lp) from the descendant V1-V2 length
(L1 and L2) and branch length (b1 and b2) data.
4.2.3 Recombination Testing
Recombination is known to cause false positive results in studies that rely on a phylogenetic
tree that reflects the true relationship between sequences (Anisimova et al., 2003; Shriner et
al., 2003; Scheﬄer et al., 2006). A recombination event is likely to bias the results since it
implies that a single tree can not reliably represent the sequence alignment, and any method
that does not account for recombination can produce potentially spurious results.
A genetic algorithm for recombination detection, GARD (Kosakovsky-Pond et al., 2006b),
was used to eliminate this as source of bias. This method was applied to the aligned V1-V2
region from the original study (Chohan et al., 2005a). GARD implements a maximum like-
lihood model comparison approach to determine whether there is evidence of recombination
in a dataset of aligned sequences.
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4.2.4 Correlation Tests to Identify Potential Relationships be-
tween the Variable Loop Lengths and Further Specific Dis-
ease Stage Determinants
Once an investigation on the potential sources of bias was carried out, and a method that
accounts for phylogenetic relatedness was formulated, further correlation studies were ex-
plored. A possible extension to the notion that shorter variable loop lengths are associated
with the transmitted virus, is to compare the V1-V2 lengths to other disease stage determi-
nants. If the V1-V2 variable loop length in early and chronic infections varies significantly,
then it is possible to determine whether the association holds during subsequent related
comparisons. CD4 counts are related to disease stage, and since substantial patient CD4
count information together with the associated viral sequence data, and therefore V1-V2
loop lengths, are available, tests can be carried out to determine whether Env loop length
is correlated with the particular defined stage of disease.
HIV-1 clinical and sequence data were downloaded from the Los Alamos HIV Sequence
Database (www.hiv.lanl.gov). CD4 count data and the associated Env sequence data of
268 patients were retrieved; 107 sequences were HIV-1 subtype B, 97 subtype C, and 41
were the recombinant subtype AE. The statistical analyses, correlations tests (Spearman’s
rank correlation test) and conditional inferences (Hothorn et al., 2006) as well as tests for
significant differences (Wilcoxon rank-sum tests), were carried out in R (http://www.r-
project.org/).
4.2.5 Identification of Sites with Different Amino Acid Profiles in
Early and Chronic Infection 1
In a separate analysis, an additional phylogenetic method to identify sites that differ between
two specific groups, for example an early and chronic dataset, was developed. The method
1This section was carried out with the assistance of Graham Poulter; the idea for using, and coding of,
the multivariate hypergeometric distribution is attributed to him.
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takes the phylogenetic history, and hence the non-independence between sites, into account.
For each site, a “loss”, “gain” or “no change” of a site was determined, depicted with -1, +1,
and 0 respectively.
GASP (Gapped Ancestral Sequence Prediction; Edwards and Shields, 2004) was used to
generate the ancestral sequences of a given input dataset containing sequences from two
groups. An example tree is shown in Figure 4.2, indicating three points on the phylogeny
(A, B, and C) to illustrate how the gain, loss or no change of a site was defined. A, B, and
C each refer to an amino acid at a given site in the alignment. The site at A is the most
recent common ancestor of the entire dataset, C is the terminal amino acid, and B is the
immediate ancestor of C.



Figure 4.2: Tree topology reflecting the relationship between sites A, B, and C.
The outcome R depends on the relationship between the amino acids at sites A, B, and C,
defined by:
R =

+1 if A = C and A 6= B,
−1 if A 6= C and A = B,
0 Otherwise.
In this way, a distribution of +1 (gain), -1 (loss), and 0 (no change) is determined for each
site in the alignment. The distribution can be likened to an urn with three different colour
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balls in it, x1, x2, and x3. If n number of balls are taken from the urn without replacement,
then
X (f , n) = (x1, x2, x3)
follows a multivariate hypergeometric distribution. A population comprised of three types
of outcomes, as in this case, and where there are N1, N2, and N3, of each type. If n samples
are taken from the population at random, then the probability of selecting f1 objects from
N1, f2 objects from N2, and f3 objects from N3, is:
P (X1 = f1, X2 = f2 , X3 = f3)
(
N1
f1
) (
N2
f2
) (
N3
f3
)
(
N1+N2+N3
n
)
where f1 + f2 + f3 = n ; 0 ≤ f1 ≤ N1; 0 ≤ f2 ≤ N2; and 0 ≤ f3 ≤ N3 .
The values assigned to gains and losses for each site, represent the weights, w1, w2, and w3,
for each category. And the weighted sum of the n random draws is given by,
Y = −1X1 + 0X2 + 1X3 ,
which represents the net gain or loss at a site. The distribution of Y can then be determined
by enumerating X for each of the possible values for f1, f2, and f3; and for each outcome it
is possible to calculate the the weighted sum, t. The values of f1 , f2 , and f3 are results of
random draws from X, and thus the sum t = −f1 +f3 has the distribution of Y = −X1 +X3
.
Under the null hypothesis, the sample n is a random selection from this weighted sum of the
multivariate hypergeometric distribution. If t is the weighted sum of the observed values at
a given early infection site, then for that value of t, a test can be carried out to determine
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what the probability is that the observed sum is a random sample. If the probability of
drawing a result at least as extreme as the sum which was observed is low, then it is unlikely
that t is a random sample. The p-value is determined by summing over all the discrete
probabilities in the calculated null distribution of Y.
This method was applied to the same dataset which was analysed for determining V1-V2
loop length differences. The method finds sites in the acute group, which have undergone
gains and/or losses that are significantly different to that of the chronic group. In effect the
method is comparing the distribution of the number of changes on the terminal branches,
conditioned on the predicted common ancestor, in one group to that of another. In the
present study the groups are the early and chronic sequence datasets.
4.3 Results and Discussion
4.3.1 Simulation Analysis
The potential of sub-clades of sequences from the same stage of infection, in the data anal-
ysed by Chohan et al. (2005a), to cause false positive inferences of differences between the
variable loop lengths of the early and chronic sequences was assessed using the phylogenetic
tree inferred from the sequences from the original study (Figure 4.32).
2Duplicate sequences were included in the original paper and these samples, referred to as AF069670-
AF069670_A and M62420-M62430 in this study, were retained in the current analysis for comparative
purposes.
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Figure 4.3: Neighbour-joining tree inferred from amino acid sequences of the V1-V2 region.
Branches shown leading to sub-clades consisting only of early sequences, beginning with “A”
and are coloured in blue, or only of chronic sequences, beginning with “C” and coloured in
red, respectively.
If the phylogenetic relationships are neglected and sequences treated as though they were
sampled independently, any insertions or deletions that occurred along the blue branches
(leading to sub-clades of early sequences) or red branches (leading to sub-clades of sequences
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from chronic infection) are effectively counted multiple times. To test whether the observed
clustering of early and chronic sequences was sufficient to cause a significant bias in the com-
parison of variable loop lengths between the early and chronic groups, 1000 sequences were
simulated evolving with insertions and deletions along the tree using MySSP (Rosenberg,
2005).
Following the analysis of the original study (Chohan et al., 2005a), the length of the V1-
V2 loops of the simulated early and chronic sequences were compared using a one-sided
Wilcoxon rank-sum test. The null hypothesis for the one-sided test (variable loops not
shorter in early sequences than in chronic sequences) was rejected 109 times (10.9%) at the
5% significance level in 1000 simulated datasets. This represents a significant excess over
the expected 5% false positive rate. This analysis demonstrates that failure to account for
phylogenetic relationships between sequences can cause a bias in comparisons of the variable
loop lengths of the early and chronic sequences.
The tree in Figure 4.3 is just one estimate of the possible phylogenetic relationships between
the sequences and, in most cases, the sub-clades present on the tree are not well supported
as the sequences used are short and highly variable (mean length = 69.7 amino acids).
However, our argument does not depend on the robustness of the inferred sub-clades as
there is no reason to believe that the degree of clustering of early sequences with early
sequences or chronic sequences with chronic sequences is any less in the true tree describing
the relationships between the sequences. Instead, it is the assumption that each sequence
can be treated as an independent sample that requires justification, particularly if it is not
valid using the tree inferred from the sequences. It may be interesting to further investigate
the affect of the underlying tree by repeating the analysis using a range of phylogenetic
trees, each with different measures of support. In this way it may be possible to illustrate
the extent of bias as result of various inferred phylogenetic relationships.
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4.3.2 Comparison of Env Variable Loop Length Differences Ob-
served in Early and Chronic Infection
While the optimal data for investigating genetic characteristics associated with transmission
are sequences derived from transmission pairs, these are limited due to small sample sizes.
To address the problem of lack of independence of sequences due to phylogenetic relation-
ships (Felsenstein, 1981b), a novel tree-based method was developed that can be applied
to compare the lengths of the variable loops between the early and chronic sequences (see
section 4.2.2 for details). The method described here accounts for the non-independence of
phylogenetically related samples and can therefore be used in cross-sectional comparisons
of viruses from different infection stages. When this method was applied to the simulated
datasets (using phylogenetic trees inferred separately from each simulated dataset) 36 false
positive results (3.6%) at the 5% significance level were obtained, suggesting that the method
can prevent false positive inferences resulting from the sub-clades of early and chronic se-
quences in the data. The fact that the method performs well with the trees inferred from the
sequences (rather than the trees that were used to produce the sequences in the simulations)
suggests that the method is robust to uncertainty in the inferred trees.
This phylogenetic method was applied to re-evaluate the evidence for a reduced length of the
V1-V2 loop region in early infection sequences from HIV-1 subtype A (Chohan et al., 2005a).
The original publication reports a p-value of 0.008 (one-sided Wilcoxon rank-sum test) for
the comparison of the V1-V2 length between early [n=35] and database [n=51] sequences.
The results from our method applied to the same dataset confirm the original finding though
with a somewhat more marginal estimate of statistical significance (p = 0.02). This suggests
that the length difference is unlikely to be the result of insertions and deletions shared by
sub-clades of early and chronic sequences.
The influence of an underlying population structure on the identification of associated evo-
lutionary patterns, is widely accepted (Carlson et al., 2007; Kang et al., 2008; Pagel, 1994).
Recently, Carlson et al. (2007) evaluated two methods designed to find correlations between
discrete data while accounting for potential shared phylogenetic histories. The first is aimed
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at identifying discrete traits that have co-evolved and assumes that a change in either trait
can induce a change in the other. The second method is an extension of the approach
described by Bhattacharya et al. (2007), where a single discrete variable evolves along the
branches of the tree and the associated trait affects only the terminal branches of the tree
(Carlson et al., 2007). This method was applied to investigate the effect of a phylogeny on
identifying amino acids associated with specific HLAs (human leukocyte antigens), where the
amino acids evolve across the phylogenetic tree and the HLAs only have an influence at the
tips of the tree (Bhattacharya et al., 2007). Their observed results were inconsistent with
previously described findings, and these differences were accounted to non-independence
between genetic lineages.
Population based studies aimed at identifying correlated characteristics could be particularly
useful for finding vaccine targets that would be broadly effective. Therefore, considering the
potential impact of such a vaccine, false positives or false negatives should be minimised
as far as possible. The phylogeny aware investigation presented here, together with our
simulation study and previously reported findings (Bhattacharya et al., 2007; Carlson et al.,
2007; Kang et al., 2008), highlights the importance of accounting for shared phylogenetic
patterns when the tree structure forms a fundamental part of the analysis.
4.3.3 Evidence of Recombination
HIV-1 is known to recombine (Jetzt et al., 2000) and it is possible that the phylogenetic
method proposed here, which assumes that a single phylogenetic tree represents the relation-
ships between the samples along the entire sequence, is compromised as it does not control
for recombination. To address this issue, GARD (Kosakovsky-Pond et al., 2006b) was used
to investigate the evidence for recombination in the V1-V2 region from the subtype A dataset
(Chohan et al., 2005a). Although GARD found no evidence of recombination in the V1-V2
region, it is possible that there are undetectable recombination events in the data or other
errors in the phylogenetic tree and this can be considered as a caveat of the phylogenetic
method.
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4.3.4 Correlation between V1-V2 Length and CD4 Count
It is believed that V1-V2 loop lengths differ significantly between early and chronic disease
stages, and since CD4 counts are commonly used for classification of disease progression, the
relationship between V1-V2 loop lengths and CD4 counts could present interesting results.
As CD4 cell counts generally decline over the course of HIV infection (Arnaout et al., 1999;
Levy, 2007) it is possible to use a larger dataset as an additional, indirect, means to test
whether there is a relationship between V1-V2 length and disease stage. If there is a rela-
tionship between disease stage and V1-V2 length, then it would be predicted that V1-V2
length would correlate with CD4 count. In this case the weaker claim that V1-V2 length
is related to disease stage is being tested, and not whether this relationship is necessarily
the result of a difference between the transmitted virus and the virus from the chronic in-
fection stage. However, if the length of the V1-V2 loops is reduced in the transmitted virus
compared to the chronic stage, then, assuming a steady state (that is, that there is not an
ongoing reduction in HIV-1 V1-V2 length over time) the variable loops would be expected
to tend to increase in length, on average, over the course of infection.
A highly significant negative correlation between V1-V2 length and CD4 count (ρ = -0.207;
p = 0.0007; n = 268; Figure 4.4) was found, consistent with lengthening of the V1-V2 region
over the course of infection. This correlation remained highly significant (p = 0.0004) when
it was conditioned on viral subtype (Hothorn et al., 2006) and also when this phylogenetic
method was applied to correct for phylogenetic relationships between sequences (p = 0.005).
These data were derived primarily from subtypes B, C and the circulating recombinant form
(CRF) AE. Data from subtypes B and C alone showed marginally significant correlation be-
tween CD4 count and V1-V2 length (ρ = -0.18; p = 0.06; n = 107 and ρ = -0.19; p =
0.07; n = 91, for subtypes B and C, respectively), however the correlation for AE alone was
highly significant (ρ = -0.46; p = 0.004; n = 41). Combining the data from subtype B and
C and conditioning on subtype, the relationship between CD4 count and V1-V2 length was
significant (ρ = -0.17; p = 0.01; n = 198).
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Figure 4.4: Correlation between CD4 count and V1-V2 length. The line represents a locally-
weighted polynomial regression (lowess) curve.
Therefore, although the strength of the relationship between CD4 count and V1-V2 length
appears to vary among subtypes, these results are suggestive of a link between V1-V2 length
and the stage of disease, and consistent with a shorter V1-V2 in the transmitted virus.
To investigate the relationship between CD4 count and V1-V2 lengths further, the data
were divided into three CD4 categories based on the CDC classification system for HIV
infection (Castro et al., 1993) and the median lengths for each group were compared. There
was no significant difference in V1-V2 lengths between sequences from individuals with CD4
counts less than 200 cells/µl (AIDS defining) and individuals with CD4 counts between
200 and 499 cells/µl. However the V1-V2 loop length was significantly lower in sequences
from individuals with CD4 counts greater than 499 cells/µl compared to either of the other
two categories (p = 0.008 and p = 0.0008 for the comparison with the <200 cells/µl and
the 200-499 cells/µl groups respectively, using a two-sided Wilcoxon rank-sum test; Figure
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4.5). The difference remained significant after the phylogenetic method was applied to
correct for evolutionary relationships between the sequences (p = 0.01 and p = 0.004 for
the comparison with the <200 cells/µl and the 200-499 cells/µl groups respectively, using a
two-sided Wilcoxon rank-sum test).
Figure 4.5: Notched boxplot of V1-V2 lengths in different CD4 count categories.
The results illustrate that variable loop lengths are correlated with the immunological state
and that, on average, individuals whose CD4 counts have not been depleted, many of whom
are likely to have been sampled early in infection, have shorter V1-V2 variable loops.
Together with the findings from the phylogenetic method (see section 4.3.2), the observation
that CD4 count is significantly negatively correlated with V1-V2 length in database samples
lends further support to a relationship between V1-V2 length and disease stage. However,
the strength of this relationship appears to depend on viral subtype, with a far weaker and
marginally significant effect observed in subtypes B and C and a strong effect observed for
recombinant AE viruses. Nonetheless, the findings provide evidence for a gradual continuous
change in V1-V2 over the course of infection.
105
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
The phylogenetic method designed to identify sites that differ significantly between two
groups was used to extend the analysis of the V1-V2 loop length variation results discussed
in section 4.3.2. The method predicts the ancestral amino acids from a phylogenetic tree,
and determines whether the mutational patterns observed in two groups of sequences, at
particular sites along the alignment, are significantly different. This method has been used
in another study where the authors aimed to locate amino acids in HIV-1 subtype C se-
quences that differ significantly between samples obtained from early and chronic infection
(Treurnicht et al., 2009). The authors found 18 amino acid sites along the entire genome
that differed significantly (p < 0.05, uncorrected for multiple testing), and 17 of these (9
in env), were located within known CTL epitopes. These results illustrate the potential
value of the method for identifying sites that are selectively maintained in a defined subset
of sequences.
When the dataset from Chohan et al. (2005a) was analysed with this method only one site,
88 in the alignment, was identified (p = 0.049). Interestingly, it forms part of a PNGS, which
is implicated in early viral escape from the immune system. The result should however be
interpreted with consideration of the short sequence lengths, poorly aligned regions includ-
ing large gaps, and lack of a correction for multiple testing. Multiple testing corrections
account for the occurrence of false positives when multiple statistical tests are carried out.
The occurrence and frequency of false positives can be controlled using adjusted p-values
(Westfall and Young, 1993). This was not applied here, as the analysis was exploratory
in nature. Because the phylogenetic method identified a site considered to play a role in
early immune escape, and given the observations from Treurnicht et al. (2009), the results
may nevertheless point to broader application of the method for finding different mutational
patterns in subsets of aligned sequences.
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4.4 Conclusions
The results of the simulation study presented in this chapter indicate that inferring a differ-
ence in the variable loop lengths between viruses from different stages of infection, without
taking phylogenetic relationships into account, is subject to bias. While the optimal data for
investigating genetic characteristics associated with transmission are sequences derived from
transmission pairs, these are limited due to small sample sizes. The method described here
accounts for the non-independence of phylogenetically related samples and can therefore be
used in cross-sectional comparisons of viruses from different infection stages.
The findings presented in this chapter are consistent with the premise that an increase in
PNGSs and longer V1-V2 loop lengths play an important role during viral evasion of host
immune pressures (Chohan et al., 2005a; Derdeyn et al., 2004; Sagar et al., 2006). The
re-evaluation of an HIV-1 subtype A dataset (Chohan et al., 2005a) with the described
phylogeny aware method supports the conclusions of the original paper. The further obser-
vation that CD4 count is significantly negatively correlated with V1-V2 length in database
samples, provides additional support for a relationship between V1-V2 length and disease
stage. Collectively, these results indicate that the changes in variable loop lengths during
HIV infection are associated with the stage of disease and are therefore likely to be relevant
to our understanding of the immune pressures that drive viral adaptation in the host.
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Chapter 5
Re-evaluation of the Evidence for
Positive Selection in HIV Coding
Sequences Using a Robust Method
5.1 Introduction
The simulation study carried out in Chapter 4 illustrated that the phylogenetic relatedness
of samples can significantly bias the findings obtained from methods dependent on the
underlying tree structure. Any features that violate the fundamental assumptions of the
methods used to identify particular characteristics, have to be accounted for prior to the
research. Alternatively, the methodology can be adapted or extended to accommodate the
source of bias. Following on from the previous chapter, where shared genetic history was
addressed, here the goal was to establish the extent of bias present in positive selection
studies where recombination is likely to have taken place.
Adaptive molecular evolution is likely to shape the genome of HIV-1 on an ongoing basis
and describing positive selection in, for example, early and late infection, drug-naive and
drug-treated individuals, or in geographically distinct viral sequence datasets, would provide
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a useful characterisation of the evolutionary changes in the HIV genome when faced with
various challenges. Identifying the sites in a viral genome that are selected during viral
escape from immune responses can help guide the selection of immunogens for vaccines,
and understanding the evolution of resistance to antiviral drugs can help in the design of
effective treatment programmes. Mutations resulting in sequence changes that lead to fitter
individuals are more likely to become fixed in a population than mutations that provide
no additional benefit to the organism (Yang, 2006). Identifying these sites in HIV and
understanding their value to viral reproductive fitness is an important goal in the broader
search for effective therapeutics to treat infected individuals.
Methods to infer selection from protein-coding sequences have been applied in a wide vari-
ety of species and genes, however these methods typically assume a single phylogenetic tree
describing the relationships between the taxa. This assumption does not hold when linkage
between sites is disrupted through recombination, as this results in several distinct phyloge-
netic tree topologies describing the relationships between the taxa in different parts of the
sequence (Shriner et al., 2003). The high rates of recombination found in many pathogens,
especially viruses, have been shown to cause substantial false positive inference of positive
selection (Anisimova et al., 2003). The task of finding sites under selection, taking account
of the extent to which recombination occurs throughout the HIV genome, has not been
addressed thoroughly.
HIV has two copies of genomic RNA, and the virus readily recombines (Burke, 1997). During
reverse transcription of viral RNA to single stranded DNA, the RT (reverse transcriptase)
can switch between the two RNA strands, often resulting in mosaic HIV genomes (Ramirez
et al., 2008). Numerous circulating recombinant forms (CRFs) have been described, which
originate as result of dual infection with two divergent RNA sequences (Chan, 2004; Requejo,
2006). Intersubtype as well as intra-subtype recombinants are widespread, and recombina-
tion in HIV is one of the central ways the virus ensures genetic variability (Requejo, 2006;
Rousseau et al., 2007).
The effect of recombination on the detection of positive selection has been evaluated ex-
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tensively in recent years. An evolutionary model that does not account for recombination,
treats homoplasies resulting from recombining sequences as mutational events, and the re-
sulting tree topologies are inaccurate. This leads to a false representation of highly variable
sites containing multiple non-synonymous changes, and these sites may therefore incorrectly
appear to be evolving under positive selection (Shriner et al., 2003). In some cases the false
positive rate has been shown to be as high as 90% (Anisimova et al., 2003). High rates
of false positive inference of selection raise serious questions as to the validity of published
examples of positive selection in recombining sequences (Shriner et al., 2003; Anisimova et
al., 2003).
Scheﬄer et al. (2006) developed a novel and robust maximum likelihood method for inferring
positive selection from recombining coding sequences. The method, PARRIS (PARtitioning
for the Robust Inference of Selection), detects recombination breakpoints and then deter-
mines tree topologies and branch lengths for each partition resulting from the detected
breakpoints, independently. The synonymous substitution rate at each site is also modelled
in such a way to allow for variation across all sites, which brought about additional improve-
ments to the model for detecting selection. PARRIS analysis, together with other statistical
models for detecting signatures of selection, can be carried out online at http://www.data-
monkey.org/ .
For the present analysis, PARRIS was used to re-analyse published HIV datasets in which
positive selection was previously reported. Many of these results were published before the
realisation that recombination causes false inference of positive selection using phylogenetic
methods. The development of a robust method to infer selection creates an opportunity to
review the findings of these published results and to provide a more accurate account of the
contribution of positive selection to the evolution of HIV-1 coding sequences.
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5.2 Methods
5.2.1 Novel Approach for Detecting Selection
Previous results of positive selection were generated by standard methods, which commonly
assume that the topology, relative branch length, and total tree length over all sites remains
constant. In the present study a method proposed by Scheﬄer et al. (2006), was applied to
collected published datasets.
In the proposed method, PARRIS, recombination is taken into account and individual se-
quence partitions are defined based on where recombination breakpoints are found to exist.
The topology and relative branch lengths are assumed constant over all sites within each
partition, but may vary between partitions (Figure 5.1). However, the total tree length is
allowed to vary from site to site regardless of partitioning. This method was implemented
using the batch language of the HyPhy package (Kosakovsky-Pond and Muse, 2005).
5.2.2 Detecting Recombination Breakpoints and Partitioning
For the present analysis, breakpoint positions were estimated using a genetic algorithm
implemented in the localGARD.bf module within the HyPhy distribution (see Kosakovsky-
Pond et al., 2006b, for a description of the algorithm). The HKY85 nucleotide substitution
model (Hasegawa et al., 1985), with no rate variation between sites, was used for breakpoint
detection.
The detected recombination breakpoints were used to define the boundaries of the parti-
tions. Since the phylogenetic information (topologies and branch lengths) is dependent on
the length of the sequences used to produce the phylogeny, a limit was set on the number of
partitions used for selection analysis. When more than the maximum number of partitions
(N = 20 in the present study) were determined, only the N largest segments were used in
the subsequent analysis. It is likely that the results following inclusion of short segment
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parameter estimates can be highly unreliable, and the loss of information resulting from dis-
carding these short segments is negligible compared to the bias they could cause (Scheﬄer
et al., 2006).
Figure 5.1: A) Standard methods assume the entire sequence is described by a single tree
topology and set of branch lengths; B) PARRIS incorporates partitioning where each of
the N largest segments, that contain no recombination breakpoints, are modelled using a
separate topology and set of branch lengths.
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5.2.3 Topology and Branch Length Estimation
The topology and branch lengths for each aligned partition were computed independently,
whereas the remaining model parameters are shared across all segments. Positive selection
was detected by comparing the discrete nearly neutral and selection models: M1a and M2a
of Wong et al. (2004). Maximum likelihood topologies were estimated with the PAUP*
program (Swafford, 2002) under the HKY85 model (Hasegawa et al., 1985). Branch length
estimations were calculated with the M0 (single rate) model (Yang et al., 2000). A sequence
is reported to be under positive selection at the 5% or 1% level if model M2a provides
a significantly better fit than model M1a as measured by a likelihood ratio test with the
appropriate significance level (Scheﬄer et al., 2006).
In order for the method to allow for synonymous rate variation, another parameter is added
to the algorithm. The synonymous rate s, is treated as belonging to one of a number of
discrete rate classes, similar to the treatment of the non-synonymous/synonymous rate ratio
ω, and the instantaneous substitution rate from codon i to codon j at site h can be expressed
by:
q
(h)
ij =

0 if i and j differ by more than one change,
pijs
(h) for a synonymous transversion,
κpijs
(h) for a synonymous transition,
ω(h)pijs
(h) for a non-synonymous transversion,
ω(h)κpijs
(h) for a non-synonymous transition.
as described by Scheﬄer et al. (2006). Kappa, κ, is the transition/transversion rate ratio,
and pij is the codon equilibrium frequency of codon j. The non-synonymous/synonymous
rate ratio at site h is denoted by ω(h), and the synonymous rate at h by s(h). Similar to
the ω distribution used for the discrete M3 model of Yang et al. (2003), the synonymous
rate is drawn from a discrete distribution with three rate categories. However, unlike the ω
distribution, the synonymous rates are scaled in such a way that the average synonymous
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rate over all sites is equal to 1. Therefore, each site belongs to a synonymous rate category as
well as belonging to one of the ω categories (Scheﬄer et al., 2006). In this method, separate
parametric models are applied to the distribution of synonymous rates and of selective
strengths, whereas Kosakovsky-Pond and Muse (2005) have applied the same parametric
models to the distributions of synonymous and non-synonymous rates (Scheﬄer et al., 2006).
5.2.4 Datasets Re-analysed
The analysis included in this chapter focuses on the re-evaluation of a set of published studies
in which positive selection has been inferred in HIV. Several published datasets of HIV
coding sequences reported to contain sites undergoing adaptive evolution were downloaded
or requested from the authors for re-evaluation (de Oliveira et al., 2004; Zanotto et al., 1999;
Massingham and Goldman, 2005; Lemey et al., 2005; Yang et al., 2003).
(de Oliveira et al., 2004) analysed both subtype B and C sequences and selection was found
in all 9 HIV genes. Only sequences that were classified as nonrecombinant in the Los Alamos
HIV database (http://www.hiv.lanl.gov) were included in the study. For the PARRIS re-
analysis, a comparison between the gag, rev and tat genes was carried out (de Oliveira et al.,
2004). Separate analysis was done for the gag datasets where, in the one case the overlapping
coding regions were removed, and the other where the overlapping regions were retained.
Reanalysis of a nef dataset (47 sequences; 618bp) from a hemophiliac patient infected with
HIV-1 subtype B (Plikat et al., 1997) was also carried out. The sequences were collected over
a period of 30 months; fifteen sequences from 11 months, 16 from 25 months, and 16 from 41
months post-infection. Zanotto et al. (1999) applied a maximum likelihood method to this
nef gene datasets and compared the selection results to previous studies where contrasting
selective pressures were found.
Yang et al. (2003) investigated the selective pressure in 5 individual HIV-1 gene datasets,
which included 5, 7, and 14 sequences from subtypes A, B, and C respectively. Overlapping
as well as env hypervariable regions were removed prior to the analysis and only nonrecom-
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binant sequences, as defined in GenBank, were included. Here, reanalysis of the env, gag,
and pol datasets from the original study was carried out. A second subtype B pol dataset
for which positive selection has been shown to occur (Massingham and Goldman, 2005), was
also included in the re-evaluation. This dataset was analysed with and without the over-
lapping coding regions contained in the alignment. The final dataset used for comparison
comprised of 56 full-length coding sequences from HIV-1 group M subtypes (Lemey et al.,
2005). A summary of the datasets re-analysed in this chapter is shown in Table 5.1.
Table 5.1: Summary of the sequence datasets that were re-evaluated in this study and for
which selection has been previously described.
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The PARRIS output files include information on the partitioning results, likelihood estimates
for each evolutionary model, the p-value for inference of positive selection, as well as the
posterior probability estimates for individual sites evolving under the influence of positive
selection. The results from these files were compared to the respective published findings.
5.3 Results and Discussion
Scheﬄer et al. (2006) used PARRIS to analyse two HIV-1 subtype C datasets for which
recombination levels have been shown to be high enough to cause false inference of positive
selection. In the case of an env dataset, the four different models (standard, synonymous
rate variation, partitioning, and synonymous rate variation with partitioning) all detected
positive selection at a high significance level. However, the partition model with synonymous
rate variation, produced a far more conservative estimate of significance for the result, as
well as in the magnitude of positive selection inferred under the M2a model.
The results for the analysis of the gag sequence dataset revealed evidence for positive se-
lection only when the standard and partitioning models were used. When the synonymous
rate was allowed to vary however, the results were no longer significant, and the significance
levels dropped even lower when partitioning together with synonymous rate variation was
applied to the data.
The simulation results from the original study suggest that by using partitioned data and
allowing distinct tree topologies and branch lengths for individual segments, the false positive
rate is dramatically reduced. The reduction in false positives, to within acceptable levels
given a significance threshold, was associated with only a minor loss in power to detect
selection. These simulation results suggest that by using PARRIS, the false positives rate is
significantly reduced, and the method has the power to detect selection when the signal is
present in an aligned dataset (Scheﬄer et al., 2006).
In consideration of these initial results, as well as the problems associated with identifying
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selection in recombining coding sequences, PARRIS was used reanalyse a collection of HIV-
1 datasets (Table 5.1). The aim of the study was to compare the findings from previously
reported selection results to those obtained when a method accounting for recombination,
such as PARRIS, is applied to the same published datasets.
5.3.1 Extent of Recombination in the Datasets Re-analysed
To evaluate the extent of recombination present in the datasets re-analysed in this study,
GARD, within PARRIS, was applied to the aligned sequences. The number of recombination
events detected is shown in Table 5.2. For the datasets analysed here, no more than 2
breakpoints were identified for sequences shorter than 1500 nucleotides.
Although these results are based on a limited number of HIV-1 datasets, it is evident from
Table 5.2, that recombination occurs throughout the HIV genome. It is likely that the high
number of breakpoints identified by Yang et al. (2003) for the envelope gene, is indicative
of the extent of env sequence variation between subtypes, which can be as high as 30%
between subtypes from group M HIV-1 viruses (Gao et al., 2004). Interestingly, the same
conclusion can not be drawn from the intersubtype recombination analysis performed on the
gag gene in this study. Only a single recombination event was identified, even though gag
heterogeneity between group M subtypes can be as high as 15% (Levy, 2007). The analysis
performed on the gag datasets from de Oliveira et al. (2004), provided an indication of the
potential influence overlapping coding regions can have on the number of recombination
events occurring within a gene.
The results in Table 5.2 illustrate the extent of recombination in the HIV-1 genome, and
provide the underlying justification for re-analysing these datasets with a method that takes
recombination into account.
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Table 5.2: Summary of the sequence datasets together with the number of recombination
breakpoints for each dataset, detected by PARRIS.
...continues
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Table 5.2 continued:
5.3.2 Reanalysis of Specific Previously Published Datasets
PARRIS was used to re-evaluate the selection pressures in HIV-1 genes while taking re-
combination into account. The previously published studies reported widespread selection
acting on the HIV-1 genome. Here the results for particular studies are shown, whereas
comparisons between the results from different studies presented in the subsequent section.
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The reanalysis of the nef gene dataset, originally tested for positive selection by Zanotto
et al. (1999), produced contrasting results. PARRIS favoured the selection model for the
analysis of the 11mo dataset (p = 0.018) only, whereas the original publication reported
selection in the 25mo dataset (p < 0.0001), the 25mo in combination with the 11mo dataset
(p < 0.001), as well as the 25mo in combination with the 41mo (p < 0.001) dataset. For
the PARRIS analysis, 5 sites had a posterior probability of >95% of evolving under positive
selection. The original publication reported a total of 17 sites falling into this class (Zanotto
et al., 1999), albeit some overlap in the sites identified for different combinations of the
contemporaneous datasets. GARD identified either 1 or 2 breakpoints for each dataset.
Recombination is one possible explanation for the contrast between the PARRIS results and
those from the original publication. An additional potential bias is that the nef gene overlaps
with the 3’ LTR within which, for example, important promoter and enhancer elements are
found (Levy, 2007). More than half of the nef gene falls within the overlapping nef -3’LTR
region; the selection analysis of this region could therefore provide spurious results as the
dual functioning region can result in violation of assumptions made by codon models of
sequence evolution. PARRIS allows for synonymous rate variation, which can account to
some extent for selection acting at the nucleotide level to preserve the functions of the LTR,
whereas the method applied by Zanotto et al. (1999) does not, which may have contributed
to the contrasting results.
Reanalysis of the six datasets, and two additional gag datasets for which the overlapping
coding regions were excluded, obtained from de Oliveira et al. (2004) produced similarly
conflicting results. Where the original publication identified selection in subtype C tat, rev,
and gag, the results from PARRIS suggest that selection took place in only subtype B tat
(p = 0.01), and the subtype C gag (p = 0.02) dataset that contained no overlapping coding
regions (Table 5.3). Regarding rev and gag, the comparison between the selection results
for subtypes B and C showed the same trend in level of significance; smaller p-values were
obtained for the subtype C genes than for the subtype B genes from both the PARRIS and
the published analyses. The opposite was found for tat. de Oliveira et al. (2004) found
evidence for selection in subtype C tat and not in subtype B, whereas the converse was
true for the PARRIS results. Only one site, for subtype C gag (overlapping coding regions
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excluded) could be inferred with confidence to be evolving under positive selection when
recombination was taken into account using PARRIS.
Table 5.3: Results from de Oliveira et al. (2004) and PARRIS; for gag, the analysis was
repeated for a dataset where the overlapping coding regions were removed.
The analyses of tat and rev, upon which much of the focus was placed in the original
publication (de Oliveira et al., 2004), may have been significantly biased due to their overlap
with other coding regions. The entire rev gene shares its coding region with other genes, it
partially overlaps with tat and partially with env (Figure 5.2 1). Similarly, tat completely
overlaps with parts of rev and env.
rev
Figure 5.2: Schematic of the HIV-1 genome, showing the overlap of the rev gene with tat
and env.
1Figure created with the Recombinant HIV-1 Drawing Tool http://www.hiv.lanl.gov/content/se-
quence/DRAW_CRF/recom_mapper.html
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This means that rev (and likewise tat) does not evolve independently since it is affected by the
evolutionary constraints affecting tat and env. In this way the nucleotide substitution rate
for any gene within an overlapping coding region may be reduced due to the evolutionary
limitations imposed by the overlapping genes (Suzuki, 2006), which in turn would affect
the validity of tests of positive selection. Moreover, it has been shown that ignoring the
evolutionary constraints resulting from overlapping genes could lead to an elevated estimate
of positive selection (Sabath et al., 2008). Since PARRIS allows the synonymous substitution
rates to vary across sequence positions, and therefore permits the rates in overlapping regions
to differ according to the evolutionary constraints involved, the number of false positive
results may be reduced. However, although PARRIS may fare better than the conventional
methods that assume no synonymous rate variation, allowing the synonymous rate to differ
across the sequence is not an effective way of addressing overlapping coding regions when
dN/dS is used to infer positive selection. Only methods that allow the selection pressures
to vary by considering all the reading frames in which proteins are encoded simultaneously,
would sufficiently account for overlapping coding regions. However, it is a challenging task
to develop such a model, and these methods suffer from a lack in power to identify selection
(Pedersen and Jensen, 2001; McCauley et al., 2007). Neither PARRIS nor the approach used
by de Oliveira et al. (2004) specifically address different selection pressures over all reading
frames. The positive selection results obtained for tat and rev should be interpreted with
caution, since the observed synonymous substitution rate may not be an accurate reflection
of the neutral rate, and potential nucleotide-level selection pressures, or varying mutation
rates, may bias the subsequent selection analyses of coding genes (Ngandu et al., 2008).
In the genome-wide adaptive evolution study by Yang et al. (2003), tat, rev, and vpu were
excluded from the complete selection analyses due to the degree by which the genes overlap
with different reading frames. They did however indicate that positive selection was found by
the LRT for tat and vpu, although the non-overlapping sequence lengths of 39 and 58 codons
respectively were too short to be included in the subsequent analysis. After removing the
overlapping regions present in the remaining genes, as well as excluding the hypervariable
regions of gp160 and sequence parts harbouring large indels, positive selection was found in
all the other major HIV genes. The PARRIS analysis was carried out on env, pol, and gag.
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No evidence of adaptive evolution was found for the pol and gag genes, and GARD detected
3 and 1 breakpoint/s respectively. However, the results for env were highly significant (p =
0.0007). Five breakpoints were detected by GARD, and one site (52 in the alignment) was
identified as evolving under positive selection. The detected site maps to position 85 in the
HXB2 reference sequence and corresponds to a site identified in the original analysis (Yang
et al., 2003). It is likely that the PARRIS analysis is more conservative than the standard
methods since Yang et al. (2003) classified more than fifty other sites in env as evolving
under positive selection.
The results from the PARRIS analysis contradict one of the main findings from the original
paper where genome-wide positive selection was detected (Yang et al., 2003). No evidence
for positive selection was found by PARRIS for the pol and gag genes. Yang et al. (2003)
investigated the influence that recombination may have had on their selection analysis by
re-analysing the data with a star tree, which is expected to be wrong for all sites, instead
of the gene tree, and similar results were obtained. Moreover, the authors argue that the
positively selected sites were dispersed on the primary sequence and clustered on the tertiary
structure, suggesting functional constraints in certain regions of the genome and potential
hotspots of selection in other regions, for example, T-helper cell epitopes. Following from
this they reason that if recombination had caused false positive inferences, the positively
selected sites would cluster on the primary sequence since recombination is expected to
affect a group of neighbouring nucleotides (Yang et al., 2003).
The above arguments were used to claim that recombination may not have seriously affected
the positive selection results (Yang et al., 2003). Shriner et al. (2003), however, discussed
the demerits of using the star phylogeny approach, which disregards the phylogenetic history
of the sequences completely, as a possible alternative when recombination has affected the
underlying sequence dataset. Since for a star phylogeny each mutational event is counted in-
dependently and represents an individual step in evolution, the estimate of the total number
of mutations will generally be inflated, which may result in an overestimation of the number
of sites evolving under positive selection (Shriner et al., 2003). Overestimation of the num-
ber of selected sites is therefore likely to occur in both cases where an incorrect phylogeny
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is used for the analysis, the first as result of recombination and the second due to the star
tree approach. Phylogenetic network models may be the most preferable method to use for
this analysis (Huson and Bryant, 2006; Woolley et al., 2008), and further investigation of
these methods is an interesting avenue for future analyses.
Furthermore, the argument that the selected sites would cluster on the primary sequence,
and not the tertiary structure, if recombination biased the results, is not valid. There is
no reason to believe that true positively selected sites should be uniformly distributed on
the primary sequence or tertiary structure (Huzurbazar et al., 2010). Selection is also not
expected to occur uniformly across the primary sequence; the presence of CTL epitopes, and
linear antibody epitopes, among other causes, can result in selection hotspots. This would
lead to a non-uniform distribution of positively selected sites that can not be attributed to
recombination. Discounting the potential influence of recombination with these arguments,
is therefore not well-grounded. Since PARRIS identifies fewer positively selected sites than
the analysis carried out by Yang et al. (2003), and since simulation studies have shown
that PARRIS has a lower rate of false positive inference without significant loss of power
(Scheﬄer et al., 2006), it is likely that the PARRIS results contain a higher proportion of
true positive estimates.
Massingham and Goldman (2005) applied a slightly different method to identify adaptive
evolution in coding sequences. The test integrated the best existing features available at the
time, including the substitution models of Nielsen and Yang (1998) and the site by site testing
method of Suzuki and Gojobori (1999). This combined method, the sitewise likelihood-ratio
(SLR) test, uses the entire alignment to determine parameter values common to all sites, but
tests each site for neutrality independently. Another method was included in this study for
comparison with the SLR test; in the second method, called SNY, the M8a model (Swanson
et al., 2003) and M8b model (where ω ≥ 1 ; a restricted form of model M8 from Yang, 2000)
were used (Massingham and Goldman, 2005).
Evidence for adaptive evolution was found by all three methods (Table 5.4). Three sites,
67, 347, and 478 in the alignment, were identified by PARRIS to be evolving under positive
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selection (Table 5.4). Two of these, sites 67 and 347, were also identified by PARRIS for the
analysis where the overlapping regions were removed. Furthermore, all the sites identified
by PARRIS were also contained within the site-specific selection inference from the SNY
and SLR method described by (Massingham and Goldman, 2005). Of the 13 sites identified
by the SNY approach, sites 67, 347, and 478 were three of the six that had a posterior
probability of >99%. The remaining 7 sites all had a posterior probability of >95%. Sim-
ilarly, the SLR method found 22 sites, with the aforementioned three sites falling into the
category of highest significance (p < 0.05). Additionally, sites 67 and 347 were the only two
sites which retained significance after correcting for multiple comparisons (Massingham and
Goldman, 2005). These were also the two sites identified by PARRIS for the analysis of the
pol dataset for which the overlapping coding regions were removed, illustrating the effect
dual coding regions can have on selection analysis. The support for positive selection acting
on the gene was also not as significant for the dataset where the overlapping coding regions
were retained (p < 0.001 for the dataset including, and p = 0.02 for the dataset excluding
the overlapping coding regions, Table 5.4).
Table 5.4: PARRIS and published findings (Massingham and Goldman, 2005) showing ev-
idence for selection in an HIV-1 pol dataset; the PARRIS analysis was applied to datasets
including and excluding the overlapping coding regions.
Shriner et al. (2003) demonstrated the effect of recombination on sitewise methods designed
to detect positive selection. Due to the reliance of the method on the parameters defining
the phylogeny, factors influencing the phylogenetic reconstruction would affect the outcome
of the selection analysis. Recombination would result in a longer phylogeny due to the
erroneous assumption that multiple changes had occurred along the branches of the phy-
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logeny, where in reality, the changes are false homoplasies caused by recombination events
(Shriner et al., 2003). Recombination may therefore have affected the results obtained from
the sitewise approach used by Massingham and Goldman (2005).
The final reanalysis was carried out on a full HIV-1 genome dataset, comprising of 56 group
M sequences, previously used by Lemey et al. (2005). The authors applied the single rate
model (M0) together with the discrete model (M3) to estimate the selective pressures acting
on the viral genome (Yang et al., 2000; Lemey et al., 2005). PARRIS analysis was completed
for the same alignment of 56 sequences (8667 nucleotides), and both methods found strong
evidence for selection. The published parameter estimates indicated that the discrete model
provided a better fit for the data and suggested that 9% of the entire non-overlapping
genome was evolving under adaptive evolution, with dN/dS = 2.51 for the positive selection
class (Lemey et al., 2005). The analogous results from PARRIS suggested that positive
selection occurred at 6.5% of the genome with dN/dS = 2.21.
The authors drew a comparison of the results they found to those obtained in the study of
Yang et al. (2003), which also forms part of the reanalysis carried out in this chapter. The
collective analysis of all the HIV-1 genes analysed separately by Yang et al. (2003), suggest
that approximately 10% of the entire genome was evolving selectively (Lemey et al., 2005).
This is comparable to the estimate described by Lemey et al. (2005) (9%). Similar to the
discussion on the results from Yang et al. (2003), it is likely that the estimates from the
report by Lemey et al. (2005) also may have been biased by the presence of recombination.
The PARRIS results here suggest a slightly lower percentage (6.5%) of sites were evolving
adaptively, which again appears to suggest that this may represent a more conservative
estimate with the site-specific results containing fewer false positives.
The PARRIS site-specific analysis identified 19 codon sites in the positive selection class
with a posterior probability of greater than 0.95, suggesting that these sites were evolving
adaptively. The distribution of posterior probabilities for the full-genome analysis is shown
in Figure 5.3. Of the 19 positively selected sites, 9 were located within env, 1 in gag, 2 in
pol, and the remaining 7 were clustered within the accessory genes: vif, vpr, tat, vpu, and
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rev. These results correspond to the results from Lemey et al. (2005), where the highest
density of positively selected sites was found in env and the accessory genes.
Figure 5.3: Distribution of posterior probabilities for the full HIV-1 genome from Lemey
et al. (2005), estimated by PARRIS. The red dashed line indicates the > 0.95 cut-off of
significance.
Interestingly, 9 of the positive selected sites mapped to known epitopes in the Los Alamos
HIV Immunology Database (http://www.hiv.lanl.gov/content/sequence/ELF/epitope_ana-
lyzer.html), and 5 of these were in the accessory genes, vif, vpr, tat, vpu, and rev. Further-
more, one of the sites identified in tat (Lys at position 29, numbered according to the HXB2
reference sequence, starting from Tat exon 1) was directly adjacent to a site, Lys28, which
has previously been associated with impaired viral replication when mutated to either Gln
or Arg (Brès et al., 2002). Lastly, only 2 of the 19 sites, one in gag and one in env (within
the Rev response element), appeared to be as result of APOBEC3G hypermutation.
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5.3.3 Overall Comparison between Results from PARRIS and the
Original Publications
Collectively, the reanalysis of previously published HIV datasets (Table 5.1) illustrates how
selection results can differ when different evolutionary models or assumptions are applied
to the data; moreover, the differences in the obtained results suggest that the original se-
lection results may be unreliable, and that the conclusions drawn from the initial results
need reconsideration. Incorrect model assumptions, for example when a model does not
account for the possibility of recombination when analysing recombining sequence datasets,
may lead to results that contain a large number of false positive inferences. In two of the
five published cases, the authors only included sequences thought to be nonrecombinant (de
Oliveira et al., 2004; Yang et al., 2003); however, none of the studies explicitly tested the
sequences for recombination. Furthermore, only Yang et al. (2003) and Lemey et al. (2005)
removed overlapping coding regions before the selection analysis. Although PARRIS allows
synonymous rate variation and therefore provides a comparatively more suitable means to
analyse overlapping coding regions, this feature is not sufficient to exclude the bias resulting
from overlapping coding regions, and in all cases these areas should be removed prior to pos-
itive selection analysis. Modelling synonymous rate variation is also not unique to PARRIS,
but yet an important feature of the model. PARRIS provides a more robust method for
identifying selection in HIV by accounting for these two features, recombination and shared
coding regions, common to the pathogen.
The disparities between results obtained from PARRIS and those from previously published
reports, further demonstrate how recombination can significantly bias both the inference
of positive selection from model comparison, as well as the site-specific selection inferences
(Anisimova et al., 2003; Shriner et al., 2003; Scheﬄer et al., 2006). A high false discovery rate
has been demonstrated when standard phylogenetic methods are applied to infer positive
selection from recombining sequences (Anisimova et al., 2003; Shriner et al., 2003), and this
could lead to inaccurate predictions and therefore irrelevant results.
The reanalysis carried out in this chapter, included two separate datasets, from different
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publications, for each of the pol and gag genes. Although there is no reason to believe that
selection will be present at the same sites in different datasets, it is nevertheless interesting
to compare the results obtained. For instance, the strong support for positive selection
(p = 0.00002) obtained from the PARRIS analysis for the pol gene originally included in
the study by Massingham and Goldman (2005), contrasts with the PARRIS results for the
second pol gene dataset, from Yang et al. (2003), where no significant evidence was found.
A major difference between the two datasets used, is that, prior to analysis, Yang et al.
(2003) excluded overlapping regions as well as indels, with a final dataset of sequence length
2721 bp, while Massingham and Goldman (2005) did not (sequence length 2841 bp). It
is possible that the overlapping regions may have influenced the selection analysis, since
the evolutionary pressures acting on the different reading frames encoding proteins are not
accounted for by the method. An additional analysis was carried out on the pol dataset
from Massingham and Goldman (2005)where the overlapping coding regions were removed,
resulting in an alignment of 2739 bp in length. For this dataset, the evidence of positive
selection found by PARRIS, was far less significant (p = 0.02), further illustrating the
importance of removing dual coding regions prior to selection analysis.
The PARRIS results for the three original gag gene datasets, two from (de Oliveira et al.,
2004) and one from Yang et al. (2003), provided no evidence of positive selection, despite
the publications reporting evidence for selection in each case. However, for the additional
analysis of the de Oliveira et al. (2004) subtype C gag dataset, where the overlapping coding
regions were excluded, PARRIS did report evidence for adaptive evolution acting on the
gene, and one site was identified during the site-specific selection inference.
A total of nineteen datasets, from five separate studies (de Oliveira et al., 2004; Zanotto
et al., 1999; Massingham and Goldman, 2005; Lemey et al., 2005; Yang et al., 2003), for
which positive selection has been described, were re-analysed in this chapter. PARRIS only
identified positive selection in 7 of the 19 datasets, and the number of positively selected
sites were reported by the respective publications for five of these seven cases. The number
of positively selected sites found by PARRIS was compared to the corresponding number
provided by the original publication (Table 5.5).
129
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Table 5.5: The number of positively selected sites identified by PARRIS and the numbers
from four original publications for which the values were available.
* Number of sites identified from the combined datasets (11 and 25 months, and 25 and 41 months), values for the individual
time-point-datasets were not provided.
It is clear from Table 5.5 that PARRIS identifies a far lower proportion of sites evolving
under positive selection than the corresponding original reports. Interestingly, all but one of
the sites identified by PARRIS, were also found by the published reports. This is remarkable
consistency since not all the published studies applied the same methods to identify selection.
Furthermore, PARRIS identified no more than 25% of the sites found for the published cases.
It is therefore evident that the results PARRIS provides, includes only a fraction of the sites
that were previously believed to be evolving under positive selection. Given that PARRIS
has previously been shown to have a reduced false positive rate but without much reduction
in power (Scheﬄer et al., 2006), the majority of sites previously reported to be evolving
adaptively, may be false positives. This further illustrates the potential bias recombination
may have on positive selection inference studies and the importance of taking recombination
into account in investigations of positive selection.
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5.4 Conclusions
The preliminary findings reported by Scheﬄer et al. (2006), as well as the PARRIS results
described in this chapter, illustrate the importance of considering the assumptions made by
the evolutionary model prior to selection analysis. High recombination rates have been iden-
tified for HIV (Burke, 1997), and this is associated with large false positive rates, suggesting
that a method that takes recombination into account is very useful for HIV selection studies.
Highly disparate results were obtained in the majority of cases when PARRIS was applied to
previously published datasets reported to contain sites undergoing adaptive evolution. Since
PARRIS accounts for both recombination and synonymous rate variation, the difference in
the observed result could be due to the inclusion of either of these features.
Numerous studies have focused on identifying selection in HIV-1 coding regions, and sites
likely to be evolving under positive selection have been listed extensively (Frost et al., 2001;
Yang et al., 2003; Zanotto et al., 1999; Lemey et al., 2005; de Oliveira et al., 2004). It is likely
that many of these sites that are thought to be selected for in HIV-1, are false positives.
False positive rates provide a measure of confidence in a specific method to produce accurate
results, with fewer Type 1 errors reflecting greater reliability in the method. Compared
to the previously published results discussed in this chapter, PARRIS gives a much more
conservative estimate for the evidence of positive selection, and far fewer sites are identified
in the site-specific selection analysis. It is also very encouraging that all but one of the
sites identified by PARRIS were within the originally reported set of positively selected
sites. With less sites identified, more focused analysis can be carried out on specific sites,
for example experimentally verifying the function or effects of mutations on viral fitness.
A dramatic reduction in false positive rates has been shown with PARRIS, and although
this was associated with a slight loss in power to detect selection, the drop in power was
not significant (Scheﬄer et al., 2006). PARRIS may therefore be a very promising method
for accurately identifying sites undergoing positive selection. Therefore, the analysis carried
out, and the results described, in this chapter are an important step towards accurately
identifying adaptively evolving sites in the HIV-1 genome.
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Chapter 6
Evaluation of Covarion Models of
Codon Evolution and Application to
SIVcpz / HIV-1 Zoonosis
6.1 Introduction
The method discussed in Chapter 5, PARRIS, identifies adaptively evolving sites in coding
sequences while taking recombination into account. Furthermore, the method also allows
synonymous substitution rate variation across all sites along the sequence. This is par-
ticularly important for studies focusing on HIV evolution, as site-to-site synonymous rate
variation has been shown to be a prominent feature of RNA viruses, and specifically so
for HIV (Hanada et al., 2004; Kosakovsky-Pond and Muse, 2005; Ngandu et al., 2008). In
this chapter, the idea of site-to-site rate variation is further explored, although in this case
not specifically focussing on the variation along a sequence, but rather variation between
different lineages of a phylogenetic tree.
The covarion model of molecular evolution was developed to account for within-site sub-
stitution rate changes along the lineages of a phylogenetic tree (Tuﬄey and Steel, 1998;
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Galtier, 2001; Huelsenbeck, 2002). According to this model, a site can evolve rapidly along
one branch and more slowly along others (Dorman, 2007). This can be used to search for
specific amino acids that are responsible for functional changes between divergent branches
of a phylogeny (Gaucher et al., 2001; Knudsen and Miyamoto, 2001). Covariation occurs
when, for example, selective pressures or functional constraints either favour or prevent
change at different time points in evolutionary history (Allman and Rhodes, 2009). This
could take place during HIV infection where viral evolution is driven by immune-mediated
selection, and therefore fluctuates with the strength of the immune response (Moore et al.,
2002; Ross and Rodrigo, 2002; Guindon et al., 2004). Covariation may also take place after
gene duplication, where functional divergence of the gene families may result in adaptive
evolution (Ohta, 1993; Wang and Gu, 2001; Holmes, 2003).
Covarying evolution could also be described for zoonotic events, as well as subtype di-
vergence, where functional changes result in distinct organisms with separate evolutionary
pathways. During zoonosis, the evolutionary constraints acting on a transmitted pathogen
may change due to the varying immune responses of the infecting-species and that of the
new host (Reid et al., 1999; Furuse et al., 2009). The adaptive sequence changes will be
present as covarying sites along the phylogenetic tree relating sequences obtained prior to
and after the zoonotic event. Numerous studies have shown that site-specific switching be-
tween selection classes across lineages is likely to occur (for example Ohta, 1993; Pupko
and Galtier, 2002; Clark et al., 2003; Guindon et al., 2004; Penn et al., 2008). A recent
study focussing on HIV-1 group M sequences, reported that the rate of intersubtype HIV-1
evolution varied across a phylogenetic tree, reflecting the change in protein function for each
subtype (Penn et al., 2008). This study provided evidence for covariation in all HIV-1 genes,
and the authors suggested that differing functional constraints were affecting the course of
evolution and sequence variability in HIV-1 group M subtypes (Penn et al., 2008).
The M2a model of Wong et al. (2004) has been used as a null model in studies inferring
covarying evolution (Guindon et al., 2004; Penn et al., 2008). However, a random-effects
likelihood (REL) implementation of the M2a codon model, where the site-to-site substitution
rate variations are random variables drawn from a distribution with 3 discrete categories,
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may not provide an appropriate null model. Consider, for instance, a fit of the M2a model
to a long sequence alignment, resulting in three ω categories, one with strong purifying
selection (for example ω = 0.1), another corresponding to neutral evolution (ω = 1), and
a selection site class with ω > 1 . If the true value of ω at a site is 0.5, then a covarion
version of M2a may provide a better fit at this site, fitting the intermediate value of ω by
switching between the two discrete classes. Therefore, the site would appear to covary since
the covarion model would provide a relatively better fit for the data than the non-switching
model. In this case, a model specifying multiple rate classes would be a more appropriate
model for describing the evolution of the sequences.
One of the aims of the current study was to test whether inferred covariation (switching
between rate classes) may, in some cases, be an artifact of under-fitting resulting from the
use of too few rate classes for ω. Simulation experiments were carried out to estimate the
proportion of false positive inferences of covarying evolution in the absence of rate switching.
An alternative approach is proposed to overcome the limitations of the REL implementation
of the covarion model. The expectation is that a fixed-effects likelihood (FEL) approach
would not be susceptible to false inference of switching due to this underfitting problem
since ω is estimated separately at each site. A FEL version of the covarion model was
implemented to test this hypothesis.
The further aim was to investigate covariation in an HIV - SIV (simian immunodeficiency
virus) dataset. HIV-1 is thought to have originated through a cross-species (zoonotic) in-
fection from chimpanzees to humans (Gao et al., 1999), and SIVcpz (infecting chimpanzees)
and HIV-1 evolved independently after the zoonosis event. Although the human and chim-
panzee genomes are similar at the DNA sequence level, substantial differences between the
human immune system and that of other primates exist (Gagneux and Varki, 2001; Kehrer-
Sawatzki and Cooper, 2007; Perry et al., 2008; Danilova, 2008). These differences may have
driven the evolution of the human and simian form of the virus to varying degrees. In the
current study, the goal was to identify sites that switched between rate classes at the point
where the cross-species jump occurred, since such sites may reflect changes in selective con-
straints at positions dependent on species specific immune responses (Moore et al., 2002;
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Ross and Rodrigo, 2002; Guindon et al., 2004). Furthermore, the identified sites may reveal
sequence regions responsible for functional shifts of HIV proteins, which previously has been
reported for protein comparisons between different species (Gaucher et al., 2001; Knudsen
and Miyamoto, 2001).
6.2 Methods
6.2.1 The Covarion Model of Sequence Evolution
HyPhy was used to implement the covarion model in a maximum likelihood framework.
The model parameterisation was previously described by Guindon et al. (2004), where the
authors extended the M2a codon-based model of DNA substitution allowing flexibility in
the evolutionary rate over time (Guindon et al., 2004). The same instantaneous transition
rate matrix as described in section 1.1.3, was used. Additionally, switches between the three
rate classes (the purifying selection class: ω < 1, neutral class: ω = 1, and the positive
selection class for which ω > 1) were allowed. Figure 6.1 illustrates the switching between
selection classes.
Figure 6.1: Probabilities of switching between the three rate classes, where ω− is the puri-
fying selection class, ωN depicts the neutral class, and ω+ represents the positive selection
class. The relative rates α and β are also shown.
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A rate of interchange parameter, δ, is applicable to all switching events, and px is the
equilibrium frequency of each selection class (x= 1..3). The relative rate parameters, α and
β, apply to the switching events between the purifying and positive selection classes, and the
neutral and positive selection classes, respectively (Figure 6.1). See Guindon et al. (2004)
for detailed model specifications. Both a REL as well as a FEL approach to model rate
variation were used. The REL model approximates the values of ω across all site with a
distribution, whereas the FEL model determines separate ω−, ωN , and ω+ for each site.
Compared to the M2a selection model, the covarion model contains only three extra param-
eters (δ, α, and β) for the REL implementation. For the FEL approach, the M2a model has
a single ω value because there is no need to model a ω distribution for a single site. In this
case there are therefore 5 extra parameters (two extra ω values, δ, α, and β) in the covar-
ion model. For both approaches, if δ = 0, switching is prohibited and the covarion model
reduces to the traditional selection model (Guindon et al., 2004). The models are therefore
nested and a likelihood ratio tests (LRTs) can be used to determine whether the data fit the
covarion model significantly better than model M2a. Huelsenbeck (2002) noted that the χ2
distribution with the appropriate number of degrees of freedom does not hold for the LRT
between the M2a and covarion models. The reason for this is that the simpler model (no
switching occurs between selection classes) has parameters on the boundaries of the param-
eter space, and in the current REL example, a mixture of χ20 and χ21 distributions provide a
more appropriate null distribution (Whelan and Goldman, 1999; Huelsenbeck, 2002; Ota et
al., 2000; Self and Liang, 1987). Huelsenbeck (2002), however, further made the point that
the 95% critical value for the general χ2 distribution with appropriate number of degrees of
freedom, is larger than the critical value when a mixture of χ2 distributions is used, which
means that the former, simpler, calculation provides a more conservative estimate (Ota et
al., 2000; Huelsenbeck, 2002). In the current study, a χ2 distribution with 3 (REL imple-
mentation) and 5 (FEL implementation) degrees of freedom was used as conservative tests,
with a further aim to to avoid potential errors as result of small sample sizes (Ota et al.,
2000; Huelsenbeck, 2002; Penn et al., 2008).
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6.2.2 Simulations
To test whether false inference of covariation was taking place, HyPhy was used to simulate
datasets under a codon model that specifies four rate classes: ω1 = 0.05, ω2 = 0.5, ω3 = 1.5
and ω4 = 3. Two subsets of sequences (30 and 100 taxa) from an HIV gag dataset for which
covariation was previously inferred (Penn et al., 2008), were used for the initial likelihood
estimation. The existing likelihood function for each dataset was then used to simulate 100
datasets of the same dimensions (sequence number and length), and with the same values of
parameters (transition/transversion rate ratio and codon equilibrium frequencies) as those in
the current likelihood function. Branch lengths and substitution rate bias parameters were
approximated with values derived from the nucleotide model. The simulated datasets were
then analysed with both the REL, and FEL, implementation of the M2a and the covarion
models. For the REL implementation, the fit of each simulated alignment to each model
was compared with a LRT. The number of simulated datasets that fit the covarion model
significantly better than the M2a model, formed the false positive estimate for each group
of simulations.
For the FEL implementation a random sample from each of the 100 simulated alignments
(for both the 30 taxon and 100 taxon datasets) was drawn, and the fit of the randomly
selected site to the covarion and M2a models was compared using a LRT. The false positive
rate for the FEL implementation, was estimated by counting the number of sites inferred
to fit the covarion model significantly better than the M2a model. Although these analyses
do not present a direct comparison of the rate of false positive inference of covariation
between the REL and the FEL models, the estimates nonetheless provide an indication of the
potential false positive rate when gene- (REL) and site-level (FEL) inference of covariation
are reported.
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6.2.3 Switching Between Rate Classes Associated with Zoonosis
Thirty-two HIV-1 group M and 9 SIV complete nonrecombinant genome sequences were
downloaded from the Los Alamos HIV sequence database (http://www.hiv.lanl.gov/). The
Genbank accession numbers are AB253421, AB253429, AF004885, AF005494, AF005496,
AF061641, AF075703, AF077336, AF082394, AF082395, AF084936, AF103818, AF190127,
AF190128, AF286237, AF286238, AF377956, AF447763, AJ249235, AJ249238, AJ249239,
AY169968, AY173951, AY253311, AY331295, AY612637, AY772699, DQ373063, DQ373064,
DQ373065, DQ373066, DQ676872, DQ853463, K03454, K03455, U42720, U46016, U52953,
U88824, U88826, and X52154.1 Two SIVcpzPts sequences, ANT (Genbank accession U42720)
and TAN1 (Genbank accession AF447763), which are commonly used as outgroups for HIV
and SIV alignments (Holzmayer et al., 2009; Van Heuverswyn et al., 2007; Wu et al., 2007;
Santiago et al., 2003; Huang et al., 2003; Santiago et al., 2002; Vanden Haesevelde et al.,
1996), formed the outgroup for all phylogenetic trees in the current study. A table indicat-
ing the sequence names and corresponding Genbank accession numbers is provided in the
Appendix (Table A2).
The analysis carried out here was focussed on identifying specific sites associated with switch-
ing between rate classes along the branch representing the zoonotic event that lead to HIV-1
group M sequences, since these are the viruses that account for the largest percentage of
HIV-1 infected individuals (Levy, 2007; Butler et al., 2007; Brennan, 2007; Kandathil et al.,
2005). Furthermore, the analysis follows on from the research carried out in the previous
chapters that were aimed at characterising the most common subtypes, which form part of
the group M viruses.
The genome alignment was separated into individual genes, and the overlapping codon
regions as well as the 3’ and 5’ LTR regions, were removed. The genes and sequence length,
of each dataset used for the analysis, is shown in Table 6.1. The rev gene was excluded from
the analysis due to the complete overlap with other coding regions.
1Dr. Nobubelo Ngandu carried out the initial sequence alignment.
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Table 6.1: Genes and sequence lengths used to determine the sites where switching between
rate classes, at the point of zoonosis, occurred.
The REL implementation of the covarion model was used for the initial likelihood optimi-
sation of the 8 sequence datasets. The ancestral sequences were then reconstructed using a
method available in HyPhy (Kosakovsky-Pond and Muse, 2005), which resulted in an align-
ment that included the rate class as an extra “site” at each codon position. The additional
fourth “site” represents either purifying selection (“A”), neutral selection (“C”), or positive
selection (“T”).
6.3 Results and Discussion
6.3.1 Simulation Study
Simulated datasets were generated to estimate the false positive rate of inference of covari-
ation. The motivation for performing the test was that underfitting through the use of too
few ω rate classes could result in an improved fit of the covarion model versus, for example,
a 3 rate class null model. In the case of the M2a model, there are the following three rate
classes: a purifying selection class (ω < 1), a neutral class (ω = 1) and a positive selection
class (ω > 1). If the true ω value for a given site falls between two of these rate classes, then
the covarion model would provide a relatively better fit for the data by switching between
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the omega categories. Therefore, if underfitting of the null model occurs as in the case
described above, it is likely that false positive inference of covariation may take place.
The REL implementation of the models provides gene-level likelihoods, whereas the FEL
implementation estimates the likelihoods on a site-by-site basis. Two sets of simulations, a
30 taxon dataset and a 100 taxon dataset, were evaluated with both models. The results
are shown in Table 6.2. For the REL implementation, the null hypothesis, that no switching
between rate classes occurred, was rejected 57 times (57%) and 100 times (100%) at the
5% significance level in the simulated datasets containing 30 taxa and 100 taxa respectively
(Table 6.2). This represents a significant excess over the expected 5% false positive rate.
With the FEL implementation, the null hypothesis was rejected 5 times (0.05%) at the
5% significance level in the 100 taxon simulated datasets. There were no false positive
inferences of covariation for the FEL analysis of the 30 taxon simulated datasets (Table
6.2). Although the FEL analysis was carried out on individual sampled sites (one from
each of the simulated datasets), the lack of false positive inferences of covariation is in stark
contrast with the clearly unreliable results obtained from the REL analysis.
Table 6.2: Number of false positives present in the two sets (30 and 100 taxa) of 100 simulated
datasets for the REL and FEL implementations of the M2a and covarion models.
The analyses demonstrate that underfitting, potentially through the use of too few rate
classes in the null model, can lead to a significant bias in the inference of covariation using
a REL approach. However, specifying an adequate number of rate classes for the null model
a priori is a difficult task, and could lead to overfitting of the data (Yang et al., 2000;
Yang and Nielsen, 2002). The FEL approach provides an alternative method for estimating
covariation; the false positive rate for the analyses on both the smaller (30 taxa) and the
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100 taxon datasets, was within the accepted range at the 5% significance level. However,
the model is computationally expensive and therefore difficult to apply, in practice. The
power of the FEL model to detect covariation at the gene-level is likely to be very low, since
the number of degrees of freedom scaled up from a site specific estimation is dependent on
the sequence length. Even for a relatively small dataset the LRT will be very conservative,
resulting in few false positives, but also lacking power to detect covariation.
The simulation study presents good evidence that false inference of switching may occur
when the REL approach is used to infer temporal inhomogeneity in evolutionary rate, and
the number of rate classes is inadequate in the null model. The validity of published studies
(Guindon et al., 2004; Penn et al., 2008) may therefore be brought into question, since the
frequency of switching may not be as high as previously thought. The results appear to be
significant particularly for datasets containing more than 30 taxa, which is less than what
is commonly used for maximum likelihood covarion evolutionary analysis (n = 182 for the
dataset used in Penn et al., 2008 and between 87 and 160 taxa for the datasets from Guindon
et al., 2004) .
The number of discrete rate classes specified in the null model is an important consideration
during studies of covarying evolution, since the REL implementation may be susceptible to
false positive inference of covarying evolution. The false positive rate is significantly reduced
when the FEL approach is implemented and, given sufficient computational resources, it may
provide an effective alternative for the REL model.
6.3.2 Evaluating Switching Between Rate Classes Associated with
HIV-1 Zoonosis
The REL implementation of the covarion model was applied to 8 non-overlapping gene
alignments (env, pol, gag, tat, vpu, vpr, vif, and nef ) containing HIV (n = 32) and SIV (n =
9) sequences. In section 6.3.1 it was shown that this method can produce a high level of false
inference of rate switching at the gene level. It is possible that the site-specific inference
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of rate switching is also prone to false positive inference using the REL implementation;
however the FEL approach is computationally intensive and was not applied to the real
data due to time constraints.
The ancestral sequences were reconstructed by applying a method available in the HyPhy
package. The rate class at each site could be read directly from the reconstructed ancestral
sequences, since the rate classes were incorporated into the sequence as an extra character
at each site, that is, a fourth position where “A”, “C”, and “G” represent ω− (purifying
selection), ωN (neutral class), and ω+ (positive selection), respectively. Similarly, the most
probable rate class at each site for the terminal sequences were available from the resulting
alignment containing both the ancestral and descendant sequences. With these data, as well
as a phylogenetic tree depicting the position along the tree where zoonosis occurred, it was
possible to determine which sites switched between rate classes at the point of zoonosis.
As an example, the analysis carried out on the gag gene is shown. The phylogenetic tree
relating the gag sequences is shown in Figure 6.2. The branch between node “Z” and “X”
(Figure 6.2) represents the time at which the zoonotic event took place. Because the aim
was to identify HIV-1 group M sites that switched between rate classes upon entering the
human host, the focus was on the changes that occurred along this branch. Thirty-five rate
switching sites were found along this branch for gag; for 6 sites the results indicated a shift
from the purifying to the neutral selection class, and for 29 sites a rate switch from the
neutral to the purifying selection class. The complete results for all 8 HIV-1 genes included
in the study, is shown in Table 6.3.
142
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Figure 6.2: Neighbour-joining phylogenetic tree relating the HIV and SIV gag gene se-
quences. The branch between the nodes marked “Z” and “X” indicates where cross-species
transmission is thought to have occurred. The black branches lead to HIV sequences, and
the blue and green branches to SIV sequences. The green branch represents the outgroup
(33_CPZ_CD and 41_CPZ_TZ).
143
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Table 6.3: Number of sites inferred to have switched between rate classes along the branch
on which zoonosis is inferred.
A total of 129 sites were inferred to have switched between rate classes along the branch
of the tree leading from SIV to the HIV-1 group M sequences. The predominant observed
change was from neutral (ωN) to purifying (ω−) selection, which accounted for over 80%
(105/129) of the switches. The next most frequently observed change was in the opposite
direction, from neutral to purifying selection (18/129). Switching from positive (ω+) to neutral
selection (1/129), and from neutral to positive selection (5/129) constituted the remainder of
the switching sites. No rate switches were observed between the purifying and positive
selection rate classes.
It is interesting that all the sites inferred to switch between the positive and neutral selec-
tion classes were from two of the accessory HIV-1 genes, vpr and vpu. The change from
neutral to positive selection upon transmission to the human host may reflect adaptation
to new immune pressures, for instance, modification to escape CTL responses. For vpu, all
three ωN -to-ω+ switching sites were within known CTL epitopes, which fits the hypothesis
of immune escape. In vpr, only one of the two sites inferred to switch from ωN to ω+, and
the single ω+-to-ωN switching site, were within known CTL epitopes. This may illustrate
varying CTL immune pressures between the two species. However, in the vpr and tat phy-
logenetic trees the HIV-1 sequences were not monophyletic, and thus it was not possible to
localise the zoonosis to a specific branch (Figure 6.3). This could be the result of the short
sequence lengths (210 nt for vpr and 117 nt for tat), or alternatively for vpr, the interspersed
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HIV and SIV sequences could potentially be due to the conservation of the vpr gene across
all the primate lentiviruses (Stivahtis et al., 1997). The numbers of switching sites (Table
6.3) for these two genes were obtained by counting the changes along the branch that lead
to the majority of HIV-1 sequences, even though these clades also contained SIV sequences
(Figure 6.3). The results for these genes may therefore not present an accurate picture of
the change in selective pressure associated with zoonosis.
Figure 6.3: Neighbour-joining phylogenetic trees for (A) tat and (B) vpr. The branches
leading to SIV sequences are labelled in blue (or green for the outgroup). The zoonotic
event could not be resolved clearly from these trees, and the switches along the branches
between points marked “Z” and “X” were therefore counted.
Since recombination can affect positive selection results (Anisimova et al., 2003; Shriner et
al., 2003), GARD (Kosakovsky-Pond et al., 2006b) was used to test whether any evidence of
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recombination was present in the gene alignments. GARD found evidence for recombination
in 7 of the 8 datasets (no recombination breakpoints were found for tat). The covarion
model assumes that a single phylogenetic tree represents the sequence history of the entire
alignment; recombination results in a violation of this assumption and may therefore have
affected the results. Although recombination has not specifically been shown to cause false
positive inference of switching, it remains a caveat of the covarion, as well as any other,
phylogenetic models.
In order to further characterise the rate shifts associated with zoonosis, the proportion of
switching sites per gene alignment used in this study (excluding the overlapping regions)
was calculated (Table 6.4). The largest percentage of gene-sequence sites inferred to switch
between rate classes, was found in the vpu gene. Out of 15 switching sites, 11 were inferred to
switch from neutral to purifying, 1 from purifying to neutral, and 3 from neutral to positive
selection.
Table 6.4: Percentage of inferred switching sites in each of the 8 HIV-1 group M gene
sequence datasets analysed.
Among the roles Vpu has during HIV-1 infection, is to down-regulate CD4 glycoprotein levels
and increase viral loads (Li et al., 1995; Bour and Strebel, 2003). Furthermore, a study on
pig-tailed macaques revealed that defective vpu (mutated start codon) reverted to functional
form within 16 weeks post-infection, and that this reversion was associated with higher Env
and Nef diversity (McCormick-Davis et al., 1998; Bour and Strebel, 2003). McNatt et al.
(2009) recently reported a further function of vpu as an antagonist of the primate antiviral
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protein, tetherin. Tetherin inhibits the release of emerging viruses from HIV-1 infected cells;
however, Vpu interferes with the localisation of tetherin to these emerging HIV-1 virions,
thereby counteracting the antiviral activity (McNatt et al., 2009). Interestingly, the authors
also show that Vpu has adapted independently to retain functionality against the human
and chimpanzee forms of tetherin (McNatt et al., 2009).
Collectively, these studies suggest that vpu plays a very important part during HIV prolifer-
ation within a new host. It is therefore likely that, following a zoonotic episode, the stability
of a functional form of this gene is essential for initial survival. However, notwithstanding
the potential role of vpu after SIV cross-species transmission, the SIV sequences for the vpu
gene used in this study displayed high variability and could not be aligned with confidence;
the poorly aligned areas may therefore have affected the identification of rate switching sites.
The observation that the large majority (~80%) of switching sites involved a change from the
neutral to purifying selection class, may illustrate increased evolutionary constraints acting
on the virus upon transmission to humans. To evaluate this hypothesis, the proportion of
sites within each rate class was tabulated (Table 6.5). The percentage of sites estimated to
belong to the purifying selection class was larger in the HIV-1 MRCA than the SIV sequence
ancestral to the HIV-1 MRCA, for all genes. This suggests an overall shift towards purifying
selection, similar to the findings shown in Table 6.3. Further investigation revealed that
the increase in number of sites estimated to be evolving under purifying selection persisted
along the branches leading to the HIV descendant sequences (data not shown). These
results suggest that, upon entering the human host, HIV-1 protein-coding regions evolved, on
average, under greater selective constraints, which resulted in an increase in the proportion
of sites evolving under purifying selection.
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Table 6.5: Percentage of sites in the HIV-1 MRCA sequence as well as the SIV sequence
ancestral to the HIV-1 MRCA (node Z in Figure 6.2), inferred to belong to each rate class.
*Node Z refers to the node ancestral to the MRCA of the HIV-1 sequences (see Figure 6.2).
The different evolutionary constraints acting on the virus within humans and chimpanzees
may be due to the specific immune pressures present in each species. A recent study indicated
that CTL responses in humans, directed by specific HLAs, caused adaptation of the virus
upon initial cross-species transmission (Ngandu et al., 2009). However, the results obtained
in the present study do not provide evidence of sites switching to positive selection. There
does, however, appear to be a shift towards a higher rate of purifying selection in humans.
The observation that the large majority of rate shifts are towards the purifying selection
rate class, further suggests that the evolutionary constraints acting on HIV-1 protein-coding
sequences are, on average, greater in humans compared to the constraints affecting the
evolution of the SIV ancestral viruses in chimpanzees. This may potentially be due to
a narrower, more focussed, immune response in humans than that of chimpanzees. Future
work could include simulation studies to estimate the false positive rate of switching between
rate classes when a method that incorporates ancestral sequence reconstruction is used.
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6.4 Conclusions
The covarion model of sequence evolution is a valuable extension to the more general codon
selection models, since identifying sites that switch between different rate classes over time
may reflect important adaptations to deviating external pressures. However, using simula-
tions it is shown that apparent covariation (switching between rate classes) may, in some
cases, be an artifact of under-fitting of the distribution of rate classes with a discrete null
model. If the number of discrete rate classes does not adequately fit the ω distribution, the
covarion model of evolution may provide a statistically better fit for the data even though
no shifts between rate classes have occurred. A site-by-site model of covarion evolution is
shown to overcome the high false positive rate associated with the gene-level model; however,
due to the computational burden of the site-specific model, it does not perform well as a
feasible alternative method to detect selection class switches. Future work could contribute
to the development of a covarion model that provides a practical approach for carrying out
gene-level inference of covariation. Future analysis could further include testing the power of
the various methods to detect rate shifts, which would provide an indication of the strengths
and weaknesses of each method.
Despite the problems with false positive inference of covariation, it was possible to charac-
terise the sites implicated in rate switching after the cross-species jump of SIV to humans.
A total of 129 switching-sites were identified, and the most prevalent change was from the
neutral to the purifying selection class. The largest proportion of switching sites were iden-
tified in the HIV-1 accessory gene, vpu, suggesting that the selective pressures acting on
this protein differed upon transmission to the new host. The overall proportion of viral
sites evolving under purifying selection was higher in humans than chimpanzees, which sug-
gests that greater evolutionary constraints, potentially due to a narrower immune response,
acted on the virus after cross-species transmission. Future laboratory research could reveal
whether minor changes to the inferred founder HIV sequence affects the fitness of the virus
and/or viral replication and proliferation. These results may provide further insight into the
evolutionary history of HIV-1 and the sequence characteristics that allowed SIV to infect
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humans.
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Concluding Remarks
The work carried out in this thesis focussed on the broad topic of HIV evolution, but
particular attention was given to the early stages of infection. The sequence changes that
occur during this phase, during which the virus first encounters the host immune system are
important for the virus’ initial survival in the newly infected host. Several mutations, as well
as insertions and deletions, may contribute to the overall fitness of the virus. Identifying
these changes is important for vaccine and prophylactic drug design, since anti-HIV agents
that are effective during the earliest stage of infection could prevent further viral replication
and proliferation. Describing the characteristics of early HIV infection is therefore a valuable
and important step in the process of establishing effective treatment strategies.
In Chapter 2 a Bayesian method that samples phylogenetic trees relating a sequence align-
ment, was used to estimate the time to the most recent common ancestor of multiple early
infection sequence datasets. The estimated time needed for all the sequences to coalesce
to a single founder was compared to the clinical estimate of the time since infection. The
comparison between the coalescent estimate and the laboratory staging allowed for classi-
fication of 171 early infection isolates into either homogeneous or heterogeneous infections.
Identifying the actual virus that is transmitted provides valuable insight into the number
of viruses that successfully enter a new host and cause productive infection. Furthermore,
identifying the founder allows for further investigation of the sequence characteristics of the
virus that overcomes the barriers encountered during transmission. These sequence features
may be essential for initial viral survival and may present important targets for vaccine
and drug design. This was the aim of Chapter 3, where the HIV subtype B homogeneous
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infections (n = 81) identified in the first chapter were combined to form a single dataset
representative of the earliest stages of infection. If similar mutations are present across a
large sample of virus’s isolated during early infection, then the changes may illustrate char-
acteristic evolutionary patterns essential for early survival of the virus. Positive selection
analysis was carried out on the homogeneous dataset and 24 adaptively evolving sites were
identified. Further investigation suggested that early evolution of HIV frequently selects for
changes that lead to CTL immune escape, and that APOBEC3 is likely to play a role in the
dynamics of this early immune evasion. The results from this chapter provide supporting
evidence that concentrated regions of diversification are associated with CTL escape during
early infection.
Chapter 4 was aimed at describing further sequence characteristics of HIV that are specif-
ically features of early HIV infection. Previous publications have reported that the Env
variable loop lengths of viruses isolated from early infection are shorter and contain fewer
potential N-linked glycosylation sites that those present in chronic infection. However, the
shared history of the sequences was often not accounted for and this is shown to be a
potential source of bias. A method that accounts for the phylogenetic relatedness of the
sequences was developed in this chapter. The method was applied to a subtype B datasets
previously reported to contain significant differences between the variable loop length of
early and chronic infection sequences. Although the results were confirmed with the method
that accounts for the shared history of the viruses, the statistical evidence for the results
suggesting a significant difference, was more marginal than the originally reported result.
Further analysis revealed an association between the variable loop length and stage of dis-
ease. The results from this chapter support previous reports illustrating that changes in the
env variable loop length and number of PNGSs are a characteristic of early HIV infection.
The focus of Chapter 5 was to evaluate the impact of recombination on previously pub-
lished analyses of adaptive evolution in HIV-1 protein-coding sequences. Reanalysis was
carried out using a method that takes recombination into account, since recombination can
cause a significant bias in positive selection results. If recombining sequences are present
in a dataset, a single bifurcating phylogenetic tree cannot be used to represent the evo-
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lutionary history of the sequences. This is often not accounted for by the evolutionary
models used to infer positive selection in coding sequence, which may result in a high rate
of false positive inference of adaptive evolution. In this chapter a method that accounts
for recombination (PARRIS) was applied to several previously analysed HIV-1 datasets and
the results suggested that recombination has a marked effect on positive selection results;
PARRIS provided more conservative estimates for the evidence of positive selection, and far
fewer sites were identified in the site-specific analysis. PARRIS provides results that include
fewer false positives than methods that do not account for recombination; furthermore, the
results obtained in this chapter included only a proportion of the sites originally reported
to be evolving adaptively. Collectively, these findings suggest that the site-specific results
estimated by PARRIS present a more accurate set of sites undergoing positive selection
than those reported in the original publications. These results are very promising for future
positive selection analysis of recombining coding sequences.
The aim of Chapter 6 was twofold; the covarion model of sequence evolution was evaluated to
investigate the extent of false positive inference of rate class switching, and the covariation of
sites associated with the zoonotic episode, during which SIV successfully infected the human
species, was estimated. High false positive results were found for the gene-level approach to
model covarion evolution. Since many previously published studies focussing on selection
class switches have used the same covarion model, the validity of the reported results may
be questionable, and the conclusions may need revisiting. To address the second aim of
the chapter, ancestral sequences representing the evolutionary history of a group of SIVcpz
and HIV-1 group M sequences, were reconstructed. The implementation of the covarion
evolutionary model allowed for the identification of sites that shifted between selection classes
along the branch leading from SIV to the most recent common HIV-1 ancestor. The main
switch occurred between the neutral and purifying selection class, which accounted for more
than 80% of the individual site switches. Furthermore, an increased proportion of viral
sites was estimated to be evolving under purifying selection after SIVcpz transmission to
humans. These results suggest that the evolutionary constraints acting on the virus present
in chimpanzees and humans are different, and that these constraints are, on average, greater
in humans.
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The analysis carried out in this thesis showed that, although extremely useful for evolution-
ary and comparative research, computational models that fail to account for key features
of HIV-1 evolution may lead to invalid conclusions. Several previous studies that aimed to
describe HIV evolution therefore need revisiting. These include phylogenetic models of pos-
itive selection that neglected the effects of recombination, comparisons of sets of sequences
(for example isolated from early versus chronically infected patients) that did not take into
account the effects of phylogenetic linkage, as well as published reports on HIV covariation.
Methods that account for these features could lead to more accurate results, thereby pro-
viding a more focussed set of amino acid sites potentially implicated in HIV adaptation and
escape from antiviral drugs.
The high degree of HIV diversity is currently one of the main obstacles to developing a
broadly-effective vaccine. Characterising the transmitted virus during the earliest stages of
infection is therefore an important step towards designing effective antiviral compounds. In
this thesis it was possible to identify infections caused by a single viral strain in a large group
of recently infected individuals by using a Bayesian approach together with available clinical
data. This amalgamated homogeneous dataset provided, for the first time, the opportunity
to characterise the selective pressures present during the earliest period of infection. A
detailed analysis of this founder virus dataset showed that HIV adapts to evade CTL immune
responses, and that APOBEC3 may be implicated during early immune escape. These
results further our understanding of the nature of HIV evolution, and provide valuable
insight into future endeavours to develop vaccines and antiviral drugs.
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Table A1: Observed mutations, sequence context within specific patients, and possible
alternative explanations besides selection.
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Table A2: Sequence names and corresponding Genbank accession numbers for the HIV and
SIV sequences used for the evaluation of zoonosis.
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